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Abstract 
Many patients who suffer from aortic valve dysfunction are too weak to be 
eligible for valve replacement via surgery, due to co-morbidities and old age. 
Transcatheter aortic valve (TAV) implantation has been developed as an 
alternative to surgery, enabling replacement of the dysfunctional valve 
percutaneously. However, the inability to remove the native leaflets leads to the 
bioprosthetic being held in place inside a pseudo-cylindrical structure. The 
passive nature of heart valves means the surrounding fluid environment’s 
dynamics are critical in producing optimum performance, and would ideally be 
returned to the healthy, physiological state. The association of TAVs with 
thrombotic events, such as strokes, has not yet been fully explained. 
A pulse duplicator and particle image velocimetry were used to model and 
characterise the flow fields of a healthy, physiological aortic root and valve, 
which was then compared to those resulting from a number of typical post-
surgical outcomes, identifying the fluid mechanisms promoted by the root 
geometry to optimise the ejection and closing phases of the cardiac cycle, and 
revealing the importance of an optimal integration of valve and root architecture, 
and characterising common post-surgical environments. 
The same techniques were then used to examine the flow dynamics of the 
region following TAV implantation, revealing the effect of TAV alignment with its 
hosts’ commissures, and how the presence of native leaflets, commonly omitted 
from in vitro TAV testing, affect the valve performance. Slow and stagnant flow 
was observed within the sinuses due to the native leaflets, whilst global valve 
performance was broadly unaffected, and omission of the native leaflets 
resulted in improved haemodynamic performance.  
A model of coronary arteries was incorporated into the benchtop simulation, 
revealing increase of flow in the upper coronary sinuses, but flow at the base of 
all sinuses remained very slow following TAV implantation. The elucidation of 
this stagnation, associated with thrombotic events, provides an explanation for 
the increased levels of thrombotic-associated pathologies following TAV 
implantation. 
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Impact Statement 
The research in this thesis provides a link between the hydrodynamics of the 
aortic root following TAV implantation and the thrombotic events reported in 
medical follow-up examinations and morbidity reports. Improvements to each 
generation of TAVs since their first use on patients in 2002 have increased the 
life duration and quality to their recipients, and this has been achieved by critical 
examination of existing designs to inform and improve the following devices, 
reducing the para-valvular leakage and enabling redeployment during the 
implantation procedure. By showing that the continued presence of the native 
leaflets following TAV implantation produces flow alterations that tend towards 
the thrombogenic, design steps in the next generation of TAV devices can be 
taken to remove or mitigate this feature, reducing the likelihood of thrombosis 
and improving the outlook for patients post-TAV implantation. 
The demonstration of the need for accurate modelling of the geometrical 
arrangement of the valve and root when simulating aortic root flow has also 
been shown. The scientific community has yet found consensus on the vortical 
structure surrounding the systolic flow of blood from the aortic valve, and some 
of the characterisations have been reproduced in this thesis by placing the 
valve in over-sized roots or in a sub-annular position. This information has been 
disseminated in both written form, via articles in the Journal of Biomechanics 
and the Journal of Cardiovascular Engineering Technology and a book chapter 
in ‘Transcatheter Aortic Valve Implantation: Clinical, Interventional, and Surgical 
Perspectives’, and aurally, via a presentation at the 4th European Society for 
Vascular Surgery Spring Meeting 2016. 
There are also numerous in vitro reports on the performance of TAV devices 
that neglect to include a representation of the native leaflets, affecting both the 
global and local flow properties of the region, particularly within the modelled 
sinuses of Valsalva. This has been submitted for publication in the Journal of 
Cardiovascular Research, and has been presented at the British Cardiovascular 
Society Conference 2017, and the UCL Institute of Healthcare Engineering 
Autumn Research Symposium 2018. 
The modelling of coronary arteries is of importance to a study of the sinuses in 
the aortic root region, and this thesis has demonstrated a method of including a 
representation of these within a benchtop model. 
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1 Introduction 
1.1 Background 
The most frequent heart valve disease in the western world is aortic stenosis, a 
pathology of the leaflets of the aortic valve which drastically reduces its 
functionality, significantly affecting the life quality of the patient, and is strongly 
linked with high morbidity and mortality1–3. Due to its association with elderly 
patients4,5, occurrence of aortic stenosis is expected to increase in the next 20 
years alongside the world’s ageing population2,3. The progression of most cases 
of aortic stenosis cannot be reversed or prevented via pharmacological 
treatments6, and when the stenosis is judged to be too severe for the patient’s 
well-being, the native valve requires replacement7. 
Prosthetic devices have been developed and surgically implanted over the last 
70 years, in order to restore valve function to the patient. Mechanical 
prosthetics, typically utilising hinged rigid leaflets8, display high levels of 
durability, but require lifelong anti-coagulation therapy due to the 
thrombogenicity of the materials and fluid flow patterns9. Bioprosthetic aortic 
valves, often constructed from porcine or bovine pericardium in a trileaflet 
arrangement mimicking the native aortic valve, can also be surgically implanted, 
more closely maintaining the natural blood flow of the heart and reducing the 
necessity of anti-coagulant therapy8. 
However, due to the debilitating effects of aortic stenosis and other co-
morbidities, up to third of patients requiring valve replacement are ineligible for 
surgery10,11. A novel percutaneous treatment has been developed, wherein a 
Transcatheter Aortic Valve (TAV) can be delivered to the aortic region without 
the need for surgery, reducing the associated risks of surgery and length of 
hospital stays12, with the devices anchored in place by expansion of a 
supporting frame onto the leaflets of the native valve. These benefits are offset 
by the reported increased incidence of pathologies associated with thrombosis, 
such as strokes and silent ischemic events, when compared with surgical 
bioprosthetics, and it is crucial to understand and minimise these problems to 
improve the efficacy of TAVs13–16. Non-physiological haemodynamics, such as 
stagnation and high shear stress, have been identified as a major cause of 
platelet activation and thrombus formation17, and ischemic lesions have been 
previously linked to thrombus formation in the irregular zone around the TAV 
frame16. Identification of the hemodynamic alterations caused by TAV 
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implantation is critical in reducing their occurrence and resultant pathological 
effects. 
1.2 Overall Aims 
 In order to identify the changes to the haemodynamics of the aortic root region 
caused by TAV implantation, it is first necessary to identify the fluid dynamics of 
the healthy native physiological condition, upon which there have been many 
studies in the literature but no consensus, particularly in regards to the systolic 
vortical patterns downstream of the aortic valve18,19,28–35,20–27. Newly refined 
methods of flow visualisation can clarify these valve dynamics, and subsequent 
analysis of the flows associated with mechanical-, surgical bioprosthetic-, and 
transcatheter-aortic valves can then be compared to the characteristics of the 
physiological flow, revealing the alterations caused by each non-native device. 
For this thesis, these investigations were in vitro experiments, using a 
hydromechanical pulse duplicator to impose physiological pressures and flow 
rates upon the blood analogue fluid flowing through various prosthetic devices 
within mock aortic roots, with simultaneous image acquisition for Particle Image 
Velocimetry (PIV) analysis, enabling instantaneous velocity fields of a cross-
section of the fluid flow to be derived. 
To ensure proper testing conditions, some preliminary tests needed to be 
undertaken. Uniaxial tests measuring the stress-strain response of the 
biological tissues used in the bioprosthetic Surgical Aortic Valves (SAV) were 
required, to ascertain whether their stiffness changed after exposure to the 
chemicals used in typical testing fluids, and are presented in the appendices. 
Hydrodynamic and PIV analysis of the valve size and position within the mock 
aortic roots was necessary to reveal their effect upon the fluid dynamics of the 
test, explaining some of the inconsistencies of flow characterisations in the 
literature. Once these testing procedures were confirmed, the fluid dynamics of 
the physiological-, mechanical-, and surgical bioprosthetic-aortic valve 
environments were identified and contrasted, to reveal the characteristic 
changes caused by surgical intervention. Finally, the fluid flow alterations 
caused by implantation of a TAV were investigated and characterised, taking 
into account the variation of the device’s rotational alignment with the native 
commissures and the effect of coronary flow. 
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1.3 Thesis Outline 
The remainder of this thesis is structured as follows: the following chapter 
focuses on reviewing the relevant literature to present the current 
understanding of the fluid dynamics within the healthy native aortic root, the 
most pertinent pathologies that can affect the region, and the prosthetics that 
have been used to replace a diseased aortic valve and the fluid dynamics that 
result. Chapter 3 explains the materials and methods used to investigate and 
characterise these fluid dynamics, describing the hydro-mechanical pulse 
duplicator and PIV equipment used to simulate and analyse the flows generated 
within mock aortic regions, designed to recreate both a healthy native aortic root 
region as well as a range of post-valve replacement environments. This is 
followed by descriptions of the valves, roots, and blood analogue testing fluids 
used for these recreations. 
The three experimental chapters examining the global and local fluid flow of the 
aortic root region follow, with Chapter 4 establishing the flow characterisation of 
the healthy native aortic root, and contrasting this description with the acquired 
flow fields from typical post-surgical aortic valve-root configurations, both 
bioprosthetic and mechanical. This chapter demonstrates how changes to the 
geometry of the root and/or valve, often as a result of surgical valve 
implantation, can result in distinct alterations to the vortical patterns during the 
forward flow of blood through the valve, impacting the efficiency of the heart. 
Chapter 5 determines the fluid dynamic alterations due to implanting a TAV 
rather than a surgical valve, including the effect of non-alignment of the TAV 
with its host valve commissures, which results in little change to the 
haemodynamics performance of the valve, but affects sinus washout and 
vortical patterns downstream of the TAV. Chapter 5 also examined the impact 
of modelling the native leaflets during the in vitro TAV assessment, the 
exclusion of which can give a false indication of higher valve performance than 
would be expected physiologically. Chapter 6 investigates the same aortic root 
region after TAV implantation, but with the inclusion of modelling coronary 
artery flow, examining whether these additional outlets of flow affect the 
dynamics within the root, particularly in the chambers surrounding the valve. It 
was found that the upper sinus flow of the coronary sinuses featured more 
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washout and structured flow than the non-coronary equivalent, but that the 
lower sinus flow remained slow in all cases, indicating a risk of thrombosis. 
Chapter 7 then draws together the presented work, discussing the main findings 
of the work, and providing recommendations for future investigations. 
Finally, the appendices contain a full description of the uniaxial testing carried 
out to determine the stiffness of porcine and bovine pericardial tissue before 
and after prolonged exposure to typical in vitro testing fluids, undertaken to 
ensure that the dynamic response of the bioprosthetic valves at the end of 
testing was the same as at the beginning of testing. Further PIV images from 
Chapters 4-6 follow, placed in the appendices to improve the clarity and 
succinctness of the presented reports in the main body of the thesis. 
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2 Literature Review 
2.1 The Aortic Root 
2.1.1 The Heart 
The function of the cardiovascular system is to supply oxygen, hormones and 
nutritious substances to the tissues of the body and, for some species, to 
regulate body temperature and pH2. The heart pumps blood through the 
circulatory system of the body via ventricles which provide this blood with the 
momentum to circulate around the body and return to the heart, and a series of 
valves to ensure that this blood flow is unidirectional2,36, with a cross-sectional 
schematic illustrated in Figure 2-1. For a healthy human, the heart beats on 
average 60-80 times a minute, with each heartbeat being made up of muscular 
contraction (known as the systolic phase, or systole) and muscular relaxation 
(known as the diastolic phase, or diastole) of the ventricles and atria. These 
contractions are induced by electrical stimulation which is paced by a node in 
the right atrium known as the sino-atrial node36,37, and these electrical signals 
can be detected via an electrocardiogram (ECG), with a typical resultant 
waveform displayed in Figure 2-2. 
 
Figure 2-1: schematic of the heart, with indication of local blood flow direction. 
Oxygenated blood in the left side of the heart is illustrated with red shading, and 
deoxygenated blood in the right side of the heart with blue38 
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Figure 2-2: Left Side Cardiac Cycle. (a) variations of pressure in the aorta, left 
ventricle, left atrium; (b) variation of left ventricular volume; (c) an electrocardiogram for 
a typical cycle of the left side of the heart39 
The heart is comparted into two halves, with deoxygenated blood returning from 
the body into the right atrium, from where it is pumped into the right ventricle 
which in turn pushes the blood towards the lungs, as illustrated in Figure 2-1. 
The oxygenated blood then returns from the lungs into the left atrium, is 
pumped into the left ventricle, from where the blood is impelled to the rest of the 
body via the left ventricle2,36.  
For the left side of the heart, blood is delivered to the atria throughout the 
cardiac cycle. Pressure and volume variations in the left side of the heart 
through a typical cardiac cycle are shown in Figure 2-2. During ventricular 
diastole, the pressure in the ventricle is lower than the pressure of the 
associated atrium, and as such the mitral valve, connecting the two, is open, 
whilst the downstream valve of the ventricle, the aortic valve, is shut during this 
period, as the pressure in the aorta is higher than that in the ventricle2,37. This 
allows filling of the ventricle with blood from its atrium throughout diastole, 
initially passively, but when atrial systole occurs towards the end of ventricular 
diastole, commencing at ECG signal ‘P’ and throughout the ‘a wave’ illustrated 
in Figure 2-2, the contraction of the atrial muscle wall pushes an extra, small 
amount of blood into the ventricle2,37. As the ventricle contracts, the pressure 
rises, and when it rises above the atrial pressure (shutting the mitral valve) but 
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remains below the aortic pressure, neither the mitral nor the aortic valve are 
open, as the ventricle experiences isovolumetric contraction (IVC), and the 
pressure continues to rise whilst the volume remains constant2,36,37. Once the 
ventricular pressure rises above the aortic pressure, typically around 80 mmHg, 
the aortic valve opens, and an ejection phase commences, known as 
ventricular systole2. After a period of ejection, the myocardial contraction reverts 
and the ventricular muscle starts to relax, leading to the pressure in the aorta 
becoming greater than in the ventricle, resulting in the aortic valve shutting, 
preventing backflow of blood. As the atrial pressure is still lower than the 
ventricular pressure, the mitral valve remains shut, resulting in isovolumetric 
relaxation (IVR) as the pressure continues to drop in the ventricle and the 
volume remains constant. When the pressure eventually drops beneath that of 
the atrium due to both IVR and atrial filling, the mitral valve opens, filling of the 
ventricle commences, and the cycle starts over again2,37. 
A typical human heart rate is around 70 bpm at rest, resulting in a cycle length 
of ~850 ms, with the ejection period lasting ~330 ms36,40. 
2.1.2 Anatomy of the Aortic Root 
The aortic root, illustrated in Figure 2-3, consists of: 
• the aortic annulus, the transition between the left ventricle and the aortic 
root; 
• the aortic valve 
• the sinuses of Valsalva (SoV), bulges of the aortic tract, each bulge 
aligned with an aortic valve leaflet, and two of these dilations each 
house a coronary ostium; 
• the sinotubular junction (STJ), where the transversal cross-section of the 
aortic lumen becomes approximately circular, indicating the transition 
between the dilations of the SoV and the tubular ascending aorta and 
the downstream end of the aortic root, and also the furthest downstream 
point of the attachment of the aortic valve leaflets41–44 
Due to pressure changes and the compliance of the root walls, the dimensions 
of the aortic valve and root vary throughout the cardiac cycle27,45. 
Measurements of the diameters of the aortic root region show notable 
variability across different sources in the literature, as shown in Table 2-1, 
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which may be due to a combination of anatomic variability and the difficulty of 
ascertaining the dimensions of a pressurised, fluid filled architecture once 
removed from its dynamic environment46,47. 
 
Figure 2-3: The aortic root. (a) cross-section of the aortic root and schematic of the 
aortic valve, adapted from Gripari 201448; (b) cross-section of the aortic root showing 
the leaflets49; (c) 3D modelled of the aortic root 
Some reports state that when normalised against the annulus, the dimensions 
of the aortic root are proportional for men and women47, although other 
investigations report that this changes with age46. The diameters of the annulus, 
the sinuses of Valsalva, and the STJ all increase in relation to body surface 
area after the age of 2050. Some works in the literature indicate that this 
increase occurs at a similar rate for both sexes47 but other reports state the rate 
of annulus diameter increase with age is higher for men46. 
It should be stressed that the diameter of the aortic annulus can be identified as 
different parts of the aortic root anatomy, and the annulus referred to by 
surgeons is usually the ‘crown-like structure demarcated by the hinges of the 
leaflets’, as described in Figure 2-451. Future reference to the aortic annulus 
diameter will be in relation to the basal attachment virtual ring as described by 
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Piazza et al.51 unless noted. In between the annulus and the semi lunar 
attachment of the valve leaflets are located the interleaflet triangles, as 
illustrated in Figure 2-3(a), composed of fibrous tissue, and separating the 
leaflets from each other52. Two of these triangles have thickened basal 
connections to the annulus, one housing the bundle of His, essential in the 
correct conduction of electrical signals required to control the beating of the 
heart, and the other connecting the aortic and mitral annuli51,53. 
 
Anatomy 
𝐷PQ (mm) DRSDRT 
Vriz47  Davis46  Vriz Davis 
Annulus 21.0 ± 2.2 23.9 ± 5.3 1.00 ± 0.10 1.00 ± 0.22 
Sinuses of Valsalva 31.8 ± 3.7 31.9 ± 7.6 1.51 ± 0.18 1.33 ± 0.32 
Sinotubular Junction 26.9 ± 3.7 24.4 ± 6.2 1.28 ± 0.18 1.02 ± 0.26 
Ascending Aorta 29.1± 4.3 26.0 ± 7.3 1.39 ± 0.20 1.09 ± 0.31 
Table 2-1: Average diameters of aortic root anatomy for men of mass 76.7 ± 12.6 kg, 
presented both as an absolute value (𝐷𝑎𝑏, mm) and a dimensionless value relative to 
the annulus diameter (𝐷𝑎𝑛). The annulus for both investigations was defined as the 
basal annulus as described by Piazza et al.51 
 
Figure 2-4: Circular rings within the aortic valve. (a) the leaflets are suspended from the 
commissures in a crown-like arrangement, containing 3 distinct circular rings, one each 
at the STJ, the ventriculoarterial join, and the virtual ring formed by the basal 
attachment of the valve leaflets; (b) the rings and crown-like arrangement shown on an 
explanted aortic root with the valve removed 
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2.1.2.1 Aortic Valve 
The main function of any of the heart valves is passively ensuring that the flow 
of blood is uni-directional with minimal back flow into the chamber it has just 
flown from2,36. The aortic valve normally comprises of three crescent shaped 
leaflets, attached both to the aortic annulus, and to the aortic root in three 
separate regions, with the downstream leaflet cusps coapting during diastole to 
prevent backflow of blood, as illustrated in Figure 2-5(a). The regions where the 
leaflet conjugations run parallel, distally upstream towards the ascending aorta, 
are called the commissures44. Despite 84 % of case studies having a difference 
in leaflet size greater than 5 % within the same aortic valve50, these size 
difference between leaflets are thought to be insignificant44. Due to congenital 
disease, between 1 and 2 % of natural aortic valves are not tricuspid, but are 
instead bicuspid valves, which are associated with increased valvular 
dysfunction and pathological issues in later life, such as aortic valve stenosis34, 
which will be discussed in more detail in Section 2.2.1. 
For a normal sized adult, the main body of the valve leaflets is about 0.1 mm 
thick37, and consists of three types of tissue, as illustrated in Figure 2-5(b-d). A 
load bearing collagen-based layer on the aorta side called fibrosa is dominant in 
the mechanical response under high strain conditions, and a supplementary, 
elastin-based layer on the ventricular side called ventricularis that is effective in 
low strain conditions54–57. Separating these two tissues is a third, known as 
spongiosa, allowing the other two predominant layers to deform more easily 
relative to each other56,58. The whole leaflet is covered with a layer of 
endothelial cells similar to that coating the arterial walls37,52. This heterogenicity 
enables the leaflet to undergo large deformations during fluid-solid 
interactions55. The orientation of the ventricularis fibres results in a compliance 
that is three times higher in the radial than the circumferential direction56. Each 
leaflet has a coaptation region along its free edge, where the leaflets join 
together during closure, preventing back flow into the ventricle during diastole. 
These leaflets meet at a central nodule, known as a nodule of Arantius, halfway 
along the free margin, identified as a lunule44,52. 
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Figure 2-5: Aortic valve tissue structure. (a) systolic (top) and diastolic (bottom) 
transversal view of aortic valve; (b) schematic cross-section of leaflet cusp illustrating 
elastin and collagen in systole and diastole; (c) schematic of cellular and extracellular 
matrix architecture of leaflet, illustrating the ventricularis, spongiosa and fibrosa 
content; (d) low magnification photomicrograph of cusp cross-section during systole, 
with the outflow surface at the top. Image adapted from Schoen57 
The angles of the up- and down-stream edges of the leaflets during diastole are 
typically within a range of 17 – 28 ° and 31 ° - 37 ° respectively in relation to the 
basal annulus, as illustrated in Figure 2-6, both of which change to a range of 
89 – 99 ° in systole45. Leaflet angles of both the bottom and free edges change 
throughout the cycle, with the bottom edge angle, and the free edge angle 
varying between (with respect to the STJ) throughout diastole45. 
The shape of the orifice formed by the leaflet cusps during peak systole is not 
fully agreed upon in the literature, with some investigations reporting that the 
free leaflet edges form a triangular shaped orifice through which blood flows59–
61, whilst others describe a circular shape that tends towards a stellate outflow 
at lower blood flow or increased leaflet stiffness29,62,63. 
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Figure 2-6: Up- (denoted by 𝛼) and down-stream (denoted by ɸ) leaflet edge angles of 
the aortic valve, as reported by Thubrikar et al. 45 
2.1.2.2 Aortic Tract and Sinuses of Valsalva 
The SoV comprise of the bulges of the lumen downstream of the aortic valve 
forming three cavities, each positioned between a pair of valve leaflet 
commissures, as illustrated in Figure 2-3. The geometric proportions of the 
sinuses of Valsalva were initially considered as hemispherical64, but this 
assumption was soon revised by Swanson and Clark27, and more recently by 
Reul et al.65, who studied the transverse and sagittal plane views of the sinuses 
in depth. The SoV fulfil a number of functions that promote improved cardiac 
health and efficiency, including: reduction of valve cusp wear, both via improved 
stress distribution28 and prevention of cusp-wall impact66; promotion of superior 
haemodynamics within the root during systole19,67; modulation of the 
transvalvular pressure gradient68; increased opening of the aortic valve, 
especially at cardiac outputs above 5 l/min68; more efficient closure of the valve 
during diastole37,40,67,69. 
2.1.2.3 Coronary Arteries 
The heart requires oxygenated blood to be supplied to its muscle tissue, and 
this requirement is fulfilled by the coronary arteries (CA)40. The left CA (LCA) 
and right CA (RCA) originate in two of the SoV as indicated in Figure 2-3(c) and 
are typically positioned just upstream of the STJ, although this position varies, 
and the CAs may be closer towards the basal annulus of the aortic valve or 
above the STJ42,70. Optimal CA flow relies upon the haemodynamics of the 
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aortic root71,72, and the left CA is responsible for the blood supply of 75 % of the 
cardiac tissue, including the left ventricle40. 
If taken as a uniform diameter, typical CAs for a healthy adult male have a 
cross-sectional area of 4.8 mm2 73 after an initial ostium diameter of 4.1 ± 0.9 
mm for the LCA and 2.8 ± 0.9 mm for the RCA74. 
2.1.3 Dynamics of the Healthy Aortic Root 
Due to the cardiac cycle previously discussed in Section 2.1.1, there are four 
distinct stages that the aortic valve passes through – opening, open, closing, 
and closed. During valve opening, it is essential that the valve offers minimal 
resistance to the forward flow of blood, and that the leaflets reconfigure to 
provide the largest possible orifice area to conserve the optimum amount of 
pressure and energy within the forward flow75. At this point of the cycle, the 
majority of the valve resistance is related to the energy required to reverse the 
leaflet curvature of the shut configuration, as can be seen in Figure 2-5(a), and 
lowering the pressure difference required across the valve leaflets to achieve 
this results in reduced energy losses and lower levels of stress and strain 
across the leaflets75. 
Once the valve is fully open, the largest possible geometric orifice area (GOA) 
is desirable, in order to utilise as much of the aortic lumen as possible, again 
reducing energy losses. The GOA is defined as the smallest transversal section 
encompassed within the open leaflets at peak systolic pressure, but this is not 
directly related to the systolic performance of the valve. The effective dimension 
of the forward flow also depends on the contraction of the jet downstream of the 
GOA due to fluid flow through a constriction (i.e. from the ventricle through the 
aortic valve), the leaflet profile, and the size and position of the vortical 
structures found at the side of the central jet flow. As a result, a more indicative 
quantification of valve performance is the Effective Orifice Area (EOA), 
corresponding to the downstream point of the central jet flow’s maximum 
contraction76,77. The EOA is inversely proportional to the pressure drop across 
the aortic valve and directly proportional to the systolic flow rate, and its 
measurement is fully discussed in Section 3.2.2.2. The pressure drop across 
the valve, and hence the fluid energy losses, may also be increased by the 
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presence of turbulence associated with non-physiological random blood velocity 
fluctuations78. 
There is agreement that the valve closes due to a combination of reverse 
transvalvular pressure, as the ventricular pressure begins to decrease, and the 
action of vortices in the SoV, the latter of which are reported to guide the shape 
of the leaflets during forward flow and valve closure18. The regurgitant volume 
of blood passing back into the ventricle and loss of energy during forward flow 
is reduced by the synergy of these two mechanisms working together. In a 
reflection of efficient valve opening, the stress experienced by the leaflet tissue 
and energy loss of the flow can both be reduced by diminishing the resistance 
of the leaflet when changing configuration from open to closed, due to the need 
to reverse the leaflet curvature. Once the valve has completed closing, a cause 
of reduction in valve performance may result from intravalvular leakage of blood 
though the closed valve back into the ventricle, typically due to incomplete 
coaptation of the free edges of the leaflet cusps79, referred to as valvular 
incompetency. 
In summary, the energy lost through valve dysfunction is associated with 
transvalvular pressure loss, related to the EOA, when the valve is open, and 
with regurgitation when the valve is closing or closed80. 
2.1.3.1 Characteristics of Blood 
2.1.3.1.1 Rheology 
Blood is a two-phased suspension of formed elements, primarily comprised of 
red blood cells (RBCs, deformable and non-spherical formed elements which 
transport and deliver oxygen and carbon dioxide), within plasma, an aqueous 
solution of organic proteins, molecules and salts37,40. These constituent parts 
are a major factor in the non-Newtonian nature of blood, and as a result the 
viscosity of blood varies with shear, temperature, RBC concentration (known as 
the haematocrit) and aggregation, as described in Figure 2-7, amongst other 
factors37,40. Blood viscosity tends towards 3.5 - 4.0 cP at a shear > 100 s-1 and 
a temperature of 37 °C, which is normally reached by the relatively fast flow of 
blood as it exits the aortic valve81. RBCs undergo reversible aggregation in low 
flow or static conditions, causing an increase in blood viscosity and a decrease 
in blood fluidity as these aggregations, known as rouleaux, form in the blood 
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stream, although a subsequent increase in the local shear forces may disperse 
these rouleaux37,82. Healthy endothelium, the cells lining the interior surface of 
blood vessels, senses and responds to the shear stress levels of the 
neighbouring blood, contributing towards maintaining the alignment and 
functionality of the endothelial cells83. RBCs do not usually interact with 
endothelial cells, but there are reports that RBCs may be incorporated into 
blood clots known as thrombi, detailed in Section 2.1.3.1.3, via activated 
endothelial cells and/or exposed sub-endothelial tissue84. Areas of abnormal 
Wall Shear Stress (WSS), more likely in the presence of flow altering rouleaux 
or thrombi, have been shown to predispose to atherosclerosis (the hardening of 
endothelium via the formation of plaques), plaque rupture, and vascular 
remodelling85. Endothelial cell damage is also associated with turbulence 
(chaotic velocity fluctuations) in the blood flow85,86.  
 
Figure 2-7: Variation of blood viscosity with haematocrit and shear rate40 
2.1.3.1.2 Haemolysis 
RBCs can be physically or chemically forced into rupturing and releasing their 
contents into the surrounding blood, and this destruction of the RBC is known 
as ‘haemolysis’83. This may occur due to medical conditions such as the 
presence of specific bacteria, parasites, or auto-immune disorders, but is also 
strongly associated with the flow dynamics of the blood87, with the presence of 
turbulence and the shear experienced by the blood flow both related to 
haemolysis37. The levels of shear rate and shear stress vary greatly within each 
cardiac cycle, and haemolysis is promoted at both non-physiologically high and 
low shear rates33,88. It is not yet agreed upon in the literature what the upper 
threshold for haemolysis is, measured in vitro to range from 150 – 520 N/m2, or 
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whether turbulent viscous shear stress (related to the viscous dissipation of 
turbulent energy) or Reynolds shear stress (derived from the effect of 
convective acceleration upon the mean velocity profile) is more appropriate as a 
threshold identifying when haemolysis is likely to occur, but it is agreed that 
exposure of blood to a higher shear rate for a longer period of time will result in 
a greater level of haemolysis37,89,90.  
2.1.3.1.3 Thrombosis 
Haemolysis raises the platelet activation levels of the blood88,89, wherein 
platelets, another component of blood comprising of fragments of cytoplasm, 
change in shape and adhere to one another to form a plug37. Once this platelet 
plug is established, a fibrin mesh is produced over the formation, trapping white 
and/or red blood cells to harden the plug, known as a ‘thrombus’37. Although 
this mechanism is vital in stopping bleeding in the case of ruptured 
endothelium, it may also lead to a myriad of pathological issues for the body, 
such as stroke or myocardial infarction, when the thrombus blocks the supply of 
blood to the brain or heart respectively37. Activated platelets, also associated 
with the formation of rouleaux, have been identified as the primary cells working 
via haemostasis and thrombosis to cause cardioembolism87,91, and there is a 
growing opinion that the primary clinical problem associated with prosthetic 
heart valves is thrombosis, as opposed to haemolysis86. 
Thrombosis is described at a functional level by 3 platelet functions – adhesion, 
activation, and aggregation83. Adhesion is triggered when a thrombogenic 
surface, including most artificial surfaces, the subendothelial layers of blood 
vessels and fibrous plaques, is exposed to blood, and platelet membrane 
adheres to the uncovered surface83. The amount and type of non-native 
material the blood is in contact with strongly affects the degree of adhesion92. 
Activation occurs due to haemolysis, as previously discussed, but also at low to 
moderate shear rates, identified at shear stresses below 0.4 N/m2 via in vitro 
and in silico studies, as platelets form thrombi in sizes inversely proportional to 
the shear forces of the local environment82,88,92,93. Incoming platelets may also 
be activated by passing through a cloud of thrombin that exudes from the clot83, 
and turbulence of blood flow is associated with thrombosis85. The final function, 
aggregation, is caused by the release of fibrin causing the platelets to coagulate 
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and trap red and/or white blood cells within the mass. Exposure of tissue factor 
due to lumen injury or plaque rupture accelerates this process83, and 
coagulability of the blood depends upon haematocrit and protein levels92. 
Virchow’s triad translate these functions into pathophysiological mechanisms, 
describing 3 broad categories of factors that contribute to thrombosis – 
interrupted blood flow (resulting in stagnation or turbulence of blood), 
hypercoagulability (due to alterations to the biological constitution of blood), and 
endothelial injury/dysfunction (such as exposure to the sub-endothelium or 
foreign materials)84. 
As RBC aggregation promotes thrombogenicity, the importance of local blood 
rheology is evident in the maintenance of a healthy cardiovascular system84. 
The risk of thrombosis is decreased if a region is regularly washed out, with an 
RBC residence time below 10 s, determined in vitro, significantly reducing the 
chance of cell aggregation and blood flow speeds higher than 0.05 m/s 
associated with a drastic reduction in persistent stagnation83,92. Vortices shed 
from the valve leaflets during systole, discussed in more detail in Section 
2.1.3.2, have an associated washout effect, reducing the extended residence of 
activated platelets within the SoV92. As thrombi grow, the chance of portions 
breaking away from the initial site increases, and their downstream migration 
may block cardiovascular vessels as the lumen bifurcates and narrows, starving 
areas of the body of oxygen and other nutrients, with potentially fatal 
consequences such as stroke or myocardial infarction36. Thrombi that remain 
attached to the valve leaflets have been linked to reduced leaflet motion, 
resulting in sub-optimal valve performance and increased flow separation94. 
2.1.3.2 Fluid Dynamics of the Healthy Aortic Root 
The interaction between the leaflets and the structural/fluid dynamics that 
establish within the aortic root directly controls the correct operating function of 
the native healthy aortic valve66,95,96. An essentially radial flow causes the valve 
leaflets to open, moving from the coapted position towards the SoV, from where 
the flow follows the root wall and realigns with the root axis around the level of 
the STJ97. This results in the leaflets promptly assuming an open configuration, 
as the leaflets are pushed into the sinuses until they take a near circular orifice 
shape55, as shown previously in Figure 2-5(a). A central jet flow with an almost 
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flat velocity profile enters the aortic root, with peak blood velocity measured in 
vivo to range from 1.1 to 1.7 m/s, accompanied by minimal regurgitant flow back 
into the ventricle during systole55,98. 
Due to the viscoelastic properties of the aorta, the pressure profile in the aortic 
root is shifted with a few milliseconds lag with respect to the pressure profile in 
the ventricle. This causes a backward flow pressure gradient to act upon the 
blood in the sinus, stabilising the leaflets to prevent over-extension, and aiding 
in valve closure37,40. It is worth noting that the root compliance and the shape of 
the sinuses of Valsalva both augment the GOA and modulate the transvalvular 
pressure gradient68. 
Healthy aortic root regions experience an average WSS of 13.3 N/m2 at peak 
systole, ascertained via in silico investigation, with an increase in WSS towards 
the leaflet tips79. Oscillating shear stress at a magnitude lower than that 
experienced physiologically is associated with regions prone to atherosclerosis, 
resulting in a far more aggressive and proliferative phenotype93. As well as 
being associated with endothelial and blood damage and thrombosis as 
previously discussed, high levels of turbulence in blood flow leads to increased 
energy losses, as energy is dissipated in the turbulent fluctuations of the flow99. 
As the majority of aortic valve diseases occur on the downstream (i.e. aortic) 
side of the valve, this may be linked to the more unstable flow conditions and 
shear rates that are present, in contrast to the comparably more uniform and 
regular upstream ventricular flow100. Abnormal viscous shear stresses at the 
root lumen as a result of altered velocity gradients may change gene 
expressions, leading to endothelial remodelling and alterations of root 
geometry101. 
2.1.3.2.1 Fluid Dynamics of the Sinuses of Valsalva 
The presence of vortices within the SoV during systole was first hypothesised 
and sketched out by da Vinci in the 15th Century59, but the mechanism of 
formation and vortical dynamics throughout the cycle have not yet found 
consensus. Two mechanisms of vortical generation in the sinuses have been 
identified, depending on whether the angle that the leaflets form with the 
annulus basal ring is acute or obtuse, as illustrated in Figure 2-8 (a) i and ii102. 
When this angle < 90 °, the shear generated at the interface of the sinus and 
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forward flow leads to the induction of a vortex without any of the central jet 
entering the chamber, whilst if the angle ≥ 90 °, part of the forward flow 
detaches and recirculates into the chamber102. 
The propagation of this initial vortex and the generation of additional sinus 
vortices within the same systolic cycle also have not yet found consensus within 
the literature. Bellhouse & Bellhouse reported that the initial positive vortex 
generated by the forward flow of blood, with positive direction as defined in 
Figure 2-8(b), expands during systole, so that it dominates the late systolic flow 
and initiates valve closure, before dissipating away during diastole18. 
Subsequent studies have agreed with this mechanism, whether in vitro18–21, in 
vivo22–26, or numerical27–31. However, recent works based on in vitro testing 
using more advanced imaging techniques have identified more complex fluid 
flow phenomena, where the initial positive vortex generated during valve 
opening migrates away from the sinus cavity towards and beyond the STJ, 
and/or is replaced or accompanied by a negative vortex of lower strength, which 
remains in the sinus until valve closure, as illustrated in Figure 2-8 (c-f) 32–
35,which has also been numerically identified103. 
Vortical presence in the sinuses in late systole and early diastole promotes 
washout of the blood, preventing stagnation at the base of the sinuses that 
could result in thrombosis and associated pathologies29,30,104–106. The location 
and size of these vortices affects the pressure within the sinuses, with optimal 
position aiding coronary flow and pressure gradient30. Equal distribution of 
vortical strength across the three sinuses helps prevent sudden early closure of 
the valve 19,100, and although axial pressure alone is sufficient to close the valve 
at the end of systole55,100, the vortical behaviour around the physiological aortic 
valve can enhance swift and efficient closure30,100. The presence of the vortices 
in the sinuses also contribute to stabilise the leaflets’ position during the forward 
flow phase, keeping them away from the aortic lumen100. The flow becomes 
more complex and less characterizable further downstream in the aortic arch55. 
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Figure 2-8: Vortices within Sinuses of Valsalva: (a) (i) vortex in sinus generated by 
shear forces of adjacent forward flow whilst in (ii) vortex caused by forward flow 
entering sinus after encountering sinotubular junction102; (b) initial positive vortex 
formed during ejection phase107; (c) negative sinus vortices33; (d) positive and negative 
vortices34; (e) vortex migrating downstream away from sinus32; (f) negative sinus 
vortex35 
2.1.3.2.2 Fluid Dynamics of the Coronary Arteries 
Although there is no significant difference in blood velocity between left and 
right CAs, the left CA is larger and provides the majority of the blood flow, 
combining with the right CA for a total flow rate, measured in vivo, of around 
270 ± 82 ml/min (or 80 ml/min/100 g of heart tissue) at resting heart rate, 
slightly less than 5 % of the total cardiac output108. This flow rate increases as 
the demands and Cardiac Output (CO) of the heart increase, enabled by the 
coronary flow reserve2,40,109,110, and is auto-regulated by myocardial demands71. 
The flow rate variation over the cardiac cycle is disputed, with some claiming 
that CA flow occurs primarily during diastole, with less than 15% of CA blood 
flow occurring during the systolic phase of the cardiac cycle, and the sinus 
vortex present during systole playing a large role in this reduced CA 
flow27,40,71,109. Other literature claims there is a reduced difference between 
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systolic and diastolic flow of the CA66,95,111–114, as presented in Figure 2-9. The 
literature does agree that the flow consists of two peaks, one in systole and one 
in diastole, and the systolic peak in flow occurs due to the rapid rise in aortic 
pressure at the beginning of systole115. This flow reduces as the muscular 
tissue of the heart contracts fully, as this results in constriction of the CA115. As 
systole ends and diastole begins, this muscular tissue relaxes, widening the CA 
lumen and reducing the resistance in the vessels, leading to the second peak of 
the flow rate115. This flow rate peak is higher than the systolic flow peak, and 
after this diastolic peak flow gradually declines as the aortic pressure lowers 
throughout diastole115. 
The geometry of the SoV have been linked to affecting systolic flow, although 
with no direct effect upon the coronary flow reserve, whilst reduced turbulence 
in the sinus is hypothesised to result in a higher diastolic CA flow116. The 
pulsatile nature of CA flow dominates any secondary flows due to twisting, 
torsion or cyclic bending of the CAs during each heart beat117,118. The narrower 
diameters of the CAs compared to the upstream regions of the aortic root mean 
that the corpuscular properties of blood influence the local flow to a greater 
extent119. 
The literature has not reached a consensus on the effect of the CAs upon sinus 
fluid dynamics. Some literature reports that the low diastolic CA blood velocity is 
not related to the diastolic sinus flow102. On the contrary, there are reports that 
the presence/absence of the CAs may alter the sinus flow, predicated on 
previous reports of a greater tendency of the non-coronary sinus to calcify as a 
result of lower Shear Stress (SS), due to a lack of diastolic CA flow and 
increased opening of the coronary leaflets72,120. It is reported that due to blood 
flowing from the base of the sinus into the CAs, there is less stagnation at the 
base of these coronary sinuses, despite smaller vortices forming during 
systole72. Flow near the sinus wall is directed towards the CA rather than 
returning toward the root axis and STJ, resulting in increased washout of the 
sinus72. 
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Figure 2-9: Flow rate within coronary arteries72 
2.1.3.3 Mechanical stresses 
The maintenance of the healthy mechanical properties and function of the 
tissues of the aortic valve and root is strongly related to physiological flow 
conditions within the region. In order to avoid high shear and bending stresses, 
which could degrade the tissue, adherence to the physiological opening and 
closing mechanisms described in Section 2.1.3.2 in conjunction with proper 
annulus expansion and contraction is vital98. The SoV play an important role in 
lowering flexural stresses100 in the leaflets as the annulus expands and 
contracts through the cycle, at peak pressures of 120mmHg for a typical heart 
at rest. During systolic ejection, the contraction of the myocardial tissue of the 
ventricle causes the basal annulus to form a circular shape, increasing the GOA 
despite decreasing the perimeter, thus optimising the systolic flow12. Upon 
muscle relaxation in diastole, the annulus forms a ‘D’ shaped orifice, which 
maximises leaflet coaptation12. 
The fast reversal of the pressure gradient across the aortic valve during early 
systole causes the leaflets to open in a rapid transition121, opening in a wave 
from the basal annulus through to the free edges of the leaflets122. The 
decrease in left ventricular pressure during late systole causes this pressure 
gradient across the valve to invert again, forcing the leaflets back towards 
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coaptation121. The closed leaflets stretch both circumferentially and radially, and 
this stretching improves the coaptation of the valve, reducing intravalvular 
leakage98,123. 
The stress-strain response of the leaflets’ material to mechanical loading is 
highly non-linear, and can be described as a J-curve, as proposed by Cohn et 
al.124. The tissue initially produces a high amount of strain per unit of stress with 
an approximately linear stress-strain relationship, labelled as EL in Figure 
2-10(a), until reaching the transition phase of the J-curve, corresponding to a 
stiffening of the tissue, and the strain produced per unit of stress decreases. 
Further increase of stress to the tissue eventually produces another 
approximately linear stress-strain relationship, though with a much higher 
stiffness modulus than the initial linear region, labelled as EH in Figure 2-10 (a) 
124. This J-curve behaviour can be ascribed to the properties of the collagen and 
elastin fibres in the extracellular matrix of the tissue124. During region EL, the 
collagen fibres are still crimped to an extent, and the response of the tissue is 
primarily controlled by the stress-strain response of the elastin fibres as the 
collagen fibres are being straightened124,125. In the non-linear transition period, 
the collagen fibres, much stiffer than the elastin fibres, begin to take up more of 
the load as each collagen fibre becomes fully straightened124. Finally, in EH all 
of the collagen fibres have been straightened and the strain response to 
increasing stress continues in a linear relationship in response to the stretching 
of both the collagen and elastin fibres, until the tissue fails as the elastin and 
collagen fibres rupture124,125. 
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Figure 2-10: Stress-Strain response of native aortic valve leaflets: (a) J-curve 
presented by Hasan et al. as a description of the stress-strain behaviour of soft 
tissues125; (b) stress-strain response of human aortic valve leaflets, with linear EH 
region super imposed55 
 
2.2 Pathologies 
2.2.1 Calcific Aortic Stenosis 
Aortic stenosis is a degenerative blockage of the blood flow through the aortic 
valve, and is the most frequent heart valve disease in the western world, 
affecting 2-3 % of the population above the age of 654 and 10 % those above 
755, and is forecast to increase in prevalence alongside ageing populations in 
the next 20 years2,3. Aortic stenosis can be congenital, acquired, or a 
combination of both. Congenital stenosis is usually associated with a bicuspid 
aortic valve, where two of the aortic valve leaflets, typically the left and right 
coronary leaflets, fuse together and inhibit the performance of the valve, 
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increasing the susceptibility to calcification63. The vast majority of acquired 
aortic stenosis in Europe and the US is due to calcification of the valve leaflets, 
stiffening the leaflet to diminish its GOA during systole and preventing complete 
coaptation of the valve during diastole, increasing intravalvular regurgitation63. 
Current pharmacological treatments of calcific aortic stenosis are unable to 
reverse or prevent the progression of the pathology, and as such are limited 
and palliative6. 
2.2.1.1 Cause 
A typical stenosis progresses via calcification of the aortic side of the leaflet, 
initiated in the basal part and extending further, with the commissures affected 
to a lesser degree126,127. Mechanical damage as a result of endothelial stress 
allows lipids and inflammatory cells into the leaflets, oxidation of which leads to 
further inflammation and the secretion of proteins (profibrotic cytokines)3. These 
cytokines differentiate connective tissue cells (fibroblasts) into a more muscle-
type cell (a myofibroblast), causing disorganised fibrous tissue to accumulate, 
thickening and stiffening the leaflet3. Differentiation of these myofibroblasts into 
bone-synthesising cells (osteoblasts) causes accelerated calcification, and the 
formation of these osteoblasts may be accelerated by regions of inflammation 
around calcific deposits3. This calcification thickens and stiffens the leaflet, 
reducing the leaflet mobility, increasing the jet velocity of the blood flow, and 
narrowing the geometric orifice area of the valve3. Although initially believed to 
be a passive pathology, due to age-related wear and tear of the leaflet, 
contemporary studies indicate that it is not simply a degenerative process, 
showing that aortic valve calcification results from active inflammatory 
processes, and can be mediated or accelerated by haemodynamic factors128. 
Altered mechanical stimuli on the aortic valve leaflets may lead to deposition of 
lipoproteins, inflammation of valve tissue, culminating in the expression of bone-
related proteins and calcification of the leaflets128, and areas of leaflet 
calcification correspond to the sites of greatest flexion stress and strain 
combined with osteogenic/proinflammatory signalling129. The calcification 
process may also be accelerated by genetic expression and in the presence of 
certain enzymes, such as angiotensin-converting enzyme and angiotensin 
II3,130. In addition, the aortic side of the valve is more associated with leaflet 
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calcification, which may be related to the complex and highly dynamic shear 
stress field on this side of the valve, characterised by low magnitude and a high 
degree of unsteadiness3,128,131, and studies have shown an increased density of 
calcification lesions in these regions of highly heterogeneous shear stress 
fields132. This is reinforced by evidence of increased calcification of the non-
coronary sinus, which probably experiences lower SS as a result of no diastolic 
CA flow72,120. 
2.2.1.2 Resultant Fluid Mechanics 
In response to the increased pressure afterload and WSS as a result of aortic 
stenosis, the wall thickness of the left ventricle increases to restore WSS and 
preserve left ventricular function3. Increased thickness reduces wall compliance 
and impairs both systolic and diastolic function3. The severity of the stenosis is 
classified as mild, moderate or severe, as shown by the parameters in Table 
2-2, with the primary assessment method being catheter-based pressure 
measurements, with an increased severity of stenosis usually indicated by an 
increased transvalvular pressure drop85, as shown in Figure 2-11. Other 
methods to assess stenosis severity have also been developed, primarily 
involving echocardiography to determine the GOA133,134. There is an increasing 
need for valve replacement as the severity increases, although it is worth noting 
that the measurements of these parameters are limited by non-uniformity of flow 
rates across different patients135. 
Stenosis 
severity 
GOA 
(cm2) 
∆P 
(mmHg) 
Peak Jet 
Velocity (m/s) 
Velocity ratio 
(LVOT:AV) 
Mild 1.5 – 2.0 < 20 2.5 – 3.0 > 0.5 
Moderate 1.0 – 1.5 20 - 40 3.0 – 4.0 0.25 – 0.5 
Severe < 1.0 > 40 > 4.0 < 0.25 
Table 2-2: Effect of Severity of Aortic Stenosis. GOA – Geometric Orifice Area; ∆P – 
transvalvular pressure drop; LVOT – Left Ventricular Outflow Tract; AV – Aortic Valve. 
The velocity ratio indicates how much the flow is accelerated due to passing from the 
LVOT through the narrower AV, with a smaller number indicating more flow 
acceleration136. All measurements were taken in vivo. 
The effect of the stenosis upon the aortic root shape is shown in Figure 2-12, 
with increasing stenotic severity resulting in a more exaggerated bulge whose 
maximum diameter is located further downstream. 
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Due to the increased leaflet stiffness as a result of calcification, the 
haemodynamics of the root degrade, with less complete closing of the valve 
and a reduction of the EOA100. As the stenosis’ severity increases, the peak 
velocity of the central jet flow increases due to a reduction in jet cross-section 
diameter and some return flow back through the valve even at peak systole98, 
as illustrated in Figure 2-13 - for a reference STJ diameter of 2.5 cm, a mild 
stenosis causing a GOA of 1.5 cm2 (as opposed to 2.5 cm2 for a healthy 
condition) results in a transvalvular pressure drop of up to 20 mmHg and an 
increase of peak jet velocity increases by up to 70 % compared to the healthy 
condition137,138, established from in vivo measurements. 
The altered velocity properties of the flow elevate the levels of SS and 
turbulence in the region, increasing the probability of damage to the root walls 
and to the blood itself138. The different levels of calcification on each leaflet 
mean the jet is asymmetrical and typically inclined, resulting in complex 
conditions specific to each patient, a situation further complicated by the 
surface irregularities of calcified leaflets100. 
 
Figure 2-11: Effect of stenosis upon aortic root pressures. A much higher ventricular 
pressure is required to transfer an equivalent amount of energy to the aortic flow as the 
healthy condition [image adapted from 139] 
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As the stenosis becomes more severe, the pressure drop across the aortic 
valve may rise above 40 mmHg with a corresponding drop in EOA to beneath 1 
cm2, accompanied by a further decrease in outflow jet diameter at the aortic 
annulus, leading to a peak velocity greater than 4 times that of the healthy 
condition100,137. The numbers of regions of flow separation around the central jet 
increase, accompanied by fluctuating shear layers forming between the fast 
flow and the root walls, potentially causing damage to RBCs and platelets in the 
flow and to endothelial cells in the aortic walls100. As well as elevating the 
incidence of thrombosis and thromboembolism, the changes in WSS can lead 
to dilation of the ascending aorta, and the increased force of the higher velocity 
central jet can, over time, weaken the distal portion of the ascending arch, 
potentially resulting in aneurysm138. 
 
Figure 2-12: Effect of stenosis severity upon aortic root geometry, showing a sagittal 
cross-section of the root of (a) a healthy aortic valve; (b) a mildly stenotic aortic valve; 
(c) a severely stenotic aortic valve65. Increasing stenotic severity results in a more 
exaggerated bulge whose maximum diameter is located further downstream. 
Even simplified numerical studies have shown that the flow behaviour in the 
sinuses becomes significantly altered, with the vortices becoming bigger but 
less intense, and being located further from the leaflet tips soon after 
generation79. As a result, rather than being trapped within the sinuses during 
valve closing, these vortices disappear during late systole79. Coronary flow 
decreases as leaflet stiffness increases, possibly linked to this reduction in 
sinus flow recirculation105. 
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Figure 2-13: Effect of stenosis upon aortic valve velocity profile at the sinotubular 
junction, adapted from Yoganathan et al.140 
2.2.2 Root Dilation 
Dilation of the ascending aorta is responsible for 50 % of all thoracic aneurysms 
and can be sub-categorised into easily operable “supra-valvular aortic 
aneurysms” downstream from the STJ, and “aortic root aneurysms” which 
require sparing or replacement of the aortic valve141. As previously noted, the 
diameter of the aortic root region naturally increases by about 0.5 % /year in the 
STJ and sinuses from the age of 4047,142, but it can also become dilated due to 
connective tissue diseases, such as Marfan’s disease or Ehlers-Danlos 
syndrome143. Root dilation is also associated with aortic stenosis, as can be 
seen in Figure 2-12, especially of bicuspid aortic valves65,141,144, and is most 
likely linked to aortic wall pathology than any dysfunctional valve based 
haemodynamics143,144. Aortic dilation can lead to aortic rupture, which could be 
catastrophic for the patient, and increased dilation leads to increased wall 
tension, increasing the likelihood of rupture85,141,144. Replacing a defective aortic 
valve can retard the rate of dilation, as can treatment with 𝛽 blockers85,141,144. 
During annuloaortic ectasia, a proximal dilation of the ascending aorta 
characterised by expansion of the root and usually sinus diameter, the leaflets 
themselves don’t necessarily show signs of abnormality other than rolling of free 
edges, which is an indicator of regurgitation127. The presence of aortic 
regurgitation, or insufficiency, is often associated with the extent of the dilation, 
due to increased pulse pressure141. Interventionist surgery is recommended if 
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the dilation of the ascending aorta exceeds 55 mm with no other linked 
pathologies, if it exceeds 50 mm with a diagnosed connective tissue disorder, or 
if it exceeds 45 mm and the patient has already received aortic valve surgery143. 
Surgery is also recommended if there is growth of the dilation in excess of 1 
cm/year despite treatment with 𝛽 blockers141. Surgical intervention either 
involves remodelling the root, or reimplantation of the aortic valve into a 
replacement graft23,43. Remodelling does not address the dilation of the root as 
effectively as replacement, but preserves the geometry of the SoV better141, 
with the possibility of decreased valve deterioration in the long term43. 
2.2.2.1 Resultant Fluid Mechanics 
The dilated aortic root causes numerous deleterious changes to the fluid 
dynamics in the volume, with much more positional change of enlarged vortical 
structures that develop alongside and deflect the central jet-like flow during 
systole22,145. Dilation by a third has been shown by in vivo research to 
potentially double the time taken for the valve to fully close145, indicated by in 
silico studies to increase leaflet stress by 150%, and decrease leaflet coaptation 
by 8%, increasing regurgitant flow during diastole146. Marfan’s syndrome has 
been connected to an increase in the stiffness of the root walls, and, a 
technique called pulse wave velocity can be used to assess the wall stiffness 
and, consequently, the progression of dilation85. 
2.2.3 Coronary Disease 
Coronary artery disease is a major cause of death in the western world, with 
approximately one third of people dying as a result of CA disease, and the vast 
majority of elderly people having some disfunction of the coronary circuit2. 
The most common cause of CA disease is atherosclerosis40, a hardening of the 
arteries, which primarily builds up in the side branches and on the inner 
curvature of the CAs, and it is linked to local low WSS118,119. This impairment of 
the CAs leads to the heart producing an increased systolic flow, in order to 
maintain the coronary blood flow at a similar level to that of a healthy coronary 
system, until the CA impairment is so severe that the heart can no longer 
adequately compensate, and CA flow reduces down to around two thirds that of 
the healthy condition109,110,147. 
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Reduction of the flow in the CAs results in cardiac muscle tissue death 
(myocardial infarction), and can lead to any or all of the following: reduction in 
CO; increase in cardiovascular pressure due to blood pooling in veins; 
fibrillation of ventricular tissue; cardiac tissue rupture40. As the flow to the CA 
decreases, fluid dynamics within the associated SoV will become more 
reminiscent of those observed in the non-coronary sinus, increasing the 
likelihood of leaflet calcification and thrombosis due to lower SS in the 
region72,120. 
2.3 Valve Replacement Treatment 
When the performance of the native aortic valve diminishes to a critical level, 
prosthetic implants can be utilised to restore the functionality of the region. The 
devices available for implantation have been developed over the last 7 
decades, and have been split into three categories for clarity of explanation – 
mechanical valves, consisting of rigid manufactured materials such as pyrolytic 
carbon and metals, and displaying outstanding durability148, requiring open 
heart surgery for implantation; Surgical bioprosthetic valves, utilising tissue 
harvested from typically bovine or porcine sources, mimicking the native human 
aortic valve, and requiring open heart surgery for implantation; Transcatheter 
valves, again utilising porcine or bovine tissue designed with similarities to the 
native human heart, but able to be crimped and implanted into the patient 
without the need for surgery. 
2.3.1 Mechanical Aortic Valves 
The first implant of a mechanical prosthetic heart valves was by Hufnagel in 
1952149, and was followed by the Starr-Edwards caged ball valve in 1960150,151. 
A sphere is pushed into a retaining cage by the forward flow of the blood, 
creating a gap between the valve housing and ball through which the blood 
flows, until the reversal of pressure and flow during diastole cause the ball to 
return and occlude the housing orifice, preventing regurgitation of blood back in 
the ventricle33. The durability of the cage-and-ball valves is countered by some 
obstruction of the blood flow by the ball in forward flow, leading to large 
recirculation/turbulent regions around the axis of the aortic root, as illustrated in 
Figure 2-14. This results in a large transvalvular systolic pressure drop33, and 
the relatively large size of the valve makes it impractical for implantation in 
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many patients150,151. Almost 20% of the blood flow velocity is lost within 30 mm 
of the annulus before passing through the wake of the ball and cage, leading to 
a high velocity gradient and turbulent SS measured in vitro to be as high as 350 
N/m2, well above the threshold for platelet activation33. 
 
Figure 2-14: Mechanical valve flow diagram during systole and diastole33 
The second generation of mechanical valves were soon developed, with caged 
disc and flap disc designs leading into Bjork-Shiley’s tilting disc valves in 
1967150,151. These valves reduce flow abnormalities compared to ball-and-cage 
valves by having a free-floating disc (reducing contact-based wear) acting as an 
aerofoil when in the pre-determined open position, between 60 ° and 80 ° 
relative to the housing. This creates two differently sized orifices for the blood to 
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flow through, resulting in a larger EOA than in the ball-and-cage design140,150,151. 
Turbulent SSs have been measured in vitro to peak at 150 N/m2 and are 
typically located at the edge of the major orifice jet, whilst a recirculation region 
occurs in the sinuses33. However, the flow profile generated during systole still 
has a central recirculation region (although generally reduced from the ball-and-
cage design) resulting from a fast and slow forward flow jet emerging from the 
large and small orifice respectively33, as presented in Figure 2-14. 
The third and most recent group of mechanical valves are bi-leaflet valves, 
introduced by St Jude Medical Inc. in 1978152. Bi-leaflet valves provide 
improved uniformity of the flow profile, closer to physiological flow151, as shown 
in Figure 2-14, with the blood passing through a large central orifice with two 
smaller semi-circular orifices alongside33, and the interior positioning of the 
leaflets reduces the chance of interference with any other architecture in the 
aortic root151. This results in a larger EOA than the tilting disc design, although a 
larger regurgitant volume means that the valve still suffers from inefficiencies140. 
The recent On-X valve, by the Medical Carbon Research Institute, features 
leaflets with a similar length-to-diameter ratio to native aortic valve leaflets that 
open to 90° relative to the valve housing33. However, as with all mechanical 
valves33, thromboembolytic complications are a major concern, with lifelong 
anti-coagulation medication necessary for the patient151,153,154, alongside a 
degree of leakage back through the closed valve via gaps at the join of the 
leaflets, the join of housing and leaflet, and possibly the leaflet hinges33,140,151. 
This leakage is an inherent part of the valve, designed to provide washout of 
the valve to reduce thrombus formation, but can occurs at stress magnitudes 
that cause damage to RBCs155, and led to the withdrawal of some devices from 
the market due to severe thrombosis around the hinges33. The flow through the 
smaller side orifices is slightly faster than the central orifice flow36, with a peak 
turbulent SS measured in vitro to be as high as 150 N/m2 similar to that of the 
tilting disc33. Flow patterns in the aortic root are complex, with two recirculations 
observed in the sinuses, and counter vortices forming in the way of the leaflets 
at peak systole, degenerating into a chaotic flow field during late systole156. 
There are reports that rigid leaflet valves will also suffer from cavitation, causing 
damage to the valve itself, leading to a loss of functionality, alongside potential 
clot formation and detachment arising from damage to the RBCs, which lead to 
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thrombotic complications, platelet activation, and haemolysis33,140,151,153,157. 
However, this cavitation may be due to analysis of valves after in vitro testing, 
with non-physiologically low pressures and viscosities causing cavitation which 
has not been reported from explanted in vivo mechanical valves. 
Polymeric heart valves, made from synthetic materials but replicating 
physiological haemodynamics, have been used in the short term with assist 
devices, but shortcomings in valve design and/or material properties have 
meant that long term implantation has not yet been achieved151,158. 
Susceptibility to calcification, hydrolysis, and oxidation lead to increased 
occurrence of leaflet malfunction and premature failure159. Investigations using 
high-cycle test machines indicate that the durability and lifetime of these 
polymeric heart valves are both increasing159. Modification of the polymers used 
can bestow beneficial properties to the valve, such as reduced thrombosis (via 
addition of cholesterol-modified polyurethane) or improved biocompatibility and 
durability (via the incorporation of nanomaterials)159. 
2.3.2 Surgical Bioprosthetic Aortic Valves 
The first bioprosthetic heart valves were homografts, using antibiotic- or cryo-
treated aortic valves from donors to replace the diseased aortic valve, first 
performed in 1962, whilst the ‘Ross procedure’ dates from 1967, and involves 
an autograft of the patient’s pulmonary valve in place of the disease aortic or 
mitral valve, alongside a homografted pulmonary valve - both have satisfactory 
outcomes but are totally dependant upon donor supply33,150. 
A technique using gluteraldehyde (GA) to fixate tissue developed by Carpentier 
in 1969 improved the stability and inertness of biological tissue, enabling the 
use of xenograft tissue combined with mechanical structures to create valves 
based upon the native human heart valve, with much lower thrombogenicity 
than their mechanical counterparts, although this treatment leads to a higher 
likelihood of leaflet tearing or degeneration33,160. Porcine tissue mounted on a 
rigid support (called a stent) was introduced in 1970 in the Hancock Porcine 
Xenograft, which remains in use today, later joined by the Carpentier-Edwards 
Bioprosthetic, brought to market in 197633. The flow profile is much more similar 
to that of a native valve’s flow profile than those of the mechanical valves, 
although representative of a mildly stenotic valve, due to porcine tissue 
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stiffness, leaflet fixation, presence of a stent, and restriction of movement140,161. 
This results in a decrease in EOA and a larger pressure drop, although the 
turbulent SS does not exceed the threshold for damaging RBCs140. The size 
similarities of porcine valve leaflets to human valve leaflets enable them to be 
used ready formed in the xenograft valve, although a large amount of valves 
need to be obtained to ensure size matching and quality33. 
In order to mitigate these supply issues, and dissatisfied with the 
haemodynamic performance of available porcine valves, attention turned to 
pericardial bovine tissue, with the Ionescu-Shiley pericardial xenograft 
introduced to clinical practice in 1976162,163. This valve consisted of GA-fixed 
bovine pericardium sutured to a titanium frame with a Dacron® coating162. 
However, although initial valve performance was good, progressive structural 
deterioration within a few years of implantation led to this valve being withdrawn 
from clinical use by the late 1980s164. After a lengthy developmental period, the 
Carpentier-Edwards pericardial valve was brought to market in 1991, with the 
pericardial tissue offering improved haemodynamics than the porcine valvular 
tissue, with a higher EOA, lower pressure drop, and turbulent SSs measured in 
vitro to be < 100 N/m2, due to reduced tissue stiffness and an improved 
downstream flow profile33,140. There is a degree of regurgitation in all stented 
bioprosthetics140. 
Increasing the valve orifice, reducing stress at the leaflet-stent attachment, and 
reducing forward flow obstruction is achievable by removing the stent 
altogether, made possible by further improvement to tissue fixation techniques 
in the 1990s and requiring specific matching of patient root and valve 
geometry140,161. Initially designed for full or partial root replacement, the second 
generation of stentless bioprosthetics, the Shelhigh Super Stentless aortic 
porcine valves, enabled insertion into a calcified region via suturing of a flexible 
ring at the base of the valve alongside attachment of the commissures of the 
valve leaflets to the aortic wall161. A pericardial equivalent, the Sorin Pericarbon 
Freedom, was introduced in 1990, combining ease of implantation with high 
haemodynamic performance161, although no improvement in long-term 
durability has been proven so far154. 
Contemporary bioprosthetic valves usually have leaflets constructed out of GA-
fixed porcine or bovine tissue12, making them vulnerable to leaflet calcification, 
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which would cause valve stenosis with associated raised transvalvular pressure 
drops and peak blood flow velocity140. The bioprosthetic tissue includes residual 
antigens from the xenogenic source, which can elicit an immune response from 
the patient the valve is implanted into, especially younger patients with stronger 
immune systems165. After the host’s antibodies enter the leaflet tissue matrix, 
macrophage deposition, collagen breakdown, and calcification follows, linking 
the patient’s immune system to the presence of calcification165. 
Use of polymeric leaflets to reduce this risk of calcification tends to result in 
more constricted outflow orifices, with a similar end result to the stenotic 
valve32, whilst the polymeric leaflet edge acts as sharp flow separator, 
increasing residence time of RBCs in the resultant stagnant regions, 
correspondingly raising the thrombogenicity of the volume83. 
Whilst the resultant fluid dynamics within the aortic region following surgical 
implantation with a bioprosthetic valve are more similar to the physiological 
condition than after implantation of a mechanical valve, as presented in Figure 
2-15, there are still differences from the native state75. The valve frame and 
implantation strategy result in a shape and positional mismatch between the 
aortic root and the prosthetic leaflets, and the frame thickness and the valve’s 
sewing ring and pledget-armed sutures, that enable long-term fixation of the 
prosthetic at the basal annulus, all reduce the GOA166. The increased stiffness 
of the GA-fixed tissue and the man-made commissures of the prosthetic may 
also affect the flow in the aortic root, with possible alterations to the vortical 
dynamics and stagnation regions in the SoV167. These factors contribute 
towards producing a valve performance characteristic of a mildly stenotic native 
valve, characterised by increased peak jet velocity and transvalvular pressure 
drop, accompanied by a corresponding reduction in EOA, when compared to 
that of a native valve in the same size aortic root140. 
The forward flow has a relatively flat velocity profile32 and high distribution of 
flow, dissipating rapidly downstream of the valve, with velocities higher than in 
the healthy native valve, reported from in vitro research to peak between 2 and 
3 m/s140. This flat profile becomes parabolic around 45 mm downstream of the 
valve orifice, reattaching to the aortic wall further downstream32. Stented 
bioprosthetic valves tend to have recirculation regions downstream of the stent 
posts near the aortic wall, with in vitro  measurements indicating systolic 
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recirculation fluid speeds of up to 0.6 m/s and SSs of up to 450 N/m2 in the 
shear layer between the central jet and the slow flow and at the trailing edge of 
the leaflet32, although many modern devices never exceed 100 N/m2140. Early 
diastolic recirculation velocities can be as high as 0.4 m/s, but peak fluid 
velocity is generally no more than 0.04 m/s during diastole32. The lack of 
drainage (that the coronary arteries would otherwise provide) results in 
increased blood residence time on the non-coronary sinus leaflet of surgical 
bioprosthetic aortic valves, with the associated increased risk of calcification 
and thrombosis167. 
 
Figure 2-15: Flow field of surgical tri-leaflet aortic valve replacement: (a) summary of 
flow field during systole and diastole33; (b) PIV derived velocity field at peak systole32 
Stentless bioprosthetic valves display improved performance, offering less 
forward flow obstruction and superior haemodynamic performance when 
compared to their stented equivalents140. However, their manufacture and 
surgical procedure are both more complex and costlier, and their performance 
is more affected by irregularities of the host anatomy (which may distort the 
shape of the valve away from the ideal) and procedural inaccuracies, due the 
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absence of a supporting stent which would otherwise enforce a regular circular 
configuration140. However, when suitable for the host anatomy, stentless valves 
produce flow velocities closest to the healthy native condition, with improved 
coronary flow compared to their stented equivalent, with a lower transvalvular 
pressure drop and decreased turbulence downstream from the valve71. 
2.3.3 Transcatheter Aortic Valves 
A major drawback of the mechanical and bioprosthetic valves presented so far 
is the necessity of invasive surgery to remove the old, diseased valve and insert 
the new prosthetic valve, with up to a third of patients deemed ineligible for 
surgery due to advanced age and/or pre-existing illness10,11. A minimally 
invasive technique, drawing upon the experiences of balloon aortic 
valvuloplasty in the 1980s wherein a stenotic aortic valve is widened using a 
balloon catheter inside the valve168, has been developed and performed since 
20026, wherein a transcatheter aortic valve (TAV) is collapsed into a catheter 
tube, which is percutaneously inserted into the aortic position. The first TAVs 
were constructed of GA-fixed bovine pericardial leaflets within a tubular 
stainless steel stent, expanded via the inflation of a balloon located inside the 
bioprosthetic when the device was in the desired position within the native 
aortic annulus169, as illustrated in Figure 2-16(a). The xenogenic tissue leaflets 
have the same immune-system-led calcification risk as the surgical 
bioprosthetic heart valves as described in Section 2.3.2, but additional concerns 
have been raised that the crimping process itself may encourage further 
acceleration of the calcification process170. Whilst balloon expandable devices 
and bovine pericardium are still commonly used171, many devices now 
incorporate porcine pericardium and/or a self-expanding stent, utilising super-
elastic metal such as Nitinol™ to deploy the TAV, as shown in Figure 2-16(b). 
Other, less common, methods of expansion include lateral expansion after 
retraction of longitudinal Nitinol™ wires (the Boston Scientific Lotus valve) and 
inflation via a rapid setting polymeric agent (the Direct Flow valve)172. 
Initial TAV deployments were via a femoral artery (trans-femoral or retrograde 
approach), and this technique has been joined by the recent development of 
insertion through the apex of the heart (trans-apical approach)12. Trans-femoral 
surgery involves a 1-2 cm incision in the groin to access the femoral artery, 
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following which a catheter is inserted and fed 70-100 cm through the arterial 
system including the aortic arch, up to the aortic root region173. Trans-apical 
access requires a longer incision, ~5 cm, but the catheter entry point is much 
closer, 7-10 cm, to the aortic root173. The catheter approaches from the opposite 
direction compared to the trans-femoral approach, being inserted through the 
rib cage, into the apex (i.e. the lowest part) of the heart, and through the 
ventricle to the aortic root region173. A trans-apical approach is often required for 
patients with small, diseased, and/or calcified iliofemoral arteries, as the valve-
bearing catheter is too wide to pass through174. Both insertion approaches have 
comparable mortality when comparing patients of similar baselines13,174. 
 
Figure 2-16: Methods of TAV expansion: (a) Balloon expandable – the TAV is inserted 
with an uninflated balloon located inside, which is then inflated, expanding the TAV. 
When the balloon is deflated again, the TAV remains expanded and anchored inside 
the native valve leaflets [image adapted from Auricchio et al123]; (b) Self-expandable – 
the TAV is made out of super-elastic material, which expands into the desired shape 
once released from the confines of the catheter [image adapted from Diagnostic and 
Interventional Cardiology175] 
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Regardless of insertion point, the catheter is fed into the cardiovascular system 
until in position, and if necessary, depending on the specific type of TAV, the 
valve is released from the confines of the catheter tube. The valve expands up 
to the aortic root wall, forcing the original stenotic valve into a permanently open 
arrangement, and then the catheter tube is withdrawn from the artery10,176. The 
first generation of TAV devices were not repositionable or retrievable in cases of 
non-optimal deployment, often resulting in higher than expected paravalvular 
leakage (PVL) or requiring the insertion of a second TAV device as a result of 
this erroneous positioning168. To address this, the second generation of TAV 
devices include designs which can be fully or partially re-collapsed after 
expansion, and/or include guides to enable optimal positioning168. PVL has 
been further reduced in some of the third (the most recent) generation of TAVs, 
such as the Edwards SAPIEN 3, which includes an outer sealing cuff at the 
base of the stent177. 
Successful implantation rates have been as high as 97 %12,51,176. The benefits 
of reduced hospital stays, accelerated return of body mobility, decreased major 
bleeding and onset atrial fibrillation, and improved haemodynamics of TAVs are 
however offset by the 1-year follow up of patients showing a marked increase in 
both stroke incidence (from 1.1% to 5.0%) and major vascular complications 
(from 1.1% to 16.2%), and occasional asymmetric expansion of the valve 
results in severe leaflet calcification, requiring valve retrieval via surgery10,178. 
The main two TAV technologies that have been commercially available are the 
Edwards SAPIEN (a balloon expandable TAV) and the Medtronic Corevalve (a 
super elastic, self-expanding TAV), available in the EU since 2007 and 2011 
respectively. Other devices are in various stages of development, such as the 
JenaValve, the Direct Flow, the Boston Scientific Lotus, the Acurate, and the 
Portico10,179. 
TAVs include a frame which supports and guides the attachment line of the 
leaflets, but minimises frame thickness to around 0.5 mm180,181. However, the 
functional orifice area of the device may be impaired due to the presence of the 
calcified native leaflets, operating in a sub-optimal configuration smaller than 
the ideal fully expanded geometry182,183. Additionally, TAV implantation into a 
non-spherical annulus, possibly as a result of heavy calcification, can lead to 
deployment with an oval shape, with less recourse for correction when 
 65 
compared to a surgical procedure182,184. The positioning of the TAV has an 
increased variability compared to its surgical equivalent, due to the nature of the 
implantation procedure185. A high degree of orifice eccentricity is linked to 
increased levels of regurgitation, most likely as a result of diminished leaflet 
apposition182,186. TAV oversizing is often utilised to mitigate this issue, as well 
as attaining more secure device anchoring, but valve haemodynamics can be 
adversely affected by this approach51,187, and moderate to severe stenosis of 
the TAV can occur when there is excess leaflet tissue relative to the stent orifice 
area, with more associated haemodynamic deterioration188. 
If the device is fixed into position a few millimetres further up- or downstream of 
the ideal location, any or all of the following can occur: decreased ventricular 
functionality; alteration of aortic root fluid dynamics; reduced TAV functional 
lifetime; PVL as a result of seal zone mismatch; CA obstruction; conduction 
abnormalities; elevated wall stress, potentially resulting in valve embolization or 
annulus rupture185,189. 
In spite of these limitations, the expansion of TAVs into their destination 
annulus, including distension of the TAV to conform to the physiology better, 
results in reduced patient-prosthesis mismatch when compared to surgical 
procedures181. A successful TAV procedure is usually characterised by a larger 
increase in the systolic performance in comparison to the post-surgical 
condition, with transvalvular pressure drops below 10 mmHg and EOA up to 2.0 
cm2 for a reference STJ diameter of 2.5 cm181,190. 
2.3.3.1 Specific TAV types 
2.3.3.1.1 SAPIEN 
The SAPIEN valve family combine bovine pericardium fixed in a tri-leaflet 
arrangement into a balloon-expandable cobalt chromium frame, resulting in a 
relatively rapid expansion of the valve once released from the confines of its 
sheath, radially pushing away the native calcified leaflets, and utilising the 
elastic recoil of the aortic annulus to fixate the valve10,12. The XT valve, 
approved for use in the US market, is presented in Figure 2-17. The valve is 
shorter than its diameter, with valve lengths of 14.5, 17, and 19 mm for 23, 26, 
and 29 mm diameter valves respectively. Less protrusion into the left ventricle 
and/or the aortic root reduces the amount of non-physiological architecture in 
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either volume, ideally reducing non-physiological effects on the haemodynamics 
of the root due to fluid interaction with the bioprosthetic. However, vortices 
within the sinuses of Valsalva are altered from the physiological condition, to an 
as yet unascertained degree12 with the central jet developing a helical flow in 
mid-systole that results in a mild retrograde flow187. According to in vitro 
experiments, 32 % of RBCs remain in the SoV after each cycle, compared to 9 
% of RBCs in Corevalve treated regions and 0 % in the healthy native condition, 
requiring 4 cycles to fully flush the region, with the associated elevated risk of 
thrombus formation191. Sub clinical leaflet thrombosis (SCLT) has been 
observed at a higher rate in Edwards SAPIEN valves, present in 14 % of follow 
up examinations, based upon reduced leaflet motion192, and has been linked to 
over-expansion of the TAV, as this may cause endothelial damage, larger neo-
sinus formation, and reduced washout. 
 
Figure 2-17: Edwards SAPIEN valve: (a) Photo of valve depicting leaflets and frame 
(reproduced from www.edwards.com); (b) Schematic of flow during systole and 
diastole12 
The larger diameter of the crimped Edwards SAPIEN valve, and hence of the 
catheter used for implantation, often necessitates a transapical approach174. 
The accompanying WSS of the root has been measured during in vitro 
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investigations to be 1 - 1.2 Pa, within the physiological range of 1 - 1.5 Pa, 
whilst the TAV itself experiences WSS of up to 3.5 Pa during each cycle184,193. 
However, the raised occurrence of asymmetric deployment, present in around 
20% of procedures194, may result in severe leaflet calcification, requiring the 
valve to be retrieved via surgery, or become the outer component of a Valve-in-
Valve procedure10,178, as described in Section 2.3.3.3. 
2.3.3.1.2 CoreValve 
The CoreValve family of TAV devices, with an example of the first generation 
presented in Figure 2-18, can utilise a thinner catheter than the Edwards 
SAPIEN valve, as the combination of using porcine leaflets, as opposed to 
thicker bovine pericardial tissue, and a self-expanding Nitinol® stent, as 
opposed to a balloon expansion, enables tighter crimping for a thinner profile, in 
turn enabling a higher percentage of transfemoral implantations12,174. The 
longer and tapered profile of the CoreValve relies on self-expansion of the 
Nitinol® frame rather than the elastic properties of the annulus, which may 
affect the haemodynamics of the aortic root as the blood flows through the stent 
mesh, although this is mitigated somewhat by the stent’s tapered design12. This 
self-expansion can be affected by leaflet calcification, which is often asymmetric 
across a valve, with one leaflet more calcified than another, leading to an 
asymmetric orifice12. As Nitinol® conforms to the shape of its containing 
volume, this asymmetry can be replicated in the deployed valve, possibly 
leading to unexpected leaflet kinematics in the implanted valve12,195. 
Post mortem examinations of CoreValves show that whilst there is little 
exhibition of tissue overgrowth in regions of high blood velocity, slow flow 
regions in contact with the frame results in neo-intimal tissue, particularly where 
the TAV frame struts contact the aortic wall, suggesting pathological change 
due to fluid flow alteration196. The leaflet position within CoreValves results in a 
relatively supra annular TAV orifice for a standard implantation height, with the 
associated haemodynamic performance improvement but also with the 
associated susceptibility to diminished sinus washout196. 
Regurgitation is at a similar mild-to-moderate level to the Edwards SAPIEN 
valve, possibly leading to future impairment of left ventricular function, whilst 
pressure drops across the valves are also similarly mild, in the 5-15 mmHg 
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range, although long-term effects are still under review181,197. The downstream 
ends of the stent mesh may induce more regions of flow separation and non-
physiological flow profiles, whilst RBCs backflowing into the sinuses during 
diastole may also be damaged and slowed as they travel through the mesh, as 
indicated in Figure 2-1812. Conduction issues are a particular problem following 
procedures using CoreValves, such as atrioventricular node interference due to 
the metallic frame, disrupting the signalling of heart beats for up to 40 % of 
patients198–200. 
 
Figure 2-18: Medtronic Corevalve: (a) Photo of valve depicting leaflets and frame, and 
function of each level of the valve; (b) Schematic of flow during systole and diastole, 
with regions of increased interaction between blood and frame indicated12 
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2.3.3.2 Flow Alterations 
The fluid dynamics of the aortic root following TAV implantation are different to 
both the healthy native condition and the post-surgical condition, with 
complications such as flow separation, energy losses, non-physiological CA 
flow, and PVL12. TAV implantation is also associated with serious complications 
further downstream, such as an increased occurrence of stroke, silent ischemic 
lesions, and cerebral embolism14–16,174. The primary cause of flow pattern 
difference is the continued presence of the native calcified leaflets, which are 
not ablated as they would be as part of the surgical procedure, but radially 
displaced in a permanently open configuration towards the SoV. The available 
volume of the SoV is reduced by these displaced leaflets, and systolic sinus 
flow is mostly confined to the upper regions of the SoV, in the vicinity of the 
cusps of the native leaflets201, average flow in the SoV is reduced to a quarter 
that observed in the healthy physiological condition, and peak velocity is 
halved35. Flow within the SoV plays an important role in both CA blood supply 
and sinus washout18,96,202, and the associated reduction in shear rate increases 
the risk of thrombus formation10,97. In addition, the start-up vortices generated at 
the start of systole do not generate at the tip of the dynamic leaflet tips in the 
upper part of the sinus, but further downstream at the edge of the now static 
native leaflets97. This has been associated with further reductions in sinus 
washout97,186, and a delay of ~10 ms in the opening of the valve35,203. 
The volume between the permanently displaced native leaflets and the stent of 
the TAV can be considered as a neo-sinus, with a size and shape dependent 
upon the geometry of the native region, the geometry of the prosthesis, and the 
angular orientation of the TAV with respect to the native architecture, and non-
alignment of the opening TAV leaflets with the native SoV may further reduce 
the SoV flow204. Flow within these neo-sinuses may be especially prone to 
stagnant flow regions, increasing the thrombogenicity of the root204. 
Consequently, clinical thrombotic events are associated with TAVs, especially in 
the first 3 months after implantation, and most cases happening within 6 
months205,206. Even if the thrombosis has no direct effect upon quantified 
haemodynamic performance, SCLT may be occurring, resulting in lesions and 
reduced prosthesis leaflet motion192,207. SCLT is associated with strokes and 
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transient ischemic attacks, so prevention may improve long-term clinical 
outcomes192. 
In the majority of TAV designs, the stent prevents the working leaflets from 
opening beyond 90 °, producing a narrower systolic jet than for an equivalent 
sized native or surgical valve35,203, with peak blood flow velocities up to twice as 
high as for the healthy native condition55,78,202. The resultant higher viscous 
shear stresses, established via in vitro investigation to be up to 6 N/m2186, 
remain beneath the haemolytic threshold201. The return of fluid during valve 
closure is not accompanied by the vortical structures reported in the healthy 
native condition, again reducing wash out of the SoV97, and fluid suction 
generated by the closing leaflets has minimal effect upon the sinus volume due 
to the continued presence of the static native leaflets201. Consequently, 
broadened and drawn out stagnation zones develop in each SoV throughout 
both the systolic and diastolic cycles, with shear rates lower than 100 s-197,185. 
Due to the rheology of blood, these regions of permanent low level shear 
observed at the base of the SoV substantially increase the local dynamic 
viscosity, extending RBC residence time and enhancing thrombogenic 
conditions97, especially in the non-coronary sinus which does not have this low 
shear mitigated by flow accessing the CA167. 
The effect of TAV implantation upon the coronary flow has not yet reached 
consensus. As central flow speed is decreased from the pathological condition, 
some reports claim that a resultant reduced Venturi effect improves systolic CA 
flow, alongside enhanced coronary bed pressure gradients71. However, other 
findings indicate that patients with coronary ostia positioned closer towards the 
basal annulus may have a reduction in coronary flow by up to 20%95,96,208. As 
left ventricular efficiency improves, less work is required by the myocardium to 
generate the pressure required to pump blood around the body, so this loss of 
coronary efficiency may not be a critical issue on its own, but severity depends 
on the specific long-term myocardial needs of the patient and combination with 
other cardiac deficiencies71. Ostia also risk being obstructed when close to 
native leaflets thickened by calcification and/or when an oversized TAV is 
deployed10,73. Fragmentation of the native leaflet during TAV implantation, use 
of a balloon expansion technique, or high implantation of the TAV can all also 
cause obstruction of the ostia or increase the chance of coronary ischemia190. 
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Low positioning of the TAV carries its own risks of post-procedure conduction 
abnormalities, with atrioventricular block occurring after 16 % of TAV 
implantations, contrasted with a 1 % occurrence following surgical 
implantations180,198,199,209. 
PVL during diastole is more common following TAV implantation than after 
surgical implantation, due to the reliance of frame expansion to hold the 
prosthesis in place rather than suturing onto the native tissue171,205,206. Eccentric 
deployment may also lead to intra-valvular leakage, as full leaflet coaptation is 
prevented by the deployed frame shape182,210. Redilation of the TAV can reduce 
the PVL, and more recent devices use skirts around the upstream base of the 
frame203,211, but moderate and severe PVL is still a common occurrence after 
TAV implantation, and is associated with increased mortality210. This 
regurgitation imposes a high workload upon the left ventricle to maintain a 
sufficient supply of blood to the body188. Tissue overgrowth and/or blood 
coagulation in the gaps between the TAV and the host tissue of the annulus in 
the months following the TAV implantation procedure may reduce this PVL, but 
mild leakages are reported as persisting, and statistics implying severe and 
moderate PVL improves with time may be biased by the accompanying 
elevated mortality of increased PVL210,212. 
2.3.3.3 Valve-in-valve 
In addition to treating patients with a pathological native valve, TAV implantation 
can also be used as a non-surgical method of replacing underperforming or 
dysfunctional prosthetic valves, expanding the new TAV inside the previous 
prosthetic, referred to as a ‘valve-in-valve’ (ViV) configuration73,190,210. The 
orifice area is further reduced by this approach, and may not be suitable for 
patients requiring smaller prostheses if this results in critically reduced valve 
performance210,213,214. This orifice reduction can be mitigated to an extent by 
supra-annular positioning of the TAV, although this does increase the risk of 
reduced flow within the SoV213. Additionally, as the original prosthetic’s stent 
posts tend to be more flexible than the native annulus, the downstream portion 
of the new supra-annually positioned TAV tends to splay outwards, creating a 
‘flower pot’ arrangement, resulting in the operating leaflets being less 
constrained at their free margin187, as displayed in Figure 2-19. The wedge 
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effect also improves the security of the valve, especially for balloon expandable 
devices, as the post-ballooning recoil reduces the radial forces at the base of 
the host stent when the TAV is fitted215. However, whilst use of the flower-pot 
arrangement reduces energy losses during systole, it frequently results in a 
narrowing of the access to the SoV, reducing sinus washout, especially in the 
non-coronary sinus167,191. The likelihood of coronary obstruction is also raised, 
especially when: the old prosthesis has badly calcified or damaged leaflets; the 
coronary ostia are located closer towards the basal annulus; the aortic root and 
especially the SoV are particularly narrow71,73,191,212. RBC residence time 
increase in the neo-sinuses, both in systole and diastole, raising the risk of 
thromboembolism171. Additional ViV complications include non-ideal positioning 
of the new TAV (following 15 % more procedures compared to TAV 
implantation into a native valve), leaflet thrombosis (4 %), CA obstruction (3.5 
%) and an increased occurrence of a range  of conduction issues191,210. 
 
Figure 2-19: ‘Flower pot’ arrangement as a result of supra-annular deployment: (a) 
resultant deployments following increasingly supra-annular positioning of the TAV 
within the failing prosthetic, indicating escalating splaying of the outflow prosthesis 
orifice216; (b) in vivo images of (i) a regular TAV expansion into the native aortic 
annulus and (ii) a supra-annular implantation resulting in a conical, or ‘flower pot’, 
shape187 
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2.3.4 Mechanical response of pericardial tissue 
The bovine and porcine pericardial tissue used for the bioprosthetic valves have 
a J-curve relationship between stress and strain, much like the native aortic 
valve leaflet tissue as described in Section 2.1.3.3. Fixing collagen/elastin 
based tissue in GA, an agent that preserves and cross-links the tissue, causes 
changes to the stress-strain relationship of the tissue, but as long as the fixation 
is not done under pressure, the changes in response are not large, as indicated 
in Figure 2-20, as fibre crimping during fixation will occur under pressures > 4 
mmHg217. Whilst consensus has not yet been reached as to the quantified 
properties of bovine and porcine pericardium, with the reported modulus of the 
bovine pericardium stress-strain response  measured in vitro to vary from 10 to 
170 MPa and reports of the porcine pericardium modulus ranging from 60 to 
130 MPa218, the response of both tissues can still be described as a J-curve, 
with a low stretch modulus when the elastin fibres control the stress-strain 
response, a region of transition as the stiffer collagen fibres are unwound and 
begin to take the load, and a high stretch modulus when the collagen fibres are 
fully straightened and dominate the stress-strain response until tissue 
failure124,218. 
 
Figure 2-20: Stress-strain response of GA fixed aortic valve tissue217 
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2.4 Conclusions and Objectives 
The most relevant parts of the preceding literature review can be summarised 
by the following brief sections. 
2.4.1 Cardiovascular Efficiency and Vortical Dynamics 
The role of the aortic valve has a critical effect upon the efficiency of the 
cardiovascular system, and the valve’s efficiency depends upon the 
surrounding geometry. However, the role of the valve-root system upon the 
functional mode and hydrodynamics performance of the left side of the heart 
has not yet been fully revealed. During each cardiac cycle, vortices are 
generated in the aortic root, and especially in the sinuses of Valsalva, that are 
involved in the proper function of the aortic valve. Different aortic root 
geometries relative to the valve have resulted in different vortical patterns, but 
these patterns have not yet been explained. The mechanics of vortex 
generation and the vortices’ properties and propagation within and out of the 
aortic root have also not yet found consensus. How these vortices affect the 
aortic valve, whether a healthy native valve or a prosthetic, has also not been 
agreed upon. 
2.4.2 Post-Surgical Valve-Root Configurations 
The implantation of surgical valves can result in a range of relative geometries 
between valve and root, whilst disorders such as Marfan’s syndrome result in 
distinct changes to the aortic root region, and there is some evidence that these 
variations result in a change to the local haemodynamics, requiring different 
and bespoke therapies to encourage healthy blood flow. However, there is little 
information linking the haemodynamics of these roots with a change in vortical 
structures or stagnation regions, which could be elucidated via modern 
methods. Characterisation of these geometries and resulting flow patterns could 
lead to further classifications of root dilation, leading to improved support for 
clinicians and/or engineers by informing on the best therapeutic strategy. 
2.4.3 Valve-in-valve Architecture produces Flow Alterations 
The valve-in-valve architecture present after the majority of TAV implantation 
procedures results in significant alterations to the fluid dynamics of the aortic 
root, with the original dysfunctional leaflets permanently held open. These 
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alterations have been linked to the formation of downstream ischemic lesions 
and dementia, and the valve-in-valve configuration may also affect the coronary 
artery flow, in turn having a deleterious effect upon the cardiovascular system. 
The rotational alignment of a TAV is difficult to control and determine during the 
implantation procedure, and the effect of prosthesis to native commissure 
misalignment is as yet unknown. 
2.4.4 Coronary Artery Flow linked to Root Dynamics 
The flow through the coronary arteries is linked to the fluid dynamics of the 
aortic root in both the systolic and diastolic phases of the cardiac cycle. 
However, there are few investigations into what the effect of the 
presence/absence of the coronary arteries has upon the flow within the aortic 
root, specifically the sinuses of Valsalva, following TAV implantation. 
2.4.5 Objectives 
The conclusions of this literature review have led to the following objectives: 
2.4.5.1 Objective 1 
To investigate the effect of different valve-root geometries upon the fluid 
dynamics within the aortic root, modelling a native physiological configuration 
and comparing the resultant flow with a variety of configurations that could 
result from surgical aortic valve replacement. The research towards this 
objective is presented in Chapter 4. 
2.4.5.2 Objective 2 
To characterise the flow resulting from implantation of a TAV into a stenotic 
aortic valve, and to ascertain whether the rotational alignment of a TAV within 
its host root has an effect upon the resultant fluid dynamics in the region. This 
work is reported upon in Chapter 5. 
2.4.5.3 Objective 3 
To determine whether the presence of the coronary arteries, and the flow into 
them during each cardiac cycle, has an effect upon the fluid dynamics of the 
aortic root, particularly within the sinus of Valsalva associated with each 
coronary artery, following TAV implantation. Chapter 6 elaborates upon this 
objective. 
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3 Methods and Materials  
3.1 Introduction 
This chapter introduces the experimental rigs used in the investigations, and the 
Particle Image Velocimetry (PIV) used to analyse the flows generated. Firstly, a 
summary of the bench top pulse duplicator used to generate the desired flow 
rates and pressures within the valve-root configurations, including explanations 
of the equations used to calculate the global hydrodynamic parameters which 
quantify the cycle-to-cycle performance of the valve-root configurations is 
presented in Section 3.2. Next, the theory and methodology behind the use of 
PIV in this study is outlined in Section 3.3, describing how the instantaneous 
flow velocities are calculated. The chapter then continues to detail the materials 
used in these rigs, describing the aortic valves used in the flow studies in 
Section 3.4; the design, manufacture and use of the mock roots that these 
valves were inserted into in Section 3.5; and finally the details of the different 
testing fluids that have been used in the experiments in Section 3.6. 
3.2 Pulse Duplicator – Vivitro Systems Left 
Heart Simulator 
3.2.1 Experimental Rig 
The ViVitro Systems left heart simulator (SP3891, ViVitro Systems, Canada) 
consists of a pump, a mock left heart, pressure and flow transducers, and a 
computational system, with a photo and schematic shown in Figure 3-1, and 
reproduces physiologically equivalent pressures and flow rates conforming to 
the requirements of ISO 5840:2005. A programmable waveform generator 
(WG5891, ViVitro Systems, Canada) supplies a signal to control the pump head 
and is sent to the pump (SuperPumpVSI Head SPH5891B, ViVitro Systems, 
Canada) via electronic signal through a power amplifier (SPA3891, ViVitro 
Systems, Canada) which designates whether the waveform controls the 
position or velocity of the pump head. This waveform can be altered to model 
different cardiovascular systems and states by varying the pump head 
displacement/velocity, and frequency. The amplitude of the signal is 
independently adjusted on the power amplifier, with an increase in amplitude 
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increasing the simulated CO and mean aortic pressure. The rotary motion of the 
electric motor is converted into linear translation of the piston via a linear 
actuator and lead screw. Adherence to the input waveform is maintained via 
feedback from position and velocity transducers situated alongside the piston-
in-cylinder pump head. 
The pressure changes from the pump head are fed through an impedance 
adaptor, consisting of a resistive element and two adjustable compliance 
chambers, to provide greater accuracy when modelling a range of physiological 
and pathological cardiac systems, and also filter out any high frequency noise 
during valve or conduit testing. This pressure waveform then acts upon the 
hydraulic fluid surrounding a silicone sack, representing the left ventricle, which 
is part of the mock left heart. Testing fluid from the atrium chamber, 
representing the left atrium, flows into this silicone sack/ventricle through the 
mitral valve, preventing back flow into the atrium chamber. The atrium chamber 
is open to the atmosphere, and enables testing fluid, dyes, or particulates to be 
introduced into the pulse duplicator system. The mitral valve can be replaced to 
allow for testing of different valves, but as this research was concerned with the 
aortic root region, a mechanical Sorin Allcarbon 27 mm valve (Sorin Group, 
Italy), detailed in Section 3.4.2, was used for all tests. 
All pressure signals are provided by high-resolution pressure transducers (Millar 
Mikro- tip®, Millar Inc., USA), and then passed through a bridge amplifier to a 
tri-pack (TP2001, ViVitro Systems, Canada), which is made up of three 
amplifiers (VSI AM9991, ViVitro Systems, Canada), before being collected by 
the computer. The pressure transducers were calibrated by measuring the 
voltage output of the transducers when placed under gauge pressures of 0 
mmHg and 200 mmHg, as measured by a digital manometer (Extech HD750, 
Nashua, USA) with a range of 0 - 5 psi and a resolution of 0.001 psi. Upstream 
of the mitral valve is a high-resolution pressure transducer providing the user 
with the left atrial pressure throughout testing. Another pressure transducer is 
located in the ventricular chamber, between the flow probe and the aortic valve, 
measuring the ventricular pressure throughout testing. The final pressure 
transducer is located approximately 50 mm downstream of the aortic valve, 
providing measurements of the aortic pressure throughout the cycle. 
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Figure 3-1: Vivitro Labs Pulse Duplicator System SP3891, with schematic 
(adapted from Lieber 2002219) 
1 - Pump; 2 - Ventricle Chamber; 3 - Atrium Chamber; 4 - Aortic Chamber; 
5 - Aortic standoff; 6 - Aortic Compliance chamber; 7 - Peripheral resistance; 
8 - Power amplifier; 9 - Viscoelastic Impedance Adaptor; 10 - Computer; 
11 – Flowmeter; 12 - Electromagnetic flow transducer; 13 - I/O Module; 
14 - Pressure transducer tri-pack  
 
Fluid pumped from the ventricle passes first through a flow transducer and then 
the aortic valve being tested, until it enters the aortic chamber. The flow 
transducer is an electromagnetic flowmeter (Carolina Medical Model FM501, 
Carolina Medical Electronics Inc., USA), and bases its instantaneous volumetric 
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flow rate upon the rate of ions within the fluid passing through the flow 
transducer, with an acquisition frequency of 256 samples per simulated heart 
cycle. The flowmeter is calibrated so that the transducer signal is directly 
proportional to an output from the pump controller, the piston displacement (𝐿) 
signal with respect to time (X6X?). This is achieved by applying a 50% sine 
waveform at a cycle rate of 70 bpm to the pulse duplicator and recording the 
cumulative voltages over the cycle of both the 𝑑𝐿/𝑑𝑡 and the flow rate from the 
flow meter (𝑞E). The 𝑞E signal then has a calibration factor, 𝐶0, applied to it, so 
that 𝑞E = \X6X? . 𝐶0^. 
The aortic valve can be replaced to test different valves, and a range of valves 
were used during this testing, detailed in Section 3.4.1. The aortic chamber is 
split into two main parts, with the volume immediately downstream of the aortic 
valve connected to a compliance chamber that allows modelling of various 
aortic root (or local) compliances by varying the amount of fluid and air within 
the compliance chamber. An aortic root model can also be fitted into this first 
aortic chamber volume, imposing predesignated 3D volumes on the fluid flow, 
allowing for modelling of specific lumen diameters, sinuses of Valsalva, 
coronary arteries, and surgical grafts. The second aortic chamber volume is 
connected to the first by a short tube. A second fluid and air compliance 
chamber connected to this second aortic chamber enables the more general (or 
global) arterial compliance of the remainder of the vascular system to be 
modelled. 
Outflow from the aortic chamber passes through the heating bath of a heat 
exchanger (Model HE991, ViVitro Systems, Canada, with pre-set temperature 
controlled by a compact closed circulator with digital control, Grant FH16-D, 
Grant Instruments, UK), regulating the temperature of the fluid to a pre-set 
value. Before returning to the atrial chamber, the testing fluid flows through the 
peripheral resistance regulator, which can be twisted to increase/decrease the 
amount of resistance to flow, representing the vascular resistance of the body.  
 
 80 
3.2.2 Parameters Measured 
The pressure and flow rate waveforms acquired can then be extracted from the 
Vivitro software, imported into data analysis software (Microsoft Excel, 
Washington, USA), and converted into a number of different parameters to 
assess the hydrodynamic performance of the valve-root configuration. The 
parameters chosen for these experiments were:  
• Mean Transvalvular Systolic Pressure Drop (∆𝑝); 
• Effective Orifice Area (EOA); 
• Closing and Leakage Regurgitant Volume (𝑉4/𝑉5); 
• Forward/Closing/Total Energy Loss (𝐸0/𝐸4/𝐸?); 
In order to calculate these parameters, each cycle is divided into 4 distinct flow 
periods and 4 distinct pressure periods, separated by crossover points as 
indicated in Figure 3-2, as the pulse duplicator simulates each cycle of the 
heart. The flow cross over points are determined as follows:  
F1 – first positive flow from ventricle to aorta; beginning of systolic 
forward flow  
F2 – end of positive flow from ventricle to aorta; end of systolic forward 
flow  
F3 – negative flow through outflow valve, i.e. regurgitant flow from aorta 
to ventricle, becomes constant, indicating end of valve closure and start 
of valve leakage 
F4 – end of cycle 
The flow in period F1 – F2 is defined as ‘forward flow’; in period F2 – F3 as 
‘closing flow’; and in period F3 – F4 as ‘leakage flow’. 
The pressure drop crossover points are defined as:  
P1 – ventricular pressure rises above aortic pressure; beginning of 
systolic positive pressure  
P2 – ventricular pressure falls beneath aortic pressure; end of systolic 
positive pressure 
P3 – ventricular pressure drops beneath atrial pressure; beginning of 
diastolic pressure 
P4 – ventricular pressure rises above atrial pressure; end of diastolic 
pressure 
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Period P1 – P2 is defined as ‘systole; Period P3 – P4 is defined as ‘diastole’. 
 
Figure 3-2: Flow-pressure diagram of a typical cardiac cycle, denoting the flow (F1-F4) 
and pressure (P1-P4) crossover points used to calculate the parameters described in 
Section 3.2.2 
3.2.2.1 Mean Transvalvular Systolic Pressure Drop 
The mean pressure drop (∆𝑝) of the flow as it passes from the ventricular to the 
aortic side of the valve during systole is a commonly used parameter to assess 
systolic valve performance, with a smaller pressure drop indicating a better 
performing and more efficient valve. ∆𝑝 (mmHg) is defined as the mean of the 
pressure difference between the outflow and inflow pressures (representing the 
aortic and ventricular pressures respectively) between P1 and P2 (i.e. during 
systole), which can be represented as: 
 ∆𝑝 = ∫ (𝑝E − 𝑝P)𝑑𝑡dedf𝑡de − 𝑡df  
(3-1) 
where 𝑝E is the ventricular pressure (mmHg), 𝑝P is the aortic pressure (mmHg), 𝑡 is the time (s), 𝑃1 is the beginning of the systolic pressure drop, and 𝑃2 is the 
end of the systolic pressure drop. 
3.2.2.2 Effective Orifice Area 
When a uniform flow passes through an orifice, the flow usually separates into 
three distinct zones – an axisymmetric jet-like flow; a recirculation zone; and a 
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reattachment zone220. The outflow of blood from the left ventricle through the 
aortic valve can be compared to the flow through a nozzle in a more traditional 
engineering application36. This results in the flow being constricted beyond the 
orifice, and thus the smallest cross-sectional area of the jet-like flow is further 
downstream from the orifice, known as the vena contracta37, as illustrated in 
Figure 3-3. 
 
Figure 3-3: the forward flow continues to be contracted once it has passed through the 
orifice, reaching maximum constriction at the vena contracta [adapted from Caro 
201237] 
When referring to heart valves, the cross-section of the vena contracta is 
referred to as the Effective Orifice Area (EOA), a commonly used parameter to 
assess both the severity of aortic stenosis, and the performance of a valve 
substitute220. It is important not to confuse the Geometric Orifice Area (GOA) of 
the valve with the EOA. The area of this vena contracta can be calculated from 
the Bernoulli and Continuity equations. Assuming inviscid, incompressible 
steady flow along a streamline under constant gravitational force with a 
negligible change in height, the pressures and mean fluid velocities over cross-
sections 1 and 2 in Figure 3-3, representing a cross-section of the ventricle and 
the vena contracta of the downstream flow from the aortic valve respectively, 
can be related by the Bernoulli equation: 
 𝑃f + 12𝜌𝑣fe = 𝑃e + 12𝜌𝑣ee 
(3-2) 
where 𝑃 is pressure (N/m2), 𝑣 is the mean fluid velocity over the cross-section 
(m/s), and 𝜌 is the fluid density (kg/m3), and can be rearranged to give: 
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 (𝑃f − 𝑃e =)∆𝑃 = 12𝜌𝑣ee − 12𝜌𝑣fe 
(3-3) 
where ∆𝑃 is the pressure difference (N/m2). As 𝑣fe << 𝑣ee 221, this can be further 
simplified to: 
 ∆𝑃 = 12𝜌𝑣ee 
(3-4) 
which can be rearranged to give: 
 
𝑣e = j2 ∗ ∆𝑃𝜌  
(3-5) 
The Continuity equation posits that the change of mass in an analysed volume 
is equal to the mass of the fluid entering the volume minus the mass of fluid 
exiting the volume, and the mean flow speeds at the in- and out-flow (i.e. cross-
sections 1 and 2 in Figure 3-3) are related by: 
 (𝑄 =)𝑣f𝐴f = 𝑣e𝐴e 
(3-6) 
where 𝑄 is the constant flow rate (m3/s) and 𝐴 is the cross-sectional area of the 
flow (m2), and combining and rearranging Equations (3-5) and (3-6) gives: 
 
 𝐴e = 𝑄l2 ∗ ∆𝑃𝜌  
(3-7) 
Hence, the flow contraction is associated with a pressure drop in the flow. In 
order to account for the reduction in section due to viscous effects, it is 
necessary to apply a discharge co-efficient in line with ISO 5840:2015222, and 
so the EOA (cm2) of the flow in the pulse duplicator is calculated as: 
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 𝐸𝑂𝐴 = 	 𝑞EFGH51.6 ∗ l∆𝑝𝜌  
(3-8) 
where 𝜌 is the density of the blood analogue fluid (kg/m3), and 𝑞EFGH is the root 
mean square of the forward flow (ml/s) through the flow meter, defined as: 
 
𝑞EFGH = j∫ 𝑞E(𝑡)e𝑑𝑡pepf𝑡pe − 𝑡pf  
(3-9) 
where 𝑞E(𝑡) is the instantaneous flow at time 𝑡 (ml/s), 𝑡pf is time at F1 (s), and 𝑡pe is the time at F2 (s). 
3.2.2.3 Regurgitant Volume 
Any testing fluid that flows from the aortic chamber back into the ventricular 
chamber is termed the ‘regurgitant volume’. This volume is split into a ‘closing 
regurgitant volume’, primarily due to transvalvular (i.e. through the valve) back 
flow through the leaflets during valve closure, and a ‘leakage regurgitant 
volume’, which occurs due to both transvalvular and paravalvular (i.e. around 
the valve) back flow. The closing regurgitant volume (𝑉4, ml) is useful as a 
parameter of the dynamic performance of the valve and is defined as the flow 
volume with respect to time (s) between F2 and F3 (i.e. during valve closure as 
defined in Section 3.2.2), which is calculated as: 
 𝑉4 = q r𝑞E(𝑡)s𝑑𝑡ptpe  
(3-10) 
The leakage regurgitant volume (𝑉5, ml) is defined as the flow volume with 
respect to time (s) between F3 and F4 (i.e. during leakage flow as defined in 
Section 3.2.2), which is calculated as: 
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𝑉5 = q r𝑞E(𝑡)s𝑑𝑡pupt  
(3-11) 
3.2.2.4 Energy Losses 
There are multiple ways in which the aortic valve can lose energy. During 
forward flow, the transaortic pressure drop across the valve results in a loss of 
energy in the fluid. Regurgitation back through the valve during valve closure, 
and leakage around and through the valve when the leaflets are closed are both 
ways in which the efficiency of the stroke volume is decreased. These energy 
losses incurred during each simulated cardiac cycle provided a consolidated 
value of valve performance, and a method of comparing the forward flow 
inefficiencies of one valve with the regurgitant volumes of another. The 
following integrals were used to calculate the forward (𝐸0), closing (𝐸4), and 
leakage (𝐸5) energy losses (in mJ) respectively, in accordance with the findings 
of Leefe and Gentle223: 
 𝐸0 = 𝑘0 ∗ q ∆𝑝 ∗ r𝑞E(𝑡)s𝑑𝑡pepf  
(3-12) 
 𝐸4 = 𝑘0 ∗ q ∆𝑝 ∗ r𝑞E(𝑡)s𝑑𝑡ptpe  
(3-13) 
 𝐸5 = 𝑘0 ∗ q ∆𝑝 ∗ r𝑞E(𝑡)s𝑑𝑡pupt  
(3-14) 
 
where 𝑘0 is a constant conversion factor of 0.1333, to convert from mmHg*ml to 
mJ. 
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3.3 Particle Image Velocimetry – TSI PIV 
System 
Whilst pulse duplicators are ideal for capturing the global flow parameters 
performed by the tested valve, they give little information about the local flow 
parameters, i.e. specific instants within each cardiac cycle. The unsteady nature 
of fluid flow in the aortic region makes full field measurement of instantaneous 
velocities highly desirable224. With careful setup, Particle Image Velocimetry 
(PIV) can provide information about the velocity fields by seeding the flow with 
neutrally buoyant particles, and then calculating particle displacement between 
two images of a cross-section of the flow over a known period of time. If the 
seeding particles are sufficiently neutrally buoyant and reactive to the flow, the 
displacement of the particles can be taken as the same as the displacement of 
the fluid carrying them, thus elucidating information about the flow to enable 
further valve performance improvements. A schematic of a basic PIV setup is 
presented in Figure 3-4. 
Unlike Particle Tracking Velocimetry, a Lagrangian technique where the 
seeding of the flow is much less dense and each particle is continually traced 
as it travels with the flow, PIV is a Eulerian technique that takes a pair of images 
of the same illuminated cross-section of a flow, separated by a short time 
interval. A grid is applied to the images, and patterns of particles are identified 
and matched across the two images via a process known as ‘cross-correlation’, 
under the assumption that the pattern of these particles will change minimally 
over the time period225. The displacement of the pattern over the time frame is 
assumed to be the velocity of the fluid in that particular interrogation spot, and 
this is repeated across the areas of interest of the image pair of the cross-
section225. 
The following sections describe the process of data acquisition and processing 
to obtain vector fields representing the flow cross-section using the INSIGHTTM 
4G-2DTR (TSI Inc., Minnesota, USA, version number 10.0.3.30) software. 
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Figure 3-4: PIV schematic [adapted from Sun 2015226], showing a seeded flow being 
illuminated by a laser sheet, and image pairs, separated by a time interval of ∆t 
captured by a CCD camera positioned perpendicularly to this laser sheet 
3.3.1 Image Capturing 
The PIV measurement system consisted of a laser, a synchroniser, a camera, 
and vector processing/imaging software, as shown as a schematic in Figure 
3-4. The use of a double pulse Nd:YAG laser (YAG70-15-QTL, TSI Inc., 
Minnesota, USA) was ideal due to its high amplification, good mechanical and 
thermal properties, ease of use in a triggered mode (allowing for 
synchronisation with the pulse duplicator system), and fine adjustment of ∆t225. 
A laser beam with a wavelength of 532 nm was produced, that was passed 
through a series of lenses, manipulating the beam into a thin light sheet, with 
thickness 0.4 mm. To prevent artefacts, external light sources were switched 
off, and reflective surfaces not directly required for data acquisition were 
covered up during testing. 
As the speed of light changes when it passes from a medium of one density into 
a medium of another density, any light beams that are not orthogonal to the 
interface of the two mediums may be displaced, rotated, or distorted227. The 
 88 
Refractive Index (RI, symbolized as 𝑛) of a material is the ratio between the 
velocity of light in free space (or, for practical purposes, in air) and the velocity 
of light in the material in question, with a greater amount of light beam 
deflection/distortion/etc occurring when the RI difference between the two 
mediums is greater. The transparent pulse duplicator chamber wall that the 
camera imaged through was flat and aligned perpendicularly to the camera, so 
that the RI difference between the air, the acrylic wall of the pulse duplicator, 
and the working fluid did not distort the image. Similarly, the transparent pulse 
duplicator chamber wall that the laser sheet was directed against was also 
aligned perpendicularly with the laser sheet, to minimise any distortion of the 
laser sheet shape. However, as the replication of the physiological geometry 
included curved surfaces, it was important to match the RI of the working fluid to 
that of the transparent, silicone mock root, in order to reduce optical distortion of 
the PIV images as a result of light refraction. 
The laser was positioned so that the light sheet illuminated the central sagittal 
plane of the aortic root within the pulse duplicator, as shown in Figure 3-5, and 
was triggered upon receiving a signal from a synchroniser (LaserPulseTM 
Synchroniser, Model 610036, TSI Inc., Minnesota, USA). This synchroniser was 
in turn connected to two computers, one for the PIV system and one for the 
pulse duplicator. This enabled the PIV system to repeatedly capture images 
from specific instants within the mock cardiac cycle as detected by the pulse 
duplicator system, allowing for phase-averaging over multiple image pairs. This 
synchronisation is denoted as a ‘trigger delay’ and is referenced in ms from the 
instant of the first forward motion of the pump in each cycle. 
 
Figure 3-5: Diagram of laser sheet for PIV positioned over cross-section of valve-root 
configuration under investigation 
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Once synchronised with the pulse duplicator, two pulses were fired by the laser, 
separated by time ∆𝑡 (𝜇s), at specific moments within the pulse duplicator’s 
cycle, e.g. peak forward flow, for a pre-determined number of cycles. Small, 
neutrally buoyant tracer particles (HGS-10, Dantec Dynamics, Denmark) were 
added to the testing fluid inside the pulse duplicator, scattering any light incident 
upon them. The response time, 𝜏= (s), of these particles to the fluid flow, 
indicating the delay between a change in motion of the fluid and a 
complimentary change in motion of the particles moving within that fluid, is 
calculated by225: 
 𝜏= = 𝑑9e𝜌918𝜇  
(3-15) 
where 𝑑9 is the mean diameter of the seeding particles (1 x 10-5 m), 𝜌9 is the 
density of the seeding particles (1100 kg/m3), and 𝜇 is the dynamic viscosity of 
the working fluid (Pa.s). Any difference between the densities of the working 
fluid and the seeding particles will also lead to a gravitationally induced velocity, 𝑼y (m/s), acting upon the particles, equal to: 
 𝑼y = 𝑑9e(𝜌9 − 𝜌)18𝜇 𝒈 
(3-16) 
where 𝜌 is the density of the working fluid (kg/m3), and 𝒈 is acceleration due to 
gravity (m/s2). As different working fluids were used at different stages of the 
investigations, the response times and gravitationally induced velocities of the 
seeding particles in the various working fluids are calculated and discussed in 
Sections 3.6.2 and 3.6.3. 
A frame-straddling CCD camera (with a resolution of 2048 x 2048 pixels, TSI 
PowerViewTM Plus 4MP, TSI Inc., Minnesota) with a 52 mm lens (Nikon, Japan) 
is also connected to this system, and takes an image perpendicular to the laser 
sheet, corresponding to each of the two laser pulses in each cycle, one at time t 
and one at time 𝑡 + ∆𝑡. A longer ∆𝑡 is required for a slower moving flow and is 
calculated according to the one-quarter rule225, which suggests that ‘the 
maximum displacement of a particle should not exceed 1/4 of the size of the 
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interrogation spot’ (refer to Section 3.3.2.2.1 for a description of the 
interrogation spot). This was related to the flow through the aortic valve as: 
 ∆𝑡 = 𝑛=9>? ∗ 𝑘4 ∗ 𝑣|P}  
(3-17) 
where 𝑛=9>? is the final interrogation spot size (pixels), 𝑘 is the 𝜇m to pixel ratio 
(defined in the calibration process below, and which provides the magnification 
factor from equations (3-21) and (3-23), and 𝑣|P} is the maximum flow velocity 
detected through the flow transducer (m/s), to give ∆𝑡 (𝜇s). However, the flow 
will be considerably slower in the sinuses than in the central jet-like flow during 
systole. The central jet-like flow may also be faster than the flow past the 
transducer, as the orifice created by the valve leaflets may be smaller than the 
orifice created by the flow transducer. As a result, it is necessary to capture 
images from each instant with various values of ∆𝑡 to fully reveal the fastest and 
slowest flow behaviour within the aortic root. 
3.3.2 Image Processing 
The two images from each cycle are transferred to the computational system for  
processing. Cross-correlation is used to identify matching particle patterns in 
the two images, determining the distance these patterns have moved during ∆𝑡, 
and translating this into a velocity measure, as described in Section 3.3.2.2.1. In 
the practicalities of the experiment, this cross-correlation consisted of pre-
processing, processing, and post-processing. A flow chart illustrating the image 
processing steps is presented in Figure 3-6. 
3.3.2.1 Pre-processing 
In order to perform the cross-correlation, several steps of pre-processing were 
needed to prepare the images and extract important information. The 
magnification factor, 𝑀, is required to relate the positions of the particles in the 
images to the positions of the particles in the interrogation volume and is 
provided by the 𝜇m to pixel ratio. Within the interrogation volume and captured 
by the images was an object of predetermined physical length, which was used 
to determine the 𝜇m to pixel ratio. This varied according to the focus of the 
camera lens, and a range of 20-25 𝜇m/pixel was measured across the 
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experiments. Next, a processing mask was applied to the image pairs, to save 
computing time by ensuring that only vectors within the processing mask, i.e. 
the image area of interest, were computed. This mask was altered for the 
different instants within the cycle, as the physical environment changed position 
due to the unsteady flow rate and pressures throughout the cycle. 
 
 
Figure 3-6: Flowchart illustrating the PIV processing protocol 
The final step of pre-processing was to apply an image pre-processor, labelled 
as ‘Image Filter’, to modify the image for improved vector mapping. The value of 
any given pixel in the output image is determined by applying an algorithm to 
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the value of the pixels in the neighbourhood or corresponding input pixel. A 
Gaussian low-pass filter uses rotationally symmetric kernels and a standard 
deviation of 𝜎 = 0.6 to effectively blur the particles so that they encompass a 
larger area and encompass more pixels to allow for improved recognition during 
processing. 
3.3.2.2 Processing 
Once the images have been prepared via pre-processing, the processing stage 
begins. The image is divided into smaller spots for vector field processing. In 
order to achieve the Nyquist sampling criterion required that to adequately 
reproduce a signal (in this case, the image), it should be sampled at twice the 
highest resolution required228. The interrogation spot size is denoted by 𝑛=9>? 
from equation (3-17), and the vectors of the grid are set with the x-spacing 
equal to 𝑛=9>? width divided by 2, and the y-spacing equal to 𝑛=9>? height divided 
by 2. As all the interrogation spots were square in these experiments, the x-
spacing was equal to the y-spacing. 
The image pairs are processed in two passes, with the first pass, using a spot 
size of 64 x 64 pixels, with 50% overlap spacing providing information for the 
displacement of the correlation group of particles over ∆𝑡, which can be used by 
the second pass to use a smaller spot size, half the height and width of the first 
spot size, with double the number of vector rows and columns, leading to 4 
times the number of vectors calculated. This smaller spot size can be used 
because the spot analysing the 𝑡 image is offset by the pixel displacement 
calculated from the first pass, so that the centre of the particle pattern is at the 
centre of the interrogation spot for the 𝑡 image. This method of using two or 
passes that achieve the Nyquist sampling criterion is labelled as a ‘Recursive 
Nyquist Grid’. 
3.3.2.2.1 Cross-correlation 
A cross-section of the investigated flow is illuminated by a thin laser sheet, and 
the flow is seeded with particles that are illuminated by this laser sheet. The 
illuminated volume is split up into many smaller interrogation volumes, where 
each volume contains between 5 and 15 particles225. The position of N 
particles, 𝚪, in any given interrogation volume at time 𝑡 is given by225: 
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𝚪 = 𝑿𝒊⋮𝑿𝑵 
(3-18) 
where the position of particle 𝑖 is given by225: 
 
𝑿𝒊 = 𝑋𝑌𝑍 
(3-19) 
If an image of this interrogation volume is taken in the  \𝑥𝑦^ plane, the position of 
each particle in the image can be represented by225: 
 𝒙𝒊 = \𝑥𝑦^ 
(3-20) 
Assuming the image of the volume is perfectly in alignment with the \𝑥𝑦^ plane 
of the volume, the position of the particles in the volume and in the image are 
related by a magnification factor, 𝑀, specific to the imaging technique225: 
 𝑋 = 𝑥𝑀 				and				𝑌 = 𝑦𝑀 
(3-21) 
Vector 𝑫 represents the average of the displacement of the particles within the 
interrogation spot over incremental time period ∆𝑡, so that the position of the 
particles at time 𝑡, where 𝑡 = 𝑡 + ∆𝑡, is given by225: 
 
𝑿𝒊 = 𝑿𝒊 + 𝑫 = 𝑋 + 𝐷𝑌 + 𝐷𝑍 + 𝐷 
(3-22) 
The displacement of the particles,	𝒅, in the volume within the plane illuminated 
by the laser field can be related to the displacement of the particles in the image 
by the same magnification factor, 𝑀, as used for the calculation of the position 
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of the particles in the volume in relation to the position of the particles in the 
image, given by225: 
 𝒅 = 𝑀𝐷}𝑀𝐷 
(3-23) 
The image intensity field,	𝑰 representing the light in the image received from the 
particles in the interrogation spot, for the interrogation spots at time 𝑡 is given 
by225: 
 
𝑰(𝒙, 𝜞) =𝑉(𝑿𝒊)𝜏(𝒙 − 𝒙𝒊)f  
(3-24) 
and the image intensity field at time 𝑡, 𝑰, by225: 
 
𝑰(𝒙, 𝜞) =𝑉(𝑿𝒋)𝜏(𝒙 − 𝒙𝒋 − 𝒅)f  
(3-25) 
where 𝜏(𝒙) represents the point spread function of the lens (considered to be 
identical for all particle positions), and 𝑉(𝑿𝒊) and  𝑉(𝑿𝒋) are transfer functions 
representing the light energy of the particles in the respective instants. 
Considering the light sheet and interrogation volumes as identical, the cross-
correlation function, 𝑅ff, of these two interrogation areas can be written as225: 
 𝑅ff(𝒔, 𝚪, 𝑫) = 1𝑎¢𝑉(𝑿𝒊)𝑉r𝑿𝒋 + 𝑫s, q 𝜏P£. (𝒙 − 𝒙𝒊)𝜏r𝒙 − 𝒙𝒋 + 𝒔 − 𝒅s𝑑𝑥 
(3-26) 
where 𝒔 is a separation vector in the correlation plane and 𝑎¢ is the interrogation 
area. 
By assuming that the 𝑖 ≠ 𝑗 terms represent the randomly distributed particles, 
i.e. primarily noise in the correlation plane made up from the convolution of the 
mean intensities and a fluctuating noise component, and that the 𝑖 = 𝑗 terms 
contain the sought-after displacement information, i.e. the detection of an 
 95 
identical group of particles in both times 𝑡 and 𝑡, equation (3-26) can be re-
represented so that the two term types can be distinguished from each other225: 
 𝑅ff(𝒔, 𝚪, 𝑫) =𝑉(𝑿𝒊)𝑉r𝑿𝒋 + 𝑫s¦ 𝑅§r𝒙 − 𝒙𝒋 + 𝒔 − 𝒅s 
+𝑅§(𝒔 − 𝒅)𝑉(𝑿𝒊)𝑉(𝑿𝒊 + 𝑫)f  
(3-27) 
This component of 𝑅ff can be represented by 𝑅¨, given by225: 
 
𝑅¨(𝒔, 𝚪, 𝑫) = 𝑅§(𝒔 − 𝒅)𝑉(𝑿𝒊)𝑉(𝑿𝒊 + 𝑫)f  
(3-28) 
which provides a maximum cross-correlation peak at 𝒔 = 𝒅, as illustrated in 
Figure 3-7, and the location of this peak gives the average in-plane 
displacement and hence the 𝑈 and	𝑉 components of the velocity of the group of 
particles analysed. 
For each interrogation spot, the highest correlation map pixel was assumed to 
be the particle image displacement peak, with the other peaks in the correlation 
map taken to be noise peaks created by random pairings of different particle 
patterns. The correlation peak was found by fitting a Gaussian curve to the 
highest pixel and its four nearest pixels. 3-point fits in the 𝑥-direction and 𝑦-
direction were done, on the peak pixel and each pixel to the left and right of (for 
the 𝑥-direction) or above and below (for the 𝑦-direction) this peak pixel, was 
done. The Gaussian peak equation was defined as: 
 𝑑𝑥 = 𝑥 + (log(𝑙) − log	(𝑟))2(log(𝑙) + log(𝑟) − 2log(𝑐)) − 𝑥 
(3-29) 
where the intensity values for left, right and peak pixels in the correlation map 
are denoted by 𝑙, 𝑟, and 𝑐 respectively, 𝑥 is the integer shift and	𝑥 is the zero-
shift location. A Peak to Noise-Peak ratio threshold of 1.3 was applied, so any 
correlation peaks less than 1.3 times the height of the biggest noise peak in the 
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same correlation map were rejected and labelled as ‘bad’ vectors. Those that 
passed this requirement were labelled as ‘good’ vectors. 
 
Figure 3-7: Composition of peaks in the cross-correlation function [adapted from Raffel 
2007225] 
3.3.2.3 Post-processing 
After this processing, vector validation, or post-processing, is undergone, with 
two post-processor functions utilised. The first function was labelled as ‘Vector 
Field Conditioning’, and the resultant vectors were labelled as ‘interpolated’ 
vectors. These ‘interpolated’ vectors were then validated by the second post-
processor function, which compared each new vector with a reference vector 
equal to the median velocity of all the vectors within its 5 x 5 neighbourhood. 
The new vector was re-designated as ‘bad’ if its value was not within a 
tolerance range of the reference vector, with a tolerance of 𝑑𝑈 = 𝑑𝑉 = 2 pixels. 
The second function, ‘Local Validation’, filled holes in the vector field, which 
were primarily due to vectors failing the Peak to Noise-Peak ratio requirements. 
The holes were filled by the mean vector of neighbourhood vectors, with a 
minimum of 3 ‘good’ neighbour vectors needed in a 5 x 5 neighbourhood.  
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After post-processing, the calculated vectors designated as ‘good’ or 
‘interpolated’ were included in the exported vector field, with the ‘bad’ vectors 
excluded from this matrix. 
3.3.3 Data Analysis 
3.3.3.1 Vector Properties 
The vector fields generated by the processes of Section 3.3.2 were used to 
quantify and illustrate the investigated flow. The velocity fields derived from all 
of the image pairs for a given instant were averaged. Calculating the velocity of 
the flow enables elucidation of the flow structures present in the flow, such as 
vortical structures, separation regions, and stagnant volumes, and was derived 
from the vectors by the following equation: 
 𝑣|Py = °𝑈e + 𝑉e 
(3-30) 
where 𝑣|Py is the velocity magnitude of the vector (m/s), 𝑈 is the x component 
of the vector (m/s), and 𝑉 is the y component of the vector (m/s). 
When a flow is laminar, the fluid flows in parallel layers, with little disruption 
between the layers of flow, and little lateral mixing. As a flow speeds up and 
traverses more complex geometry, the flow may become turbulent, 
characterised by eddies and mixing of the layers of flow. As turbulence has 
been linked with elevated wall and blood stress, leading to increased 
endothelial damage, blood damage and thrombosis37,85–89, information on the 
level of turbulence within a flow is desirable. The Reynolds equation can be 
used in steady (as opposed to pulsatile) flows, characterising flow according to 
the density, viscosity, and average speed of the flow alongside the diameter of 
the vessel it is flowing through, to dichotomise flows as laminar or turbulent, but 
is of less applicability in the pulsatile flows generated by a pulse duplicator, and 
give little discrete information across a cross-sectional image. By assuming that 
regions of greater turbulence will have a greater amount of cycle-to-cycle 
variation in the phase-resolved calculations of velocity for each node in those 
regions, the standard deviation of the velocity can be related to the turbulence 
of the flow, with a greater standard deviation of velocity for a particular node 
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over the image pairs of a specific pass indicating a greater fluid turbulence in 
that part of the flow. The presence of turbulence in blood flow results in a loss of 
energy and can lead to blood damage and haemolysis88,89. This standard 
deviation was calculated via: 
 𝑆𝐷?²³Q = °𝑈e + 𝑉e 
(3-31) 
where 𝑆𝐷?²³Q is the standard deviation representing turbulence in the flow, and 𝑈e and 𝑉e are the standard deviations of the 𝑢 and 𝑣 components of the 
velocity respectively. 𝑈 for each node is calculated via: 
 
𝑈 = j∑(𝑈 − 𝑈¶)e𝑛  
(3-32) 
where 𝑈¶ is the mean 𝑢 component of velocity for that node across the image 
pairs, and 𝑛 is the number of image pairs. The 𝑉 component of 𝑆𝐷?²³Q is 
worked out in the same way, but for the 𝑣 components of the velocity. 
The Reynolds shear stress (RSS) (derived from the effect of convective 
acceleration upon the mean velocity profile, i.e. related to the shear stresses 
between layers of the fluid caused by temporal variations in the velocity field) 
has been related to blood damage potentially leading to haemolysis37,89,90, as 
detailed in Section 2.1.3.1.2, and so provides useful information for the 
investigation. By establishing the fluctuating component of the x- and y-
velocities at node i,j (𝑢,  and 𝑣,  respectively) from: 
 𝑢, = 𝑢, − 𝑈, 
(3-33) 
and 
 𝑣, = 𝑣, − 𝑉, 
(3-34) 
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where 𝑢, and 𝑣, are the instantaneous x- and y-velocities at node i,j (i.e. at 
location 𝑥, 𝑦), and 𝑈, and 𝑉, are the mean x- and y-velocities at node i,j, the 
RSS is derived from the vector field by multiplying the following equation by the 
density of the fluid: 
 (−𝑢𝑣),,PEy = 1𝑁−𝑢, 𝑣,  
(3-35) 
The vorticity of the flow describes the spinning motion of the flow at each point, 
giving an indication of the intensity of a vortex or the degree of washout of a 
volume within the flow. The vorticity component orthogonal the plane of 
measurement for each point, 𝜔¹ (s-1), is defined as: 
 𝜔¹ = 𝑑𝑣𝑑𝑥 − 𝑑𝑢𝑑𝑦 = 𝑣ºf, − 𝑣»f,𝑥ºf, − 𝑥»f, − 𝑢,ºf − 𝑢,»f𝑦,ºf − 𝑦,»f  
(3-36) 
3.3.3.2 Streamlines 
Calculating and illustrating the streamlines of the velocity fields generated 
provided enhanced visualisation of the cross-section, highlighting wash-out 
regions, vortices, and stagnant, unstructured regions of flow. A streamline is 
defined as a line which is tangent to the instantaneous velocity field, as 
illustrated in Figure 3-8. 
 
Figure 3-8: Example of a streamline derived from instantaneous velocity field229 
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3.3.3.3 PIV Velocity Uncertainty 
An error on the velocity calculated by the above methodology is inherently 
present, due to the random error on the determination of the finite interrogation 
windows within sub-pixel accuracy, and this uncertainty is calculated as the 
smallest measurable displacement divided by the time spacing at each 
acquisition point225. As the maximum absolute uncertainty of the measured 
displacement is around 0.1 pixels225, the velocity uncertainty, 𝑣¼, is calculated 
via: 
 𝑣¼ = 𝑘 ∗ 0.1∆𝑡  
3-37 
3.3.3.4 Image Pair Quality 
Due to the practicalities of testing, a balance between the time taken to acquire 
and process the data and the quality of the final vector maps was required. 
1000 image pairs were captured as described in Section 3.3.1 and processed 
as described in Section 3.3.2, at peak flow of the ideal surgical configuration, 
described fully in Section 4.2. The velocity component for each node of the 
cross-section was calculated as described in Section 3.3.2, and then the 
standard deviation of the velocity magnitudes across the image pairs for each 
equivalent node was calculated. The average standard deviation of each 
quantity of image pairs was then calculated by taking the mean of the standard 
deviations for all of the nodes of the cross-section across the chosen quantity of 
image pairs. The resultant mean standard deviations for each quantity of image 
pairs are displayed in Table 3-1 and Figure 3-9. 
As a result of this analysis, a selected number of 100 image pairs for each value 
of ∆𝑡 being investigated at each instant, as this was a good balance of 
acquisition and processing time with quality of results, with an error < 0.19% 
compared to the standard deviation of the average of 1000 image pairs for each 
value of ∆𝑡. 
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Image Pairs Standard Deviation (%) 
20 2.6762 
50 2.6819 
100 2.6383 
200 2.6339 
350 2.6337 
500 2.6334 
750 2.6334 
1000 2.6334 
Table 3-1: Standard deviation of velocities calculated via PIV 
 
Figure 3-9: Variation of standard deviation of velocity with quantity of image pairs 
3.4 Valves 
3.4.1 Aortic Valves 
Four different aortic valves were used to represent the various root-valve 
configurations in these studies - two surgical porcine valves with external 
diameter 25 mm and 29 mm, a transcatheter aortic valve replacement, and an 
integrated mock root-valve manufactured from silicone. 
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3.4.1.1 Labcor TLBP Surgical Valves 
The two bioprosthetic surgical valves used in this report, a TLPB 25 aortic 
valve, Model TLPB A Supra, size 25, and a TLPB 29M mitral valve, Model 
TLPB M, size 29 (Labcor Laboratórios Ltda, Brazil). These valves are currently 
in usage as aortic and mitral valve surgical replacements, with over 100,000 
implanted worldwide, and demonstrate good haemodynamic performance in 
comparison with other bioprostheses230,231. The valves are presented in Figure 
3-10, with the relevant dimensions given in Table 3-2. The valves consist of a 
stented frame, to which three separated and GA treated porcine valve leaflets 
are attached in a tri-composite arrangement, mounted upon an acetal 
copolymer frame and covered with polyester fabric. The positioning of the 
sewing ring at the inflow level of the valve allows for supra- or intra-annular 
valve implantation. 
The TLPB 25 aortic valve was used to model the aortic valve in the following 
experiment setups: 
• Chapter 4, setup ii – optimal surgical aortic root 
• Chapter 4, setup iii – sinusless aortic root 
• Chapter 4, setup iv – sub-annular aortic root 
• Chapter 4, setup v  - dilated root/undersized valve aortic root 
The TLPB 29 aortic valve was used to model the aortic valve in the following 
experiment setup: 
• Chapter 4, setup i – physiological aortic root 
 
Valve 
Di 
Diameters 
(mm) Do Dsr 
hp (mm) 
TLPB 25 23 25 27 13 
TLPB 29M 26 29 31 9 
Table 3-2: Dimensions of surgical valves. Di – inner diameter; Do – outer diameter; Dsr 
– suture ring diameter; hp – downstream projection from basal annulus after 
implantation 
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Figure 3-10: Surgical aortic valves: (a) TLPB A Supra; (b) TLPB M; (c) description of 
valve dimensions, for reference with Table 3-2, where DSR is the suture ring diameter, 
Di and Do are the inner and outer diameters of the leaflet frame respectively, and hp is 
the downstream projection of the valve from the basal annulus. 
3.4.1.2 Sorin Bicarbon Mechanical Valve 
The mechanical aortic surgical valve utilised in this report was the Sorin 
Bicarbon 25 (Sorin Group, Italy), a bi-leaflet mechanical valve, composed of two 
curved pyrolytic carbon leaflets in a titanium housing ring, surrounded by a PET 
suture ring cover, and coated with Carbofilm. The valve and its dimensions are 
shown in Figure 3-11. There is no protuberance of the leaflets into the upstream 
(ventricular) chamber. The valve was used with its suture ring removed, and an 
o-ring fitted instead, which was then put into a custom-made housing for use in 
the pulse duplicator. 
The Sorin Bicarbon 25 mechanical valve was used to model the aortic valve in 
the following experiment setup: 
• Chapter 4, setup vi – mechanical aortic root 
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Figure 3-11: Mechanical aortic valve. (a) Sorin Bicarbon 25; (b) description of valve 
dimensions Di is the diameter of the orifice (21.3 mm), Do is the outer diameter of the 
rigid carbon frame (25.6 mm), Dsr is the outer diameter of the suture ring (28.2 mm), 
and hp is the distance the fully open disc axially projects into the downstream (aortic) 
chamber from the basal annulus (6.0 mm). The semilunar leaflets are convex–concave 
shaped and tilt up to 80° and close at 20°, with a maximum central orifice width of 10.0 
mm, and side orifices with a maximum width of 6.7 mm 
3.4.1.3 Edwards SAPIEN XT Valve 
The transcatheter valve used in this report was a 26 mm Edwards SAPIEN XT, 
a transcatheter valve system clinically utilised around the world232. The valve 
and its dimensions are presented in Figure 3-12, and it consists of a cobalt-
chromium balloon-expandable cellular frame into which three separate and GA 
fixed pieces of bovine pericardium are attached. A fabric polyethylene 
terephthalate skirt is attached to the upstream side of the valve, to reduce 
leakage. 
The 26 mm Edwards SAPIEN XT was used to model the aortic valve in the 
following experiment setups: 
• Chapter 5, all aortic root configurations (TA1-4) 
• Chapter 6, all aortic root configurations (NoCA, LCA, RCA, and NCA) 
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Figure 3-12: Transcatheter Aortic Valve: (a) Edwards SAPIEN XT 26 valve, in open 
and closed configurations; (b) description of valve dimensions, where De and Di are the 
external and internal diameters of the frame (26.0 mm and 25.2 mm respectively), and 
hp is the total height of the frame(17.2 mm).  
3.4.1.4 Mock Human Healthy Aortic Valve 
To simulate the native root-valve system, a silicone valve was integrated into 
one of the silicone roots described in Section 3.5. The valve was based upon 
the description of an idealised healthy human closed valve as provided by 
Thubrikar126, scaled to a basal annulus size of 25 mm, shown in Figure 3-13(a). 
A 3D-model of the valve was produced using SolidWorks (Dassault Systemes, 
France). As the TLBP bioprosthetic valve described in Section 3.4.1.1 is 
characterised by a semi open shape when at rest in saline solution, and silicone 
has a micro structure different to that of fibrous tissue (affecting the opening 
dynamics of the leaflet, in particular the change in leaflet shape from closed to 
open), a pre-expansion procedure was undertaken on the 3D model, 
undertaken by Anna Maria Tango (PhD candidate, Mechanical Engineering, 
UCL), using a pre-expansion Fluid Structure Interaction procedure in the explicit 
finite element software LS Dyna (Release 9.2, LSTC, Livermore, CA, USA). The 
leaflets were modelled as linearly elastic, with a Young’s modulus of 1 MPa, a 
Poisson’s ratio of 0.45, and a uniform thickness of 0.5 mm. The expansions 
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were achieved by applying a uniformly distributed opening pressure of 5 mmHg 
to the leaflets’ belly, resulting in the model presented in Figure 3-13(b). The 
annulus of the modelled valve was then modified to transition into a tapered 
lower part, matching the lower parts of the root cores described in Section 3.5.2, 
as shown in Figure 3-13(c). 
This 3D model was converted into an .stl file, and printed on a 
stereolithographic 3D printer (Form 2, Formlabs, USA) to produce a 
polymerized resin model of the closed valve, as presented in Figure 3-13(d). 
This was dip-coated with silicone (Transil 40-1, Mouldlife, Bury St Edmunds, 
UK) than that used for the roots as described in Section 3.5.2, as the resultant 
cured silicone would need to be dynamically responsive and operate as a 
working valve, but did not need to be optically clear. The dip coated mould was 
inverted and left to cure for 24 hours at 25°C, before removing the cured 
silicone from the mould, and trimming away unwanted material, resulting a final 
silicone valve as displayed in Figure 3-13(d), with leaflet thickness of 0.39 ± 
0.04 mm. 
This silicone valve-root was used to house the 26 mm Edwards SAPIEN XT 
valve in the following experiment setups: 
• Chapter 6, all aortic root configurations (NoCA, LCA, RCA, and NCA) 
  
Figure 3-13: Design and manufacture of silicone valve: (a) i - dimensions of closed 
Thubrikar valve, scaled to a basal annulus size of 25 mm, ii - .stl model of closed valve; 
(b) semi open valve after numerical expansion; (c) .stl model of semi-open valve; (d) 
3D printed model of valve and resultant cured and trimmed silicone valve 
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3.4.2 Mitral Valve 
A mechanical surgical mechanical valve was used to represent the mitral valve 
throughout all investigations using the pulse duplicator. 
3.4.2.1 Sorin Allcarbon 
A Sorin Allcarbon 29 mm (Sorin Group, Italy) was employed in the mitral valve 
position of the pulse duplicator. This is a tilting disc valve, with a pyrolytic 
carbon disc housed in a cobalt-chrome ring, surrounded by a knitted 
polytetrafluoroethylene (PTFE) suture ring, and coated with a thin film of 
pyrolytic carbon (Carbofilm™). The valve and its dimensions are presented in 
Figure 3-14. 
The Sorin Allcarbon 29 mm was used to model the mitral valve in the following 
experiment setups: 
• Chapter4, all aortic root configurations (physiological, optimal surgical, 
sinusless, sub-annular, dilated root/undersized valve, mechanical) 
• Chapter 5, all aortic root configurations (TA1-4) 
• Chapter 6, all aortic root configurations (NoCA, LCA, RCA, and NCA) 
 
Figure 3-14: Mitral valve: (a) Sorin Allcarbon 27 mm; (b) description of valve 
dimensions, where DSR is the suture ring diameter (35.4 mm), Di and Do are the inner 
diameter (26.7 mm) and outer diameter (31.6 mm) respectively, hp is the distance the 
fully open disc axially projects into the downstream direction (14.5 mm), and hap is the 
distance the fully open disc axially projects in the upstream direction (2.7 mm). The 
carbon disc is 1.8 mm thick, with a diameter of 23.3 mm. 
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3.5 Roots 
3.5.1 Size and Shape 
The size and shape of the sinus roots were modelled based on the geometric 
proportions described by Swanson & Clark27, the epitrocoidal top view profile 
defined by Reul et al.65, and the size and shape of the interleaflet triangles at 
the base of the root was taken from leaflet angles identified by Thubrikar et 
al.45, as illustrated in Figure 3-15. Idealised root geometry represents the 
population average, which is useful for initial investigations of particular 
phenomena in the region. However, as the physiology varies between aortic 
roots, the modelling of blood flow within patient specific models should be 
carried out to establish how the fluid dynamics of the region alter in comparison 
to this idealised model, as well as quantifying the usability and validity of the 
idealised geometry, although this is beyond the scope of the work in this thesis. 
 
 
Figure 3-15: the geometry of a normal aortic root: (a) a sagittal cross-section of the root 
shown in proportions of the STJ diameter27 (b) the epitrochoidal shape of a transversal 
cross-section of the sinuses of Valsalva233; (c) the angles of the basal interleaflet 
triangle45; (d) Resultant 3D model of the root with sinuses of Valsalva and base for 
assembly into silicone mould 
An epitrochoid profile is defined as a curve produced by a point within a circle 
(radius 𝑏¾9) which rolls around the perimeter of a second circle (radius 𝑎¾9), with 
the circles related by the diameter ratio of 3:1, due to anatomical symmetry 
between the 3 sinuses, and whose x- and y-coordinates are defined by the 
equations65: 
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 𝑥 = r𝑎¾9 + 𝑏¾9s cos 𝛼 − 𝑑 ∗ cos Á𝑎¾9 + 𝑏¾9𝑏¾9 𝛼Â 
(3-38)  
And 
 𝑦 = r𝑎¾9 + 𝑏¾9s sin 𝛼 − 𝑑 ∗ sin Á𝑎¾9 + 𝑏¾9𝑏¾9 𝛼Â 
(3-39) 
where 𝑑 is a constant (m), equal to: 
 𝑑 = 𝜆𝑏¾9 
(3-40) 
where 𝜆 is a dimensionless constant that varies with the condition of the root, 
equal to 0.5 for healthy, normal human hearts65. This results in the maximum 
and minimum radii (𝑟|Å and 𝑟|P} respectively) of the epitrochoid profile being 
related to each other by the following equation65: 
 𝑟|Å = 4 − 𝜆4 + 𝜆 𝑟|P} 
(3-41) 
where 𝑟|P} is also equal to the radius of the modelled sinuses at their largest 
diameter. The sagittal plane sinus profile was obtained from Grigioni et al. and 
their approximation of the Swanson, Clark, and Reul geometry234. The location 
of the ostia for the coronary arteries was taken from Knight et al70, where for an 
average sinus height (from the basal annulus) of 20.9 mm, the ostium height 
was in the range of 15.9 – 18.0 mm, i.e. an average of 17.0 mm, equal to 81 % 
of the sinus height, and centrally located around each section of the epitrochoid 
profile. The diameter of each ostium was 4.1 mm, as reported by Sirikonda and 
Sreelatha74. Each sinus had an ostium included, so that the same root model 
could be used for a variety of coronary configurations by clamping or opening 
the tubing connected to the various ostia, without the need to remove the root 
and valve from the pulse duplicator and PIV setup. 
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The roots were labelled by their sinotubular junction (STJ) diameter, e.g. a root 
labelled as ‘25’ has a diameter of 25 mm at the STJ. Five roots were made: 
• 25P - a physiological root with a 25 mm STJ and no mock coronary ostia. 
The 25P root was used to represent the aortic root in the following 
experiments: 
o Chapter 4, setup ii (optimal surgical) 
o Chapter 4, setup iv (sub-annular) 
o Chapter 4, setup vi (mechanical) 
o Chapter 5, all setups; 
• 25G - a root identical to the 25P, but with the inclusion of a groove, in the 
shape of the frame of the TPPB 29M valve, in the root wall around the 
basal annulus of the root, as illustrated in Figure 3-16(a). This groove 
allowed for the embedding of the TLPB 29M valve, as without the groove 
the stent of the valve would not fit into the root without considerable 
distortion of valve and/or root. The 25G root was used to represent the 
aortic root in the following experiment: 
o Chapter 4, setup i (physiological); 
• 29P - a root with the same internal shape as the 25P, but scaled up to an 
STJ diameter of 29 mm. The 29P root was used to represent the aortic 
root in the following experiment: 
o Chapter 4, setup v (dilated root/undersized valve); 
• 25C – a root identical to the 25P, but with a mock coronary ostium 
included on each sinus. The 25C root was used to represent the aortic 
root in the following experiments: 
o Chapter 6, all setups; 
• 25S - a sinusless mock root, modelled as a simple 25 mm diameter tube. 
3D models of the root were made using SolidWorks, and then converted 
into .stl files for use with a 3D printer, as illustrated in Figure 3-15(d). The 
25S root was used to represent the aortic root in the following 
experiment: 
o Chapter 4, setup iii (sinusless). 
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3.5.2 Manufacture 
3D models of the various root sizes and shapes were printed out of polymerized 
resin on a Form2 3D printer, based on the CAD models described in Section 
3.5.1. For all of the roots with the exception of the 25C, the printed models 
consisted of a mould core and a mould exterior, as shown in Figure 3-16(b-e). 
The outer surface of the core was designed so that it would match the contours 
of the lumen of the modelled root, and the core itself was hollow and thin-
shelled, so it would be easily crushable if the core was not easily extractable 
from the silicone after curing. The mould exterior was designed as three 
identical parts that fit together around the core for the casting procedure, so that 
the outer surface of the resultant silicone root would fit into the pulse 
duplicator’s first aortic chamber, immediately downstream of the left ventricle 
chamber and aortic flow transducer. The external surface of the mock root block 
was characterised by flat faces on planes parallel to the root axis, on each 
commissure-to-commissure plane, to reduce distortion and refraction of the 
laser sheet during image capture for PIV. The bottom of the core and exterior 
sections including complimentary tapering to reduce leakage, and locating 
grooves to enable alignment of core and exterior. Teflon tape was placed in 
between each exterior section before assembly, and the bottom of the core-
exterior assembly was sealed with modelling clay to prevent leakage. 
The roots were manufactured from an optically clear, solvent free, low viscosity 
silicone elastomer (MED-6015, NuSil Technology, Carpinteria, CA, USA), with a 
refractive index of 	𝑛 = 1.4. Although the cured silicone has different mechanical 
properties to that of the endothelial tissue that makes up the aortic root walls, its 
casting, durability and optical properties mean it is well suited to: accurately 
produce the desired geometry specified in Section 3.5.1; be placed in the pulse 
duplicator for long period of testing; work within the context of a PIV study. Use 
of a native porcine aortic root, for example, would not enable the projection and 
photography of a laser plane over the cross section of the root. After mixing of 
Part A and Part B in a 10:1 ratio, the resultant solution was de-bubbled in a 
vacuum chamber (4.2 L Stainless Steel Degassing Vacuum Chamber and 
Hose, HVac Store Ltd, UK) to ensure optimal optical properties after casting. 
Use of silicone grease to facilitate ease of removal from the mould was 
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investigated, but it was found that this penetrated into the silicone during the 
curing process, resulting in a thin, cloudy layer next to any application of the 
grease, which had a deleterious effect upon the optical properties. The solution 
was poured into the assembled mould, and then placed in an oven at 50°C for 
12 hours, which is a lower temperature than the curing temperature 
recommended by the manufacturer but prevented mould damage/warping from 
heat exposure during curing. After this period, the mould exterior was separated 
and removed, whilst the central core mould was either crushed or pushed out, 
depending on the elastic deformability of the resultant silicone model and shape 
of the core used. The resultant mock root was then ready for insertion into the 
pulse duplicator. 
Due to the integration of the silicone valve described in Section 3.4.1.4 and the 
modelling of coronary arteries, the manufacture of the 25C root included some 
additional and modified steps compared to the other roots. 
The 3D model of the root was made up of the same sinuses and aortic tract as 
the 25P root, but with cylindrical nubs included to allow modelling of the 
coronary arteries, as shown in Figure 3-17(a). One end of these nubs was 
located at the position of the ostia, described in Section 3.5.1. In order to 
reduce any optical distortion, the path of each nub was individually modified to 
lead away from the sagittal cross-section of the root to be analysed, indicated in 
Figure 3-17(b), and towards the downstream end of the mock root. These nubs 
were hollowed out at the join with the mock sinuses, to allow for easier 
fragmentation of the 3D printed model during disassembly, and included a 
cupped end on the downstream end. Brass rods (4 mm diameter) with 
connector moulds (4 mm internal diameter, 8 mm external diameter) were 
placed into these cups, creating mock coronary arteries leading away from each 
sinus in the final mock root and allowing for connection to the outflow tubing. 
The same outer core as for the other mock roots was assembled around this 
central collection, before pouring in the uncured silicone and curing with the 
same method as for the other roots. 
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Figure 3-16: Manufacture of root: (a) illustration of groove in 25G root, required to fit 29 
mm valve; (b) 25S and 25P 3D printed root cores; (c) Root core and exterior; (d) 
Assembled core and exterior, prior to addition of silicone; (e) finished silicone cast, 
ready for use, alongside halved silicon root 
Once cured, the brass rods and connector moulds were removed and the 3D 
printed 25C model was carefully crushed, followed by removal of the resulting 
fragments. The silicone valve had its commissures and tapered base coated in 
Med-6015, and was inserted into the silicone root, aligned commissure to 
commissure, and was cured in at 50°C for 12 hours. The resultant root is 
displayed in Figure 3-17(c). 
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Upon assembly within the pulse duplicator, each downstream end of these 
mock arteries had a tubing connector inserted, and a 500 mm length of silicone 
tubing (6 mm external diameter, 4 mm internal diameter) attached. This tubing 
was then passed through the aortic compliance port of the pulse duplicator, to 
drain into either the open atrial chamber, as shown in the schematic presented 
in Figure 3-18, or a container on top of a computer attached balance (ADAM 
PGW 253e, Adam Equipment Co Ltd, Milton Keynes, UK) for coronary flow 
assessment. 
  
Figure 3-17: Design and manufacture of mock aortic root with coronary arteries: (a) 3D 
printed model of aortic root with coronary artery nubs inside outer mould, with rod and 
tubing connector mould insert; (b) proximal schematic of 25C root, showing path of 
each mock coronary artery from its sinus to the outflow tubing in relation to the laser 
sheet and camera angle used for PIV; (c) resultant silicone mock aortic root with 
coronary arteries, alongside cross-section showing valve placement. The wall of the 
root in the cross section is highlighted with black, the outflow cusp of the valve in 
green, and the cross sectioned edge of the valve leaflet in blue. 
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Figure 3-18: Schematic of the route of the coronary artery outflow from aortic root, 
through aortic compliance tubing, flowing out into left atrium 
3.6 Testing Fluids 
3.6.1 Properties of Analogue Fluids 
As blood itself is not transparent and would cause operating difficulties as it 
dried and coagulated inside the pulse duplicator, an analogue fluid is required. 
ISO 5840 requirements state that235 “testing shall be performed using a test fluid 
of isotonic saline, blood, or a blood-equivalent fluid whose physical properties 
are appropriate to the test being performed”. The analogue fluids used needed 
to fulfil 3 exclusive criteria: 
i. presence of ions; 
ii. viscosity matched to that of blood; 
iii. refractive index (RI) matched to that of the silicone elastomer used to 
construct the mock roots. 
3.6.1.1 Presence of Ions 
In order for the flow transducer of the pulse duplicator to detect and quantify the 
fluid flow, ions were required to be present in the flow so that the 
electromagnetic. The FM501 flowmeter required a final concentration of > 0.9% 
NaCl236. 
3.6.1.2 Viscosity 
As noted in Chapter 2, the non-Newtonian nature of whole blood leads to many 
discrepancies with a Newtonian testing fluid when comparing flow profiles and 
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behaviour, and an ideal testing fluid would replicate the shear-thinning 
properties119,237,238. However, as this investigation requires the use of an 
optically transparent fluid to enable PIV, it is beyond the scope of this project to 
model the non-Newtonian nature in great detail, especially as the effects are 
less pronounced in relatively large diameter vessels such as the sinuses of 
Valsalva or the STJ237, and so it is preferred to replicate the viscosity of blood 
for a given shear. Blood viscosity tends towards 3.5 - 4.0 cP at a shear > 100 s-
1 and a temperature of 37 °C, which is normally reached by the relatively fast 
flow of blood as it exits the aortic valve81. Some investigations have used 
glycerol to increase the viscosity of a buffered saline to this range21,102,239, but 
there have been reports of the glycerol causing changes in the mechanical 
properties of the leaflet tissue of bioprosthetic valves240,241. This may represent 
a major limitation for the proposed tests, as these tests typically require several 
hours, and for comparison reasons they may need to be repeated on the same 
valve on different days. It was therefore decided to study the effect of glycerol 
upon the leaflets to establish the reliability of bioprosthetic valves after 
prolonged immersion before using glycerol as a blood analogue fluid, which is 
reported in the appendices in Section 9.1. 
3.6.1.3 Refractive Index 
As the interface between the silicone mock aortic root and the surrounding 
analogue fluid is curved, mismatch of the RI of the blood analogue fluid and the 
silicone would lead to distortion of the images used in cross-correlation, leading 
to subsequent errors in the fluid velocities reported over the cross-section. 
Accordingly, it was important to reduce these errors by matching the RI of the 
analogue fluid to that of the silicone used to construct the mock root (𝑛 = 1.4). 
3.6.2 Refractive Index Matched – Water and Potassium Iodide 
In order to raise the RI of the fluid to match that of the silicone mock root, 	𝑛 = 
1.4, potassium iodide (KI) can be added97,242, attaining the required RI at a ratio 
of 100:77 by weight of water and KI. A small amount of sodium thiosulphate 
was mixed into the water-KI solution to make it completely transparent. The 
resultant clear, colourless solution had the same dynamic viscosity as buffered 
phosphate saline at 25 °C, 𝜂Æ = 0.001 Pa.s), but a much great density (𝜌Æ = 
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1.77g/cm3). Photos displaying the image distortion before and after the RI 
matching are presented in Figure 3-19 (a) and (b). 
Due to the difference in density between this fluid and the seeding particles 
used to capture PIV data, the response time of the seeding particles in the 
water-KI solution, 𝜏=F, was 6.11 x 10-6 s, and the gravitationally induced velocity, 𝑼yF, was a maximum of 6.00 x 10-5 m/s. As these values were well outside of 
the expected scale of results, they were deemed to be acceptable. 
 
Figure 3-19: Refractive Index (RI) matching of the working fluids, with a square grid 
showing the optical distortion due to the difference in RI of the silicone and the 
surrounding fluid: (a) RI matching of silicone root in saline; (b) RI matching of silicone 
root in saline and KI solution described in 3.6.2; (c) RI matching of silicone root in 
saline; (d) RI matching of silicone root in saline, KI and glycerol solution described in 
3.6.3 
3.6.3 Viscosity and Refractive Index Matched – Water, Glycerol 
and Potassium Iodide 
In order to realise a working fluid with a viscosity of 3.5 – 4.0 cP, glycerol can be 
added to water191,242–244. Addition of glycerol also raises the RI of the solution, 
but as glycerol has a natural RI of 𝑛 = 1.47, matching the RI of the silicone 
 118 
would require a very large proportion of the fluid to be glycerol, raising the 
viscosity of the fluid to non-physiological levels at testing temperatures. 
However, when used in conjunction with KI salt in a ratio of 1000:314:746 (by 
weight) of water, KI, and glycerol, a working fluid with a viscosity matching that 
of blood at high shear and a RI matching the silicone mock root when testing at 
25°C was achieved97. The solution also has a much lower density than if the RI 
is raised with just KI alone (𝜌ÇÆ = 1.29g/cm3). Similar to the water and KI 
working fluid described in Section 3.6.2, sodium thiosulphate was added to 
prevent yellowing of the solution. Photos displaying the image distortion before 
and after the RI matching are presented in Figure 3-19 (c) and (d). 
As again there was a difference in density between this fluid and the seeding 
particles, the response time of the seeding particles in the water-KI-glycerol 
solution, 𝜏=ÈF, was 1.74 x 10-6 s, and the gravitationally induced velocity, 𝑼yÈF, 
was a maximum of 1.71 x 10-5 m/s. Similar to the particles in the water-KI 
working fluid, these values were deemed to be acceptable. 
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4 Physiological Vortices in the Sinuses of 
Valsalva and the Effect of Surgical Valve 
Replacement1 
4.1 Introduction 
As far back as the early 16th century, the propagation of vortical structures with 
the sinuses of Valsalva (SoV) have been reported59,245, and the development of 
replacement heart valve prosthetics during the 1960s prompted further research 
to improve the understanding of the fluid dynamics within the aortic root during 
the cardiac cycle18,67,96. As a result of these investigations, it is now well 
accepted that the geometry of the SoV influences the kinetics of the opening 
and closing valve leaflets, as well as the flow of blood into the coronary arteries, 
the ostia of which are located in two of the SoV20,37,40,69,246. However, the 
specific flow conditions that these chambers promote within the root are not yet 
fully understood, with multiple and often contradictory interpretations within the 
literature32,102,247. 
The mechanism proposed by Bellhouse and Bellhouse18 suggested that the 
SoV host and expand a vortex ring generated at the downstream exit of the 
valve in the early stages of systole, and that this vortex persisted through 
systole, eventually aiding in leaflet closure. In the proximity of the root axis, this 
vortex follows the direction of the ejected central fast flow, with opposite 
direction alongside the arterial wall, as indicated in Figure 4-1, and this direction 
will be referenced henceforth as ‘positive’. These vortical dynamics have been 
                                            
1 The research presented in this chapter has been published in two articles: 
- 2016, Physiological vortices in the sinuses of Valsalva: an in vitro approach for bio-
prosthetic valves, R. Toninato, J. Salmon, F. M. Susin, A. Ducci, and G. Burriesci, J. 
Biomech. Sep 6;49(13):2635-2643 
- 2018, Validation and Extension of a Fluid-Structure Interaction Model of the Healthy 
Aortic Valve, A.M. Tango, J. Salmonsmith, A. Ducci, and G. Burriesci, J. Cardiovasc 
Eng Tech. Dec;9(4):739-751 
And has been presented by the author at: 
- 4th European Society for Vascular Surgery Spring Meeting 2016, London, UK 
Research from this chapter has also been included in a chapter of a book currently in press: 
- Chapter 1.8, Hemodynamic Issues with Transcatheter Aortic valve Implantation, J. 
Salmonsmith, A. Ducci, and G. Burriesci., Transcatheter Aortic Valve Implantation: 
Clinical, Interventional, and Surgical Perspectives, A. Giordano, G. Biondi-Zoccai, G. 
Frati, Springer International Publishing, Cham Switzerland) Due for publication May 13, 
2019 
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observed in recent in vivo high intensity Magnetic Resonance Imaging (MRI) 
studies22–26, although these studies are restricted by the spatial and temporal 
resolution of the imaging to provide a conclusive answer. The same fluid 
response has also been identified by a number of numerical investigations from 
different research groups27–31. However, despite agreement within the scientific 
community that valve opening is accompanied by a vortex ring, recent in vitro 
work has reported different and more complex fluid dynamics, where this initial 
vortex ring is convected away from the valve opening and towards the 
ascending aorta. In its stead, a secondary vortex with opposite rotational 
direction forms, remaining within the chambers of the SoV for the remainder of 
systole until the valve begins to close32–35,248. These alternate vortical dynamics 
have also been revealed in silico, which also reported that the number and 
strength of the vortices generated within the SoV during systole are dependent 
upon the extension and depth of the chambers103. As stated in section 2.4.1, 
different aortic root geometries relative to the valve have resulted in different 
vortical patterns, but these patterns, nor the mechanics of vortex generation 
and the vortices’ properties and propagation within and out of the aortic root 
have not yet been explained. The effect of these various vortices upon the 
aortic valve itself has also not been agreed upon. 
 
Figure 4-1: Diagram indicating the direction of a positive vortex ring during systole 
Following replacement of the aortic valve with a bioprosthetic tri-leaflet valve, 
the forward flow retains a relatively flat velocity profile32, with a high distribution 
of flow, dissipating rapidly downstream of the valve, but with peak blood flow 
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velocities peaking between 2 and 3 m/s140, approximately twice that of the 
physiological range of 1.1 – 1.7 m/s55,98. In addition, the stent posts of these 
surgical valves often produce recirculation regions close to the aortic wall140. As 
the instability of the flow conditions of the aortic side of the valve have been 
linked to diseases in the region100, adding further recirculation volumes to the 
flow may increase the susceptibility to pathologies, such as endothelial 
remodelling and alterations to the root geometry as a result of abnormal shear 
stresses at the root lumen101. Use of mechanical surgical aortic valves instead 
of bioprosthetics is sometimes preferred due to their durability249, but although 
bi-leaflet valves produce a more physiological flow than their tilting disc or ball 
and cage brethren151, the resultant flow patterns are reported to be complex, 
with multiple recirculations in the SoV, and a chaotic flow field in late systole156. 
As stated in section 2.4.2, there is little information linking the haemodynamics 
of post-surgical roots with changes to the vortical structures or stagnation 
regions of the volume. Characterising these geometries and the resulting flow 
patterns could lead to improved support for clinicians and/or engineers by 
informing on the best therapeutic strategy. 
The aim of this chapter is to provide an in-depth investigation into the fluid 
dynamics within the aortic root in a number of different configurations with the 
aortic valve, justifying the various haemodynamics reported in the 
aforementioned previous studies and investigating the first objective presented 
in Section 2.4.5.1, ‘to investigate the effect of different valve-root geometries 
upon the fluid dynamics within the aortic root, modelling a native physiological 
configuration and comparing the resultant flow with a variety of configurations 
that could result from surgical aortic valve replacement’. Various combinations 
of aortic root geometries and prosthetic valves were studied in vitro on a pulse 
duplicator which was used to extract global haemodynamics, whilst local flow 
characteristics were analysed via the use of 2D Particle Image Velocimetry 
(PIV). The configurations chosen to be investigated were representative of an 
idealised healthy native valve, an ‘ideal’ surgical treatment, and three common 
departures from this ideal treatment, modelling a mismatch of valve-root size, a 
sub-annular valve fixation, and a valved-graft (resulting in the absence of the 
SoV). This work presented in this chapter is an adaptation of work previously 
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published by the author in the Journal of Biomechanics107, and was also as part 
of an article involving in vitro validation of a numerical model250. 
4.2 Methods 
4.2.1 Valve-root Configurations 
The following five different valve-root configurations were modelled and studied, 
as illustrated in Figure 4-2: 
i. A physiological configuration, describing an idealised, healthy, native 
aortic valve and root region; 
ii. An optimal surgical configuration, representing an aortic root region 
following an ideal implantation of a bioprosthetic valve sized to be 
sutured into the basal annulus of the physiological configuration 
described above. Due to the presence of a stent in the bioprosthetic, 
which must fit inside the patient’s aortic root and are required to give the 
leaflets their shape for valve functioning, the functioning leaflets of this 
SAV are smaller than the leaflets of the original native valve that it is 
replacing251; 
iii. A sinusless surgical configuration, describing the fluid flow downstream 
of a surgical bioprosthetic in the absence of sinuses, which are 
sometimes occluded by synthetic grafts used as vascular substitutes252; 
iv. A sub-annular surgical configuration, reproducing an infra-annular 
implantation of the bioprosthetic valve. This is also the default positioning 
for the valve housing in many commercial pulse duplicators21,60,253; 
v. An oversized surgical root/undersized SAV configuration, describing the 
optimum implantation of a bioprosthetic valve in an enlarged root, 
common in testing situations32–35,248. This configuration was also 
representative of root dilation as a result of pathologies such as Marfan’s 
Syndrome or Ehlers-Danlos syndrome143, or the undersizing of a SAV. 
vi. A mechanical configuration, representing the use of a typical mechanical 
valve instead of a bioprosthetic valve, sutured into the basal annulus of 
the aortic root 
One of the porcine bioprostheses described in Section 3.4.1.1, the TLPB Mitral 
29 valves, was used to model the physiological healthy human aortic valve, due 
to its similarity in terms of material, shape and thickness126, and the other, the 
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TLPB Aortic 25, was used to represent the valve used in the various surgical 
bioprosthetic configuration. The mechanical valve used was the Sorin Bicarbon 
25, as presented in Section 0. A selection of the mock aortic roots described in 
Section 3.5 were used to investigate the impact of the various SoV and aortic 
root proportions on the fluid dynamics of the region, replicating common testing 
arrangements and post-surgical configurations.  
 
 
Figure 4-2: Valve-root configurations investigated in the study. (a) Physiological; (b) 
Optimal surgical; (c) Sinusless; (d) Sub-annular; (e) Oversized/Dilated root; (f) 
Mechanical 
For ease of reference, the 4 roots used are summarised below: 
• The 25P root, a physiological root with a 25 mm STJ diameter, for use 
with the TLPB Aortic 25 valve; 
• The 25G root, identical to the 25P root, but with the addition of a groove 
to house the TLPB Mitral 29 valve without distortion of the root; 
• The 29P root, with the same internal shape as the 25P, but scaled up to 
an STJ diameter of 29 mm, for use with the TLPB Aortic 25 valve; 
• The 25S root, which did not reproduce the SoV, instead modelled as a 
simple 25 mm diameter tube, for use in combination with the TLPB Aortic 
25 valve. 
The reference diameter of 25 mm at the STJ was representative of an average 
size for a healthy adult human46, with the scaled up 29P root used to verify the 
effect of valve under sizing and/or root dilation. The physiological condition was 
represented by using the 25G root in combination with the TLPB Mitral 29 valve, 
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as the leaflets of this larger valve were originally extracted from a porcine aortic 
root with a STJ diameter equal to about 25 mm, thus better representing the 
native human anatomy of equivalent size. The influence of the stent of the 
larger bioprosthetic valve was minimised by its housing within the groove of the 
25G root, located at the basal annulus of the mock root. The optimal surgical 
configuration consisted of the TLPB Aortic 25 valve within the 25P root, again at 
the level of the mock root’s basal annulus, matching the sizing used in a typical 
surgery. The same valve was positioned 8.5 mm lower within the same root to 
represent the sub-annular configuration, whilst using the valve positioned at the 
basal annulus of the 25S root produced the sinusless configuration. The 
oversized/dilated root configuration was produced by placing the TLPB Aortic 
25 valve at the basal annulus of the larger 29P root. Finally, the mechanical 
valve configuration consisted of the Sorin Bicarbon 25 mechanical valve 
secured into the basal annulus of the 25P root. 
As described in Section 3.5.2, all the roots were made of optically clear, solvent 
free, low viscosity silicone elastomer with refractive index n = 1.4. The 
physiological elasticity of the root wall depends upon a number of in vivo 
factors, including the age and healthiness of the tissue or the prosthetic 
materials and degree of cellular infiltration following the surgical introduction of 
a graft. The geometry of the different chamber sizes would also produce varying 
compliance, and so it was decided to exclude this variable from the experiment, 
with the thick walls of the silicone roots resulting in negligible compliance, 
representative of older patients254. 
4.2.2 Global Parameters 
In this study, all experiments were carried out using the hydro-mechanical pulse 
duplicator described in Section 3.2.1, using pressure transducers positioned 
within the mock ventricular and aortic chambers, i.e. upstream and downstream 
of the aortic valve respectively. Combined with instantaneous volumetric 
flowrate data provided by the electromagnetic flowmeter positioned just 
upstream of the aortic valve, this allowed estimation of the following 
haemodynamic data: 
• The systolic transvalvular pressure drop (𝛥𝑝) across the valve, in mmHg 
• The Effective Orifice Area (𝐸𝑂𝐴) of the valve, in cm2 
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• The closing regurgitant volume (𝑉4) of the valve, in ml 
• The energy losses during forward flow (𝐸0) and valve closure (𝐸4), and 
the combination of these to give the total systolic energy loss (𝐸=), in mJ. 
The calculation of these parameters from the various data acquired from the 
pulse duplicator is detailed in Section 3.2.2, with an average cycle calculated 
from 20 cycles for each experimental setup, taken from the first and last 10 
cycles during the PIV data acquisition. As the investigation described in Section 
9.1 in the appendices was still on-going, the decision was made not to include 
glycerol in the testing fluid, in order to minimise the chance of the testing fluid 
affecting the dynamic response of the valve as the testing proceeded, as 
suggested by previous investigations in the literature240,241. This resulted in the 
dynamic viscosity of the testing fluid not matching that of blood. Though this 
limitation is accepted by international regulations for the testing of bioprosthetic 
valves (ISO 5840:2009), it may have resulted in some departure in fluid 
dynamics from the physiological environment. However, as the local flow 
characteristics to be elucidated by the PIV study were expected to be critical to 
the findings of the experiment, the testing fluid did contain potassium iodide, in 
order to match the Refractive Index (RI) of the testing fluid to that of the silicone 
mock roots to be used, as detailed in Section 3.6.2. 
A heart rate of 70 bpm was simulated using the pulse duplicator, controlling the 
displacement of the piston head of the pump with respect to time, applying an 
FDA approved displacement waveform with 35 % systole per cardiac cycle. A 
physiological flowrate of 4 l/min, calculated as the net flow through the 
flowmeter each cycle multiplied by the number of cycles per minute, at a mean 
aortic pressure of 100 mmHg was imposed across the valve by combination of 
adjusting both the amplitude of the pump’s piston head movement and the 
resistance of the system via constriction or expansion of a hose clamp. 
4.2.3 Local Fluid Property Acquisition  
The systolic cycle for each root-valve configuration was characterised by the 
elucidation of a velocity field for each of 5 instants, representative of a distinct 
part of the systolic cycle. These reference instants could occur at different times 
of the cycle for the various configurations, as they were dictated by the flow 
displayed by each configuration as opposed to a predetermined time interval. 
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These flow conditions, presented in Table 4-1 for all configurations and 
illustrated for the Optimal Surgical configuration in Figure 4-3, were defined as 
the instants of: 
A. Maximum increasing flowrate 
B. Peak flowrate 
C. Maximum decreasing flowrate 
D. The most significant change of curvature of the flowrate during late 
systole 
E. The end of forward flow 
 
Figure 4-3: Typical diagram of the flowrate vs the time through the heart cycle with the 
analysed instants shown. 
Configuration 
Instant Time through Cycle (ms) 
A B  C D E 
Physiological 110 147 174 234 342 
Optimal Surgical 117 154 174 234 354 
Sinusless 114 154 177 228 348 
Sub-annular 114 147 171 228 352 
Dilated 110 151 174 234 347 
Mechanical 117 151 174 231 352 
Table 4-1: Time elapsed through cycle for each analysed instant for PIV data 
acquisition for each valve-root configuration 
The local fluid dynamics at each of these instants were captured via 2D PIV 
using the bench top equipment and techniques presented in Section 3.3. As 
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detailed in Section 3.3.3.4, 100 image pairs were captured for each instant, 
allowing for phase-resolved processing of the resultant velocity fields, in order 
to identify and compare the large-scale flow features for the different valve-root 
configurations. The choice of the time interval between the images of each 
image pair (𝛥𝑡) for the fast fluid flow of each instant was chosen by estimation 
of the fluid velocity through the flowmeter at that time, in accordance with the 
equation (3-17). This initial fluid velocity estimation was carried out by dividing 
the flowrate at that particular instant by an approximated valve orifice area, 
assuming each of the two bioprosthetic valves formed a triangular orifice during 
systole255, with dimensions in accordance to an equilateral triangle inside the 
circular suturing annulus of the bioprosthetic. As a result, the different image 
pair time intervals were used for the specified instants across the various 
configurations, as displayed in Table 4-2. In order to capture the anticipated 
slower fluid flow in the sinuses, a second set of 100 image pairs with a 𝛥𝑡 of 
250 𝜇s was captured at instants A-E for each configuration. 
 
Configuration 
Time interval of image pair, Δt, at each Instant 
(𝜇s) 
A B  C D E 
Physiological 158 88 108 184 250 
Optimal Surgical 154 100 120 200 250 
Sinusless 162 95 114 195 250 
Sub-annular 177 104 126 194 250 
Dilated 187 100 116 101 250 
Mechanical 183 94 109 204 250 
Table 4-2: Time interval for image pairs at specified instants. NB - as, by definition, the 
fluid flow speed was calculated as 0 m/s for Instant E, a Δt of 250 𝜇s was used for this 
instant across the valve-root configurations 
The maximum PIV velocity uncertainty for each instant was then calculated 
from these image pair time intervals and the 𝑘 value (the 𝜇m to pixel ratio) for 
each PIV setup for each valve-root configuration, presented in Table 4-3. 
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Configuration 
PIV Velocity Uncertainty for each Instant (m/s) 
A B  C D E 
Physiological 0.0133 0.0237 0.0195 0.0114 0.0084 
Optimal Surgical 0.0149 0.0231 0.0192 0.0115 0.0092 
Sinusless 0.0136 0.0232 0.0194 0.0113 0.0088 
Sub-annular 0.0142 0.0241 0.0199 0.0129 0.0100 
Dilated 0.0107 0.0201 0.0172 0.0099 0.0080 
Mechanical 0.0120 0.0233 0.0201 0.0108 0.0088 
Table 4-3: Maximum PIV Velocity Uncertainty for each instant in each configuration 
Measurements were carried out on a root cross-section (sagittal plane), 
bisecting one of the sinuses, as illustrated in Figure 4-4(a). As the bileaflet 
design of the mechanical valve results in 2 segments of symmetry and the root 
has 3 segments of symmetry, each sinus does not have its own valve leaflet 
associated with it. The mechanical valve was aligned as shown in Figure 4-4(b), 
with the laser cast over where the line of symmetry for the root and valve 
aligned, as recommended by the manufacturer in order to avoid a prosthetic 
valve hinge being in the vicinity of one of the coronary ostia. In order to study 
the cross-sectional downstream flow of the valve at 90 ° rotation to this, the PIV 
setup illustrated in (c) was also used for image pair acquisition. 
After image pair acquisition, cross correlation processing was carried out, as 
detailed in Section 3.3.2, to produce velocity fields for each instant across the 6 
configurations. These fields were then converted into velocity magnitude, 
Reynolds shear stress (RSS), standard deviation (as an indication of 
turbulence), and vorticity, as described in Section 3.3.3.1. The velocity fields 
had streamlines applied to them, as described in Section 3.3.3.2, in order to 
enhance the visualisation of the fluid flow dynamics. 
The peak velocity was identified as the highest velocity magnitude calculated 
via the PIV process, across the entire investigation region for each flow 
condition, A-E. The average sinus velocity, 𝑣=, was calculated by averaging the 
velocity magnitudes for any non-zero vectors within the sinus area of the PIV 
cross-sectional image. 
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Figure 4-4: Laser sheet positioning. (a) Diagram of laser sheet for PIV positioned over 
sagittal equivalent cross-section of valve-root configuration under investigation, in this 
instance the optimal surgical configuration; (b) Laser sheet position across the 
mechanical configuration, splitting the sinus where the root and valve share a line of 
symmetry; (c) Laser sheet position at 90 ° rotation to this. 
The sinus area is indicated as the green shaded region in Figure 4-5(a), and is 
defined as the region of the cross-section that is downstream of the basal 
annulus and upstream of the STJ of the mock root, and radially positioned in 
relation to the mock aortic wall downstream of the STJ. To quantitatively 
measure and compare the central jet flow width resulting from each 
configuration, the fast flow width (𝑥0) of the flow was defined as the width of the 
velocity profile across the mock STJ where the downstream velocity magnitude, 𝑣ÊËÌ, is higher than one third of the peak velocity detected via PIV analysis for 
the whole cross-section at peak flow, 𝑣9, for each configuration, measured from 
the PIV data, as indicated in Figure 4-5(b). 
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Figure 4-5: Sinus and Sinotubular Junction regions of PIV cross-section: (a) Sinus area 
of cross-section for calculation of average sinus velocity from PIV data; (b) Calculation 
of fast flow width (xÍ) from velocities across the STJ profile 
4.3 Results 
4.3.1 Global Data 
The global haemodynamic data across the 6 configurations, in terms of 𝐸𝑂𝐴, 
mean systolic transvalvular pressure drop (𝛥𝑝), closing regurgitant volume (𝑉4), 
and systolic energy losses (𝐸0, 𝐸4 and 𝐸=) components), alongside the 
maximum velocity (𝑣9) and the maximum RSS measured for each configuration 
at peak flow (instant B) from the PIV data, is presented in Table 4-4. The 
haemodynamic performance of each configuration is compared to that of the 
physiological setup, as this configuration was designed to reproduce the most 
similar flow conditions to those expected for a healthy native anatomy. The 
variation of flow and pressure throughout a typical cycle during PIV acquisition 
for each configuration is illustrated in Figure 4-6. Bar diagrams to enable visual 
comparison of the variation of 𝛥𝑝, 𝑉4, and the energy losses for each 
configuration are shown in Figure 4-7. Errors in the haemodynamic data are 
equal to the range of pressure over the 20 cycles and the resolution of the 
pressure and flow transducers, and are indicated both in the table and the 
figures above. 
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Global Parameter Physiological Optimal 
Surgical 
Sinusless Sub-
annular 
Dilated Mechanical 
Effective Orifice 
Area (cm2) 
2.43 ± 0.02 
1.65 ± 0.01 
(68 %) 
1.56 ± 0.02 
(64 %) 
1.41 ± 0.01 
(58 %) 
1.53 ± 0.01 
(63 %) 
1.56 ± 0.02 
(64 %) 
Pressure Difference 
(mmHg) 
5.27 ± 0.08 
8.63 ± 0.13 
(164 %) 
11.16 ± 0.23 
(212 %) 
10.91 ± 0.07 
(207 %) 
9.29 ± 0.15 
(176 %) 
15.82 ± 0.34 
(300 %) 
Closing Volume 
(ml) 
3.52 ± 0.16 
0.36 ± 0.08 
(10 %) 
0.70 ± 0.09 
(20 %) 
0.16 ± 0.04 
(5 %) 
0.37 ± 0.11 
(11 %) 
1.27 ± 0.12 
(36 %) 
Forward Energy 
Loss (mJ) 
33.96 ± 1.1 
63.35 ± 1.01 
(187 %) 
100.88 ± 2.32 
(297 %) 
86.59 ± 1.56 
(255 %) 
73.67 ± 1.71 
(217 %) 
134.21 ± 3.11 
(395 %) 
Closing Energy 
Loss (mJ) 
15.18 ± 0.56 
1.28 ± 1.22 
(8 %) 
2.74 ± 0.29 
(18 %) 
0.50 ± 0.12 
(3 %) 
1.57 ± 0.41 
(10 %) 
7.04 ± 0.76 
(46 %) 
Systolic Energy 
Loss (mJ) 
49.14 ± 1.66 
64.63 ± 1.23 
(132 %) 
103.62 ± 2.61 
(211 %) 
87.09 ± 1.68 
(177 %) 
75.24 ± 2.12 
(153 %) 
141.25 ± 3.87 
(287 %) 
Peak Velocity 
(m/s) 
1.7 ± 0.024 
2.9 ± 0.021 
(171 %) 
3.0 ± 0.022 
(176 %) 
2.9 ± 0.020 
(171 %) 
2.8 ± 0.021 
(165 %) 
1.9 ± 0.023 
(112 %) 
Peak Reynolds 
shear stress (N/m2) 
53 ± 0.75 
223 ± 1.60 
(421 %) 
276 ± 2.01 
(521 %) 
159 ± 1.08 
(300 %) 
191 ± 1.43 
(361 %) 
138 ± 1.03 
(260 %) 
Table 4-4: Hydrodynamic global data for all configurations: mean value, ± standard 
deviation, and percentage value with respect to physiological configuration. 
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Figure 4-6: Pressure-time and pressure-flow charts for each configuration throughout a 
typical cardiac cycle during PIV acquisition. (a) Physiological; (b) Optimal surgical; (c) 
Sinusless; (d) Sub-annular; (e) Oversized/Dilated root; (f) Mechanical. 
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Figure 4-7: (a) Transaortic pressure drop and closing volume for each configuration; (b) 
Transaortic energy losses during forward flow and closing phases for each 
configuration. 
4.3.2 PIV data 
PIV data for the fast flow width (𝑥0) and average sinus velocity (𝑣=) for each 
instant of each configuration is presented in Table 4-5. Visual comparison of 
these parameters is provided via line charts in Figure 4-8. The velocity profile of 
each instant of each configuration is also displayed via line charts in Figure 4-9. 
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Parameter Instant Physiological Optimal 
Surgical 
Sinusless Sub-annular Dilated Mechanical 
Fast Flow 
Width 
(mm) 
A 23.8 18.5 15.6 3.2 0.0 22.1 
B 18.9 15.2 15.6 11.2 17.7 11.1 
C 13.8 13.9 14.2 9.9 8.4 4.7 
D 7.7 11.1 12.4 6.1 4.3 0.0 
Average 
Sinus 
Velocity 
(m/s) 
A 0.199 0.516 n/a 0.186 0.239 0.294 
B 0.108 0.298 n/a 0.117 0.100 0.332 
C 0.147 0.186 n/a 0.171 0.108 0.444 
D 0.085 0.166 n/a 0.110 0.138 0.134 
E 0.049 0.090 n/a 0.050 0.104 0.198 
Table 4-5: Instantaneous data from PIV analysis for all configurations at all instants, 
with the exception of instant E for the fast flow width (as this was zero for all 
configurations) 
  
Figure 4-8: (a) Fast flow width at instants A-E of each configuration; (b) Average sinus 
velocity for each instant of each configuration 
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Figure 4-9: Velocity profiles across sinotubular junction at each instant analysed for 
each configuration, with the 1/3 peak velocity line used to calculate the fast flow width 
indicated by a dotted line on each plot. (a) Physiological; (b) Optimal surgical; (c) 
Sinusless; (d) Sub-annular; (e) Oversized/Dilated root; (f) Mechanical 
4.3.2.1 Physiological configuration  
The contour maps for velocity are presented in Figure 4-10, whilst a contour 
map for the Reynolds shear stress (RSS) at peak flow (instant B) for each 
configuration is presented in Figure 4-11. Contour maps of the RSS, turbulence, 
and vorticity captured by the PIV analysis process for each instant of the 
physiological configuration are presented in the appendices, in Section 9.2. At 
the beginning of the ejection phase, a positive start-up vortex forms, which is 
captured within the sinus chamber throughout the systolic cycle until valve 
closure, only dissipating once the valve has fully shut (instant E in Figure 4-10). 
The valve leaflets extend into the SoV during the early stages of systole, whilst 
the central fast flow jet has a slightly divergent profile, occupying the majority of 
the root cross-section above the STJ, excepting a small vortical region which 
forms above the commissures of the leaflets, which can be most clearly 
observed at peak systole in Figure 4-10. The peak velocity detected throughout 
the cycle was 1.7 m/s, with an uncertainty error of 1.41 %, whilst the average 
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sinus velocity peaked during early systole at around 0.2 m/s, dropping to 0.05 
m/s at valve closure. The fast flow width was also at its maximum as the flow 
increased (23.8 mm at instant A), shrinking as systole progressed. 
The RSS remains low throughout the systolic cycle, with just a small region 
above the commissural side of the valve during peak systole (displayed in 
Figure 4-11) at a maximum magnitude of 50 N/m2. The turbulence, indicated by 
the standard difference of the velocity calculated for each image pair within the 
100 image pairs captured for each instant, is indicated to be at the greatest at 
the edge of the central jet flow during peaks systole, particularly on the sinus 
side of the valve, reaching a standard deviation of 0.9 m/s. The regions of 
vorticity greater than 500 /s are restricted to two volumes, close to and 
downstream of the exit to the opening leaflet and the valve commissure. 
 
Figure 4-10: Velocity contour maps and streamlines for the physiological configuration. 
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Figure 4-11: Reynolds shear stress contour maps for the various configurations at peak 
flow (instant B). 
 
Figure 4-12: Velocity contour maps and streamlines for the optimal surgical 
configuration. 
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4.3.2.2 Optimal surgical configuration  
Figure 4-12 illustrates the resultant optimal surgical configuration velocity field, 
whilst the RSS, turbulence, and vorticity contour maps are presented in the 
appendices, in Section 9.2. The streamlines shown on the velocity contour 
maps suggest similar fluid flow to the physiological configuration, with a 
stronger positive start-up vortex generating on the sinus side of the root cross-
section during valve opening, which remains within the SoV chamber 
throughout systole, with diminishing intensity, and having shrunk in size at valve 
closure (instant E in Figure 4-12). The commissural vortex is again present from 
the beginning of systole, although in this configuration the vortex is larger and 
more intense than that observed in the physiological case, expanding towards 
the centre of the root to a much greater degree, especially as the flow 
decreases, most clearly shown during instants B, C, and D in Figure 4-12. Peak 
velocity through the cycle was detected as 2.9 m/s, observed during peak flow, 
with a velocity uncertainty of 0.82 %. The fast flow width was initially smaller 
than that observed in the physiological configuration (18.5 mm as compared to 
23.8 mm at instyant A) in the early stages of systole, but did not shrink as much 
as each cycle progressed, and in fact was still as wide as 11.1 mm in late 
systole (instant D). Average sinus velocity was much higher than the 
physiological configuration as the flow through the valve increased (0.516 m/s 
in contrast to 0.199 m/s at instant A), and remained twice as high on average 
throughout systole. 
The RSS of the configuration is much higher than that of the physiological 
setup, with regions of positive and negative stress, up to the magnitude of 225 
N/m2, mixed together downstream of the valve within and in the vicinity of the 
central jet flow, particularly at the start of the cycle, shown in Figure 4-11. A 
standard deviation of at least 0.5 m/s throughout the central part of the aortic 
root is indicative of the turbulence accompanying the forward flow through the 
valve, with peak standard deviation up to 1.5 m/s at the valve exit in early 
systole (instants A and B). The vorticity either side of the central jet flow during 
early systole is also higher than in the physiological configuration, reaching 900 
/s in both regions. 
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4.3.2.3 Sinusless configuration  
The contour maps for the velocity of the sinusless configuration are presented 
in Figure 4-13, and the RSS, turbulence, and vorticity contour maps are again 
provided in the appendices, in Section 9.2. Although there are no sinuses in the 
root model for this configuration, a positive start-up vortex generates in a similar 
position to the previous configurations, above the exit of the opening leaflet and 
in close proximity to the aortic wall. However, contrary to the first two cases 
examined, this vortex is then translated along with the ejected central flow, 
away from the valve, a mechanism which appears to repeat several times 
during the ejection phase, as shown in instants A-D in Figure 4-13, ceasing only 
with valve closure (E in Figure 4-13). In line with the two previous 
configurations, a positive vortex also generates above the commissural stent 
post, remaining throughout systole. The central jet flow has a narrower cross-
section than is observed for the previous two setups. The highest velocity in the 
cycle was 3.0 m/s during peak flow, with an accompanying PIV uncertainty of 
0.77 %, whilst the fast flow width was broadly similar to that obtained from the 
optimal surgical configuration. 
Well defined regions of RSS are observed either side of the central jet, initially 
quite narrow, but growing in both size and magnitude as systole progresses 
(Figure 4-11), peaking at 275 N/m2, until reducing to negligible quantities at 
valve closure (instant E). Little turbulence is indicated in the central fast flow of 
the root throughout the cycle, although a standard deviation of around 1.0 m/s 
can be observed above the exit of the valve leaflet and the commissure stent 
post at peak flow, gradually reducing in size and magnitude after peak systole 
(instants C and D). The vorticity on the sinus side of the valve peaks as the flow 
increases, reaching 850 /s, but the rest of the cycle exhibits low levels of 
vorticity on this side of the valve. On the commissural side, a constant region of 
vorticity can be observed, also peaking in early systole at a level of 900 /s, but 
this region persists throughout the forward flow phase of the cardiac cycle. 
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Figure 4-13: Velocity contour maps for the sinusless configuration. 
 
Figure 4-14: Velocity contour maps for the sub-annular configuration. 
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4.3.2.4 Sub-annular configuration  
The velocity contour maps for the sub-annular configuration are represented in 
Figure 4-14, with the RSS, turbulence, and vorticity provided in the appendices, 
in Section 9.2. Once more, a positive start-up vortex ring develops on the sinus 
side of the valve, although in this case the vortex is generated at the base of the 
SoV chamber, from where it moves towards the STJ during peak flow, as 
shown in instant B of Figure 4-14. Remaining at a relatively low intensity, the 
vortex then expands to fill the entire sinus cavity (instants C-D in Figure 4-14), 
before dissipating at valve closure (instant E). A positive vortex forms above the 
commissural stent post again (instants B-D of Figure 4-14), with similar 
dimensions and intensity to that observed in the optimal surgical case (instants 
B-D of Figure 4-12), expanding towards the root axis at the end of systole. 
During peak flow, the greatest velocity detected was 2.9 m/s, with an 
uncertainty of 0.83 %, and fast flow width was narrower than for the previous 
configurations, peaking at 11.2 mm during maximum flow (instant B). The 
average sinus velocity was very reminiscent of that measured for the 
physiological setup throughout the cycle, remaining on average within 10 % of 
the physiological values, and peaking at 0.186 m/s as the flow increased 
(instant A). 
The RSS measured in the sub-annular setup are reminiscent of those in the 
optimal surgical configuration for the same instants, made up of much less 
distinct regions than the equivalent for the sinusless root, with intermixing of the 
positive and negative stresses in the central part of the flow (Figure 4-11), and 
reaching magnitudes of 160 N/m2. The turbulence detected is spread across the 
fast flow portions of the cross-section, reaching a maximum standard deviation 
of 0.8 m/s at peak flow (instant B). Similar to the optimal surgical and sinusless 
configurations, a region of negative vorticity persists throughout systole on the 
commissural side of the valve, although closer to the base of the root, reflecting 
the sub-annular fixation of the valve, reaching 800 /s in early systole (instants A-
C). 
4.3.2.5 Dilated/oversized root configuration  
Figure 4-15 presents the velocity contour maps obtained for the dilated root 
configuration, whilst the contour maps for the RSS, turbulence, and vorticity are 
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again located in the appendices, in Section 9.2. The forward flow spreads 
across the entire aortic cross-section at the STJ as the valve opens, 
accompanied by the formation of a positive start-up vortex in the SoV chamber. 
However, this vortex soon escapes the sinus, moving towards the ascending 
aorta and increasing in intensity at peak flow, as can be seen in instant B of 
Figure 4-15, before stabilising in position alongside the aortic wall at the level of 
the STJ (instants B-D in Figure 4-15). With the absence of this first vortex, a 
second vortex generates towards the base of the sinus as the forward flow 
decreases, with opposite direction (i.e. a negative vortex) to the initial vortex, 
evidenced in instants C and D of Figure 4-15. As with the optimal surgical and 
sub-annular configurations, a positive vortex also forms above the commissural 
stent post, moving downstream during systole, with the centre of the vortex 
positioned about 20 mm downstream of the distal portion of the stent just after 
peak systole (instant C). The maximum velocity in the cycle was detected at 2.8 
m/s at peak flow, with a velocity uncertainty of 0.72 %, with a fast flow width that 
varied greatly through the systolic cycle – at peak flow, this was within 7 % of 
that measured for the physiological case (17.7 mm compared with 18.9 mm at 
instant B), but diminished very quickly, dropping to 72 % of the physiological at 
the next measured instant (9.9 mm in contrast to 13.8 mm at instant C). The 
average sinus flow followed a different trend to the other configurations – after 
similar sinus flow speeds to the physiological and sub-annular setups in the 
early stage of systole (instants A and B), the sinus velocity remains fairly 
constant at high flow through the valve, and then increases in late systole 
(instant D), in contrast to the slowing of sinus flow velocity in the other 
configurations. 
The RSS distribution is more distinct than for the optimal surgical or sub-annular 
setups, but less than that observed for the sinusless configuration. Regions 
reaching 190 N/m2 are observed either side of the central jet flow at maximum 
flow (Figure 4-11), diminishing in both size and magnitude as the flow 
decreases, before dissipating completely at valve closure. The turbulence is 
highest in the regions downstream of the valve leaflet exit and the commissures 
at and just after peak systole, at similar levels to that observed in the sub-
annular configuration, whilst the vorticity is highest at peak flow, reaching -950 
/s on the commissural side of the valve in a similarity to the 3 previous post-
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surgical configurations, with little vorticity observed in the rest of the systolic 
cycle. 
 
Figure 4-15: Velocity contour maps for the dilated/oversized root configuration. 
 
Figure 4-16: Velocity contour maps for the mechanical valve configuration, with the PIV 
laser sheet across the shared line of symmetry of the root and valve. 
 
 144 
4.3.2.6 Mechanical valve configuration 
The velocity fields for the mechanical valve configuration are illustrated in 
Figure 4-16, and contour maps of the RSS, turbulence and vorticity for each 
instant, alongside the velocity measurements for the rotated cross-section, are 
provided in the appendices, in Section 9.2. 
Once developed at peak flow, the central jet flow is narrower than in any of the 
previous configurations, with a similar peak flow (instant B) forward flow width 
(11.1 mm) to that of the sub-annular configuration (11.5 mm). This jet width then 
shrinks quickly, down to 4.7 mm in mid-systole (instant C), less than half that of 
any other fast flow width at this point, and then reducing to zero at the next data 
acquisition point. A positive vortex is apparent from peak systole, in a similar 
position to that observed in the sub-annular setup. The vortex grows in size, 
filling more and more of the sinus as systole progresses (instants C and D in 
Figure 4-16), although no vortex is captured at any instant on the non-sinus 
side of the root cross-section. The average sinus velocity is generally the 
highest of any of the configurations, reaching a maximum of 0.444 m/s and 
averaging 0.280 m/s across the 5 analysed instants. The greatest velocity 
detected during peak flow (instant B) was 1.9 m/s, with an uncertainty of 1.21 
%. 
The peak RSS captured by the PIV analysis did not cover a large area of cross-
section, concentrated on the outside of the central jet flow as indicated in Figure 
4-11, although they did reach a magnitude of 138 N/m2, slightly less than that 
measured for the sub-annular configuration. The turbulence of the analysed 
region is indicated to reach a maximum either side of the jet at peak flow 
(instant B), reaching a standard deviation of 0.8 m/s, although much of the 
cross-section appears to experience turbulence from early- to mid-systole 
(instants A-C). Similar to the RSS measured, regions of high vorticity across the 
region are small, with small areas reaching a magnitude of 800 /s either side of 
the central jet flow at peak systole (instant B). 
4.4 Discussion 
To enhance the clarity of the PIV findings, summaries of the various flow within 
each root are presented in Figure 4-17. 
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Figure 4-17: Summary of the fluid flow for each configuration. (a) Physiological; (b) 
Optimal surgical; (c) Sinusless; (d) Sub-annular; (e) Oversized/Dilated root; (f) 
Mechanical 
The physiological setup, which represents the healthy native anatomy the most 
closely, is characterised by a start-up vortex which becomes entrapped within 
the sinus chamber for the majority of systole. The ejected flow is accordingly 
relatively unrestricted as is passes from the open valve to the STJ, leading to 
the largest 𝑥0 and an evenly distributed flow profile in the early stages of systole 
compared to the other configurations. RSS throughout the cycle remain well 
below any reported haemolysis thresholds, ranging from 150 – 520 N/m2 in the 
literature37,89,90 and measured at values no greater than 53 N/m2 across all 
instants for this configuration. 
The optimal surgical configuration - modelling the same root geometry as the 
physiological setup but following the ablation of the native valve and 
replacement with an ideally sized and positioned bioprosthetic valve, with 
necessarily smaller leaflets than the physiological valve - has a very similar 
opening mechanism to the physiological case, with the start-up vortex captured 
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and contained within the SoV in early systole. However, the vortices within the 
sinus and just downstream of the valve stent commissures are larger, due to the 
smaller valve leaflets and increased presence of the stent inside the root lumen, 
constraining the systolic jet flow and decreasing the haemodynamic 
performance of the setup. Specifically, the 𝐸𝑂𝐴 is 32 % smaller than for the 
physiological configuration, corresponding to an increase in ∆𝑃 of 64 %, and the 𝑣9 increasing by 70 %. The smaller valve displays an improved closing energy 
efficiency, due to the reduced distance of leaflet travel and diminished 
geometric orifice area, but this cannot compensate for the systolic losses, and 
the 𝐸= for the setup is 32 % higher. The peak RSS measured during the early 
stages of systole were higher than the lower threshold of haemolysis reported in 
the literature, indicating a risk of blood damage and platelet activation in the 
region after even an ideal surgical procedure. The increased sinus velocities for 
this case in comparison to the other setups may mitigate this to an extent 
however, indicating increased washout and reducing the thrombogenicity of the 
SoV chambers during systole. 
Whilst the sinusless configuration appears to be an extreme scenario, it is 
representative of clinical cases of an aortic valve being implanted into a tubular 
aortic graft, and could be analogous to the case of transaortic valves, for which 
the native leaflets (which are not ablated as in surgical valve implantation) held 
open by the surrounding TAV frame act as a containing tube35. This setup is 
characterised by the repeated formation and migration of vortices on the sinus 
side of the valve, constricting the central flow and, in comparison to the 
physiological case, leading to an increase in both 𝑣9 and ∆𝑃 of 76 % and 112% 
respectively, and a corresponding reduction of 𝐸𝑂𝐴 of 36%. This configuration 
also displayed the highest levels of RSS acquired, up to 276 N/m2 which was 
more than 5 times that measured in the physiological setup, and well above the 
lower threshold of haemolysis reported in the literature. 
A major function of the SoV appears to the systolic hosting of the start-up vortex 
that generates as a result of the associated leaflet opening, enabling the central 
fast flow to reattach to the aortic wall at the STJ, as illustrated in Figure 4-12. 
The absence of the SoV chambers also causes a significant decrease in the 
closing efficiency when compared to the optimal surgical configuration, as 
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shown by the increased 𝑉4 and 𝐸4, most likely due to the reduction of the radial 
aspect of the flow, which develops in the sinuses and promotes the closure of 
the leaflets. Over the whole cycle, 𝐸= is more than twice that of the physiological 
configuration, and 60 % higher than the optimal surgical case. This is in 
agreement with findings in the literature stating that the geometry of the root 
and the presence of the SoV chambers have a major impact upon the flow 
characteristics downstream of the aortic valve18,20,69,246. Improvements in the 
performance of the valve due to the presence of the SoV has been reported in 
other in vivo and in vitro studies68,256, and a clear and reasonable explanation is 
provided by the fluid dynamics mechanisms identified here. 
The remaining 2 configurations indicate that the dimensional parameters of the 
valve and root as well as the positioning of the valve have a strong influence 
upon the valve performance. In the sub-annular case, the start-up vortex moves 
away from the low position of the valve into the upper region of the sinus, 
which, due to the absence of the leaflets adjacent to the upper portion of the 
chamber, cannot provide effective containment. The vortex is resultingly pushed 
away from the sinus by the central fast flow, escaping towards the ascending 
root, which confines the ejected flow from the valve onto the other side of the 
root and narrows the vena contracta of the flow. In comparison to the 
physiological case, the 𝐸𝑂𝐴 is reduced by 42 % and 𝑥0 is diminished throughout 
the cycle, particularly in early systole, and the configuration produces a ∆𝑃 very 
similar to that measured in the sinusless setup, whilst the levels of RSS 
acquired indicate that very little of blood exceeds the haemolysis threshold. 
However, the increase of space available in the sinuses enables the formation 
of a larger vortex, supporting the closure of the valve leaflets and resulting in 
the lowest 𝑉4 of any of the investigated cases, although across the systolic cycle 
as a whole, energy losses were 77 % higher than for the physiological setup. 
Sub-annular configurations are common in in vitro testing, where the prosthetic 
is often clamped into a housing component situated beneath the mock aortic 
root with sinuses, and the observed mechanism of vortex migration shows 
similarities to those reported in the literature in some benchtop studies21,60,253. 
This study therefore implies that the axial positioning of the valve needs to be 
replicated with care within the test rig, as it can significantly affect the 
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haemodynamic performance. These results also suggest that the current supra-
annular implantation approach used clinically, as opposed to infra-annular 
positioning, may result in significantly improved haemodynamics as well as a 
more favourable geometric orifice area. 
The STJ root diameter was increased by 16 % for the dilated root configuration, 
which impaired the potential of the sinus to constrain the start-up vortex to its 
chambers. The vortex escapes downstream, narrowing the central flow and 
decreasing the 𝐸𝑂𝐴 by 37 % and increasing the ∆𝑃 by 76 % in comparison to 
the physiological case, whilst the RSS briefly exceeds the lower reported 
haemolysis threshold during peak flow, reaching a maximum of 191 N/m2, 
although this soon subsides and remains well below any reported threshold for 
the rest of the cycle. Once the vortex has escaped the SoV, 𝑥0 is diminished, as 
shown in instants C and D in Figure 4-15. Once this initial vortex has moved 
away from the sinus, a secondary negative vortex forms in its stead, increasing 
sinus flow velocity and supporting valve closure, and leading to values of 𝑉4 
similar to those acquired from the optimal surgical setup. Accordingly, 𝐸= for this 
configuration is in between those obtained for the optimal surgical and sinusless 
cases. Despite a much larger transversal aortic root cross-sectional area (35 % 
larger) than in the other cases investigated, the vortical mechanism observed 
results in a significant reduction in 𝐸𝑂𝐴 when compared to the optimal surgical 
case, which is otherwise identical in valve size and position. Similar root-valve 
geometries can be expected in clinical situations where the implanted valve is 
under-sized, or when the aortic root dilates due to either pathological scenarios 
or ageing47,142, and oversized roots (relative to the valve used) are common in 
in vitro tests, where a universal root is used for various valve sizes33,34,155,248, 
with the mechanism identified for this case often observed. 
Replacing the surgical bioprosthetic with a mechanical valve resulted in the 
greatest ∆𝑃 during systole, 3 times that of the physiological level, with 
correspondingly high systolic energy losses. 𝑉4 was higher than any of the 
surgical bioprosthetic setups, possibly indicating that any vortices present in late 
systole have less effect upon the rigid pyrolytic carbon material than on the 
flexible biological tissue leaflets. The vortical patterns within the sinus during 
mid-late systolic flow is reminiscent of those observed in the sub-annular 
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configuration, which correlates with the relative low outflow of the mechanical 
valve in comparison to the standard bioprosthetic fixation. With no leaflet 
containment within the sinus, the vortex spreads and impinges upon the central 
jet flow of the root in this cross-section. Although the small 𝑥0 measured during 
peak flow does not appear to correspond with the relatively low 𝑣9, it must be 
considered that the bileaflet mechanical valve does not align with the 3 sinuses 
in the same manner as the trileaflet bioprosthetics, as shown in Figure 4-4. 
Examination of the velocity fields from the alternate mechanical valve-root 
cross-section, as described in Figure 4-4 (c) and which can be referred to in the 
appendix in Section 9.2, shows a much larger 𝑥0, accompanied by very little 
vortical patterns. The RSS measured remains below the majority of the 
thresholds described in the literature, and the sinus flow speed is high in 
comparison to the bioprosthetic surgical configurations, indicating that the high 
levels of blood damage reported for mechanical valves is not related to the RSS 
observed in the flow downstream of the valve outlet, but may be more 
associated with the mechanical valve itself, primarily the shear stress around 
the hinge joints, the systolic backflow jets, and the thrombogenicity of the 
material surface, possibly worsened with wear9. Despite the associated lifelong 
anti-coagulant therapy required after implantation, mechanical valves are 
sometimes used instead of bioprosthetic valves due to their high durability in 
comparison to current bioprosthetic valves9. 
4.4.1 Limitations 
The investigation included some limitations, which need to be taken into 
account when considering the above discussion. The blood analogue used in 
the experiment is Newtonian, with a lower dynamic viscosity than that measured 
in human blood at high shear. There may accordingly be some departure from 
the physiological fluid dynamics. The PIV system used is both phase-averaged, 
therefore unable to reveal cycle-to-cycle variations of the flow patterns, and 2D, 
rendering it unable to capture out of plane fluid structures. Imaging of the hinge 
joints of the mechanical heart valve, indicated to be a region of high turbulence 
and shear stress in previous research9, was not possible. Finally, the roots 
constructed for this investigation were designed from an idealised physiology, 
with no presence of coronary ostia of vessel compliance, and only one set of 
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pressure and flow conditions, representing a typical healthy physiological 
condition at rest, were used throughout the analysis. Inclusion of root 
compliance and different operating conditions could provide further insight into 
the flow mechanics of the valve. The limitations described here do not overly 
detract from the work, which clearly identifies varying fluid mechanisms for the 
same valve, as a result of alterations to the system configuration. 
 
4.5 Concluding Remarks 
The results acquired from this investigation clearly show the important role that 
the relationship between the aortic valve and root plays on the functional mode 
and haemodynamic performance of the left side of the heart, and clarify the 
reasons for the contrasting mechanisms reported in the literature. The setup of 
the physiological configuration was considered successful, with peak blood 
velocity, effective orifice area, pressure drop across the valve, and RSS 
representative of measurements taken from in vivo studies55,98,137,138. The setup 
designed to replicate the native condition produces superior hydrodynamic 
performances to the other cases, and any significant alteration to the valve 
position or variation to the geometric proportions of the root in relation to the 
valve results in major changes to the fluid dynamics downstream of the valve, 
negatively affecting the haemodynamic performance. This rationale could 
explain the difference in the number and direction of the vortical structures 
identified in previous reports in the literature, elucidating the experimental 
complications previously encountered in the assessment of prosthetic heart 
valve performance, even when these reports are limited to the calculation of 
whole cycle parameters such as the effective orifice area, the transvalvular 
pressure drop, and regurgitant volumes. 
The systolic vortical patterns of the model of the physiological aortic root and 
valve can be summarised as follows – the interaction between the central fast 
flow and the lower inertial flow in the surrounding boundary layer result in the 
generation of vortices at the exit of the valve, which are soon captured by the 
encompassing SoV chambers and remain here throughout systole, dissipating 
only after complete valve closure. With the vortices confined to the sinuses, the 
central flow is broadly unrestricted and spreads across the root at the STJ, 
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filling most of the root cross-section, before the flow becomes more complex 
further downstream in the aortic arch. This summary can now be used to 
compare and contrast the resultant fluid flow patterns acquired from the 
investigations of a TAV setup, revealing the haemodynamic changes as a result 
of the interventional treatment, which will be presented in Chapter 5, ‘Does 
Transcatheter Aortic Valve Alignment Matter?’. 
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5 Does Transcatheter Aortic Valve Alignment 
Matter?2 
5.1 Introduction 
As described in the previous chapter, the fluid dynamics of the healthy native 
valve exploits the possibility of vortical generation within each of the sinuses of 
Valsalva. This allows the systolic ejected flow to pass through to the STJ 
relatively unrestricted with an evenly distributed flow profile, and the blood is 
indicated to remain well below the haemolytic shear stress threshold, when 
blood is at risk of rupturing due to the shear stress imposed on it, indicated by 
the literature to be as low as 150 N/m2,  throughout the cardiac cycle37,89,90. 
However, degenerative conditions such as aortic stenosis, a common disease 
in the world’s elderly population4,5, are often irreversible6, and require the native 
aortic valve to be replaced in order to restore the region’s functionality. 
Replacement of the native valve with a prosthetic via surgery is deemed to be 
ineligible for around a third of patients, due to advanced age and/or co-
morbidities10,11, and so a minimally invasive technique, involving delivery of a 
crimped bioprosthetic valve – known as a Transcatheter Aortic Valve (TAV) - to 
the aortic annulus via a catheter12, has been developed and has been 
performed on over 200,000 patients since 2002189. 
The fluid dynamics of the aortic root region are different to those observed for 
the healthy native valve, and complications such as energy losses, non-
physiological CA flow, and PVL12 frequently follow TAV implantation, and 
serious downstream pathologies such as an increased occurrence of stroke, 
silent ischemic lesions, and cerebral embolism14–16,174 have been linked to the 
procedure. The native leaflets are not ablated as they often would be during 
surgery, but instead are permanently radially displaced into a pseudo-cylindrical 
                                            
2 The research presented in this chapter is under review for publication as an article in the 
Journal of Cardiovascular Research 
- Does Transcatheter Aortic Valve Alignment Matter?, J. Salmonsmith, A. Ducci, and G. 
Burriesci, submitted December 2018 
And has been presented by the author at: 
- British Cardiovascular Society Conference 2017, Manchester, UK 
- UCL Institute of Healthcare Engineering Autumn Research Symposium 2018, London, 
UK 
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configuration. As the TAV stent restricts the opening of the working leaflets to 
90 °, the systolic jet is narrower than for an equivalently sized native of surgical 
valve35,203, potentially doubling the peak blood velocity55,78,202 and raising the 
shear stresses of the flow186, although these remain beneath haemolytic 
thresholds201. 
It has been reported that the systolic vortices no longer generate within the SoV 
at the start of forward flow through the valve, but instead form at the edge of the 
now static native leaflets97, reducing sinus washout97,186, particularly the shorter 
TAV style such as the Edwards SAPIEN XT valve191, associated with a delay in 
valve closure of ~ 10 ms35,203. Similarly, it has been reported that vortices are 
not present following the return of fluid during valve closure, again reducing 
chamber washout97. The decreased shear stress and increased red blood cell 
(RBC) residence time in the native sinuses97,185 enhance the thrombogenic 
conditions within97. Additionally, the ‘neo-sinus’, formed between the native 
leaflets and the stent of the TAV, may also promote fluid dynamics that are 
prone to stagnation204. This would increase the thrombogenicity of the region, 
enhancing the risk of sub clinical leaflet thrombosis (SCLT), which could lead to 
lesions and diminished TAV leaflet motion192,207 and has been associated with 
strokes and transient ischemic attacks, and has been observed in 14 % of 
follow up examinations after implantation of Edwards SAPIEN XT valves192. 
Reduction of these stagnation regions may improve long-term clinical 
outcomes192, which are currently affected by thrombotic events in the first 6 
months following TAV implantation205,206. 
Placement of the TAV device into the native aortic annulus is typically achieved 
using intra-operation 2D imaging techniques, such as angiography or 
fluoroscopy. These techniques, whilst adequate in ensuring a sufficiently 
accurate depth of implantation, are not ideal in identifying the angular position 
of the TAV, and methods which would establish the rotation of the device, such 
as real-time 3D Computed Tomography-fluoroscopy or 3D transoesophageal 
echocardiography-fluoroscopy fusion imaging, are not commonly used257,258. 
Correspondingly, orientation of the TAV in the same leaflet-to-sinus 
arrangement as the native valve is rather haphazard259, raising concerns about 
the effect of non-alignment of the commissures of the TAV with the 
commissures of the host root204, as stated in section 2.4.3. The interaction of 
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the leaflets and fluid flow with the geometry of the sinuses has been shown in 
vivo, in vitro, and numerically within the literature, as well as in the previous 
chapter of this thesis, to have significant effects upon the 
haemodynamics18,20,21,246. Alignment of the commissures has already been 
shown to minimise the stress experienced by the TAV’s leaflets, and although 
non-alignment has been indicated in vivo to result in similar global 
haemodynamic features259, commissural alignment may improve the flow 
dynamics of the native- and/or neo-sinuses204, and have implications for the 
central fast flow systolic jet. 
The aim of this chapter is to investigate the effect of the angular alignment of 
TAVs upon the hydrodynamics produced within the host aortic root and 
ascertain whether non-alignment of the bioprosthetic can result in sub-optimal 
haemodynamics and performance, in-line with the second objective of this 
thesis, presented in Section 2.4.5.2, ‘to characterise the flow resulting from 
implantation of a TAV into a stenotic aortic valve, and to ascertain whether the 
rotational alignment of a TAV within its host root has an effect upon the 
resultant fluid dynamics in the region’. 
A widely adopted TAV, the Edwards SAPIEN XT, was placed into a mock aortic 
root in 2 extreme rotations: 
1. prosthetic and mock host root perfectly aligned (commissure-
upon-commissure), within mock native leaflets; 
2. prosthetic and mock host root at maximum misalignment 
(commissure-upon-sinus), for a maximum angular misalignment of 
60 °, within mock native leaflets. 
The presence of the native leaflets is commonly neglected for in vitro 
experiments78,182,184,186, and therefore it is useful to verify if this assumption is 
acceptable. Consequently, 2 additional configurations were also investigated: 
3. prosthetic and mock host root perfectly aligned (commissure-
upon-commissure), with no mock native leaflets present 
4. prosthetic and mock host root at maximum misalignment 
(commissure-upon-sinus) of 60 °, again with no mock native 
leaflets present. 
For each configuration, the global haemodynamics were assessed via pressure 
transducers and a flowmeter, and local fluid dynamics were again characterised 
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using Particle Image Velocimetry (PIV), providing information on the flow 
structures (using the same methods as Chapter 4). This work presented in this 
chapter is an adaptation of work which is under review at the Journal of 
Cardiovascular Research. 
5.2 Methods 
5.2.1 Valve Configurations 
The bovine bioprosthesis described in Section 0, the 26 mm Edwards SAPIEN 
XT valve, was selected for this study. A widely implanted TAV device, the valve 
consists of a cobalt chromium balloon-expandable cellular frame, which houses 
a trileaflet bovine pericardial valve. One of the mock aortic roots described in 
Section 3.5, the 25P, was used to replicate the idealised geometry of a native 
aortic region characterised by a 25 mm STJ diameter, representative of a 
healthy human adult46. 
As in the previous chapter, the root was made of optically clear, solvent free, 
low viscosity silicone elastomer with refractive index n = 1.4, the thick walls of 
which resulted in negligible compliance, representative of older patients254. 
Expanded native leaflets were modelled by including a cylindrical vinyl wrap 
around the TAV, 0.45 mm thick, which prevented the flow of any fluid through 
the mesh of the TAV. The distal edge of the wrap was 17.5 mm from the sinus 
base, with the shape matching a fully open native human aortic valve as 
described by Thubrikar126 for an aortic root with 25 mm STJ. The expanded 
Edwards SAPIEN XT valve was placed into the mock aortic root, with the 
midpoint of the valve between 1 and 2 mm downstream of the basal annulus of 
the root51, as recommended for the clinical procedure214. The following four 
different valve-root configurations were modelled and studied, as illustrated in 
Figure 5-1: 
TA1. Aligned, native leaflets: each commissure of the TAV aligns with a 
commissure of the aortic root model, resulting in each TAV leaflet’s 
belly opening out into its associated Valsalva sinus; mock native 
leaflets were included in the aortic root model. 
TA2. Misaligned, native leaflets: the valve is 60 ° out of phase with the 
ideal alignment with the root, resulting in the belly of each TAV leaflet 
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aligning with a commissure of the aortic root model; mock native 
leaflets were included in the aortic root model. 
TA3. Aligned, no native leaflets: the same valve-root alignment as used 
in configuration TA1; No native leaflets are included in the model. 
TA4. Misaligned, no native leaflets: the same valve-root alignment as 
used in configuration TA2; No native leaflets are included in the 
model. 
 
 
Figure 5-1: Valve-root configurations considered in TAV Alignment study. (a) 
Configuration TA1; (b) Configuration TA2; (c) Configuration TA3; (d) Configuration TA4 
As the investigation presented in Chapter 4 had been concluded before the 
commencement of this experiment, it was decided that the use of glycerol or KI 
in the blood analogue would not alter the properties of the bioprosthesis during 
the span of the tests. Accordingly, the solution described in Section 3.6.3, 
utilising KI, glycerol, and deionised and filtered water, was used as the blood 
analogue, matching the blood viscosity of 4.0 cP at 37 °C, and the refractive 
index of the silicone material used in the mock aortic root. 
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5.2.2 Global Parameters 
Assessment of the various configurations was again carried out on the hydro-
mechanical pulse duplicator detailed in Section 3.2. Tests were performed at a 
heart rate of 70 beats per minute, with 35% of systolic duration and a mean 
aortic pressure of 100 mmHg. In order to reduce the effect of the different 
diastolic leakages, and to produce comparable systolic flows more appropriate 
for this study, the stroke volume rather than the cardiac output was considered 
in this investigation. As a result, 4 different stroke volumes, representing the 
amount of blood pumped from the left ventricle in one contraction (i.e. the blood 
per cycle), 28.6, 50, 71.4, and 92.9 ml (corresponding to cardiac outputs of 2.0, 
3.5, 5.0, and 6.5 litres per minute (lpm) respectively). Measurements from 
pressure transducers up- and down-stream of the TAV combined with 
volumetric flowrate data acquired from an electromagnetic flowmeter 
downstream of the aortic valve allowed estimation of: 
•  The systolic transvalvular pressure drop (𝛥𝑝) across the valve, in mmHg 
• The Effective Orifice Area (𝐸𝑂𝐴) of the valve, in cm2 
• The closing regurgitant volume (𝑉4) of the valve, in ml 
• The energy losses during forward flow (𝐸0) and valve closure (𝐸4), and 
the combination of these to give the total systolic energy loss (𝐸=), in mJ. 
As detailed in Section 3.2.2 and as in the previous chapter, an average cycle of 
pressure and flowrate fluctuations was calculated from 20 cycles, taken from 
the first and last 10 cycles of the PIV image acquisition for each configuration. 
5.2.3 Local Fluid Flow Properties 
2D PIV, as detailed in Section 3.3, was again used to investigate instantaneous 
fluid dynamics of each configuration, at a standard stroke volume of 71.4 
ml/cycle (corresponding to a systolic cardiac output of 5 lpm), to produce a 
contour map describing the instantaneous fluid motion across the measurement 
plane. The laser sheet was projected over the sagittal plane, as in the previous 
investigation, at the centre of the root-valve configuration. Velocity fields for 
each of 5 instants across the systolic portion of the cardiac cycle were captured, 
enabling characterisation of the fluid flow dynamics. As in the previous chapter, 
these reference instants could potentially alter their timing position within the 
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cardiac cycle due to the changes between the various configurations, and 
therefore the instants corresponded to the following conditions: 
A. Maximum increasing flowrate 
B. Peak flowrate 
C. Flowrate decreased to 75 % of peak flowrate 
D. The most significant change of curvature of the flowrate during late 
systole 
E. Flowrate decreased to 25 % of peak flowrate 
These instants are presented for all configurations in Table 5-1, and illustrated 
for configuration TA1 in Figure 5-2(a). 
 
Figure 5-2: PIV data properties: (a) Typical diagram of the flowrate vs the time through 
the heart cycle with the analysed instants shown; (b) Sinus area of cross-section for 
calculation of average sinus velocity from PIV data; (c) Calculation of Fast Flow Width 
(𝑥0) from velocities across the STJ profile.  
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Configuration 
Instant Time through Cycle (ms) 
A B  C D E 
TA1 112 127 152 194 287 
TA2 112 127 150 191 286 
TA3 111 127 152 193 285 
TA4 111 127 151 191 281 
Table 5-1: Time elapsed through cycle for each analysed instant for PIV data 
acquisition for each configuration 
Phase resolved processing was carried out on 100 image pairs for each instant 
of each configuration, as detailed in Section 3.3.3.4. Identification of the time 
interval of the image pairs (𝛥𝑡) for the anticipated relatively fast flowing central 
jet was calculated via equation (3-17), assuming the formation of an 
approximately triangular orifice255 inside the frame of the Edwards SAPIEN XT 
valve. The image pair time intervals used to capture the fast flow dynamics 
during each instant for the various configurations is displayed in Table 5-2. In 
order to capture the expected slower sinus flow, a second set of 100 image 
pairs with a 𝛥𝑡 of 250 𝜇s was captured at instants A-D for each configuration. 
 
Configuration 
Time interval of image pair, Δt, at each Instant 
(𝜇s) 
A B  C D E 
TA1 74 67 89 133 267 
TA2 64 58 77 116 231 
TA3 71 63 85 127 254 
TA4 63 57 75 113 226 
Table 5-2: Time interval for image pairs at specified instants 
These image pair times alongside the magnification factor 𝑘 for each PIV setup 
enabled calculation of the PIV velocity uncertainty, describing the velocity error 
due to the randomness of the determination of the finite interrogation windows 
within sub-pixel accuracy225 as defined in Section 3.3.3.3, for each analysed 
instant of each configuration, the results of which are shown in Table 5-3. 
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Configuration 
PIV Velocity Uncertainty for each Instant (m/s) 
A B  C D E 
TA1 0.0324 0.0360 0.0270 0.0180 0.0090 
TA2 0.0327 0.0463 0.0273 0.0182 0.0091 
TA3 0.0326 0.0362 0.0272 0.0181 0.0091 
TA4 0.0334 0.0371 0.0278 0.0186 0.0093 
Table 5-3: Maximum PIV Velocity Uncertainty for each instant in each configuration 
Cross correlation processing, as explained in Section 3.3.2, was undertaken 
after the acquisition of image pairs for each instant, resulting in velocity fields, 
which were then converted, as detailed in Section 3.3.3.1, into velocity 
magnitude, RSS, turbulence as indicated by standard deviation, and vorticity, 
including the application of streamlines to improve the elucidation of the fluid 
flow at each analysed instant, as presented in Section 3.3.3.2. 
Quantitative comparison of the configurations was achieved by recording the 
greatest velocity magnitude measured for the entire cross-section for each 
instant of each configuration, labelled as the peak velocity, 𝑣9. Further analysis 
was carried out by extracting the mean of the velocity magnitudes within the 
sinus area of the images, indicated by the green shaded region in Figure 5-2(b), 
was recorded as the average sinus velocity, 𝑣=. As there have reports in the 
literature97 that the flow at the base of the sinuses is particularly affected by the 
implantation of the TAV, the sinus data was categorised further into the upper 
and lower half of the sinus, divided by the median y-value of the sinus area as 
illustrated in Figure 5-3, to give an average upper- and lower-sinus velocity (𝑣²= 
and 𝑣5= respectively). Finally, the fast flow width (𝑥0) of the flow was defined as 
the width of the velocity profile across the mock STJ where the downstream 
velocity magnitude, 𝑣ÊËÌ, is higher than one third of the peak velocity detected 
via PIV analysis for the whole cross-section at peak flow, 𝑣9, for each 
configuration, measured from the PIV data, as indicated in Figure 5-2(c). 
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Figure 5-3: Illustration of upper- and lower-sinus regions. The upper sinus is shaded 
red, and the lower sinus is shaded orange, split around the centre line of the sinus, 
halfway between the basal annulus and the STJ. 
 
5.3 Results 
5.3.1 Global Data 
The global haemodynamic data across the 4 configurations for each of the 4 
stroke volumes are presented in two separate tables for clarity, with the 𝐸𝑂𝐴 
and mean systolic transvalvular pressure drop (𝛥𝑝) presented in Table 5-4, with 
line charts to enable visual comparison of the variation of 𝛥𝑝 and the systolic 
energy losses for each configuration at each stroke volume shown in Figure 
5-4, and the closing regurgitant volume (𝑉4), and systolic energy losses (𝐸0) are 
displayed in Table 5-5. The haemodynamic performance of each configuration 
is compared to that of the maximally aligned valve within native leaflets, as this 
configuration was designed to reproduce the fluid dynamics of an ideal 
implantation of a TAV. The variation of flow and pressure throughout an 
average cycle during systole for each configuration at a stroke volume of 71.4 
ml (the equivalent of a cardiac output of 5 lpm) is illustrated in Figure 5-5, 
followed by the flow-time and pressure-time outputs for configuration TA1 at all 
4 stroke volumes investigated in Figure 5-6. Errors in the haemodynamic data 
are equal to the range of pressure over the 20 cycles and the resolution of the 
pressure and flow transducers, and are indicated both in the table and the 
figures above. 
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Global 
Parameter 
Stroke Volume 
(ml) 
TA1 TA2 TA3 TA4 
Effective 
Orifice Area 
(cm2) 
28.6 1.71 ± 0.02 
1.98 ± 0.02 
(115 %) 
2.36 ± 0.02 
(138 %) 
2.03 ± 0.02 
(119 %) 
50.0 2.21 ± 0.02 
2.24 ± 0.02 
(101 %) 
2.51 ± 0.03 
(114 %) 
2.35 ± 0.02 
(106 %) 
71.4 2.35 ± 0.02 
2.32 ± 0.02 
(99 %) 
2.55 ± 0.03 
(109 %) 
2.44 ± 0.02 
(104 %) 
92.9 
(86.2 for TA2) 
2.33 ± 0.02 
2.42 ± 0.02 
(104 %) 
2.52 ± 0.03 
(108 %) 
2.40 ± 0.02 
(103 %) 
Pressure 
Difference 
(mmHg) 
28.6 3.3 ± 0.08 
3.1 ± 0.08 
(94 %) 
2.1 ± 0.06 
(63 %) 
2.8 ± 0.07 
(85 %) 
50.0 4.8 ± 0.11 
4.4 ± 0.10 
(92 %) 
3.8 ± 0.09 
(78 %) 
4.3 ± 0.10 
(90 %) 
71.4 8.1 ± 0.14 
8.2 ± 0.14 
(101 %) 
7.1 ± 0.12 
(88 %) 
7.8 ± 0.13 
(96 %) 
92.9 
(86.2 for TA2) 
14.1 ± 0.21 
11.9 ± 0.18 
(84 %) 
13.5 ± 0.20 
(96 %) 
14.7 ± 0.23 
(104 %) 
Table 5-4: Effective Orifice Area and Transvalvular Pressure Drop for all configurations 
at all stroke volumes: mean value, ± standard deviation, and percentage value with 
respect to configuration representing an aligned valve within native leaflets 
 
 
Figure 5-4: Haemodynamic Performance. (a) Transaortic energy losses during forward 
flow and closing phases for each configuration at each stroke volume; (b) Systolic 
transaortic pressure drop for each configuration at each stroke volume. 
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Figure 5-5: Pressure-time and flow-time charts for each configuration throughout a 
typical cardiac cycle during PIV acquisition. (a) Configuration TA1; b) Configuration 
TA2; (c) Configuration TA3; (d) Configuration TA4 
  
Figure 5-6: Pressure-time and flow-time charts for the aligned valve within native 
leaflets configuration throughout a typical cardiac cycle for each stroke volume 
investigated. (a) 28.6 ml ; (b) 50.0 ml ; (c) 71.4 ml ; (d) 92.9 ml 
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Global 
Parameter 
Stroke Volume 
(ml) 
TA1 TA2 TA3 TA4 
Closing Volume 
(ml) 
28.6 1.6 ± 0.32 
2.5 ± 0.46 
(153 %) 
1.7 ± 0.33 
(106 %) 
2.1 ± 0.41 
(131 %) 
50.0 1.4 ± 0.24 
1.5 ± 0.24 
(104 %) 
1.5 ± 0.25 
(107 %) 
1.6 ± 0.27 
(114 %) 
71.4 1.1 ± 0.21 
1.2 ± 0.22 
(106 %) 
1.3 ± 0.23 
(118 %) 
1.3 ± 0.23 
(118 %) 
92.9 
(86.2 for TA2) 
1.1 ± 0.21 
1.1 ± 0.21 
(83 %) 
1.4 ± 0.26 
(127 %) 
1.4 ± 0.24 
(127 %) 
Systolic Energy 
Losses (mJ) 
28.6 5.4 ± 0.3 
5.3 ± 0.2 
(98 %) 
7.1 ± 0.3 
(131 %) 
8.2 ± 0.4 
(152 %) 
50.0 32.8 ± 0.7 
28.1 ± 0.6 
(85 %) 
25.8 ± 0.6 
(78 %) 
31.7 ± 0.7 
(97 %) 
71.4 82.4 ± 2.0 
78.0 ± 1.8 
(95 %) 
71.3 ± 1.8 
(87 %) 
77.8 ± 1.9 
(94 %) 
92.9 
(86.2 for TA2) 
203.8 ± 4.8 
164.8 ± 4.5 
(71 %) 
190.5 ± 5.2 
(93 %) 
227.2 ± 5.8 
(111 %) 
Table 5-5: Closing Volume and Systolic Energy Losses for all configurations at all 
stroke volumes: mean value, ± standard deviation, and percentage value with respect 
to configuration representing an aligned valve within native leaflets 
5.3.2 PIV Data 
PIV data for the maximum velocity (𝑣9) and the maximum RSS measured for 
each configuration at peak flow (instant B) alongside the fast flow width (𝑥0) and 
average velocity for the upper-, lower-, and full-sinus (𝑣²=, 𝑣5=, and 𝑣= 
respectively), as defined in Section 5.2.3, for each instant of each configuration 
is presented in Table 5-6. Visual comparison of the fast flow width and the 
average sinus velocity is provided via line charts in Figure 5-7. The velocity 
profile at the STJ of each instant of each configuration is also displayed via line 
charts in Figure 5-8. 
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Parameter Instant TA1 TA2 TA3 TA4 
Peak Velocity 
(m/s) 
B 2.51 2.59 2.64 2.64 
Peak Reynolds Shear 
Stress (N/m2) 
B 159 127 223 191 
Fast Flow Width 
(mm) 
A 18.8 18.3 18.5 16.0 
B 20.8 20.6 18.5 18.8 
C 12.5 9.9 14.2 9.0 
D 3.75 2.0 0.0 0.0 
Average Full Sinus 
Velocity 
(m/s) 
A 0.066 0.033 0.182 0.114 
B 0.072 0.068 0.217 0.197 
C 0.047 0.024 0.182 0.087 
D 0.025 0.028 0.046 0.067 
E 0.058 0.029 0.209 0.079 
Average Upper Sinus 
Velocity 
(m/s) 
A 0.134 0.045 0.315 0.177 
B 0.133 0.104 0.380 0.286 
C 0.061 0.035 0.258 0.116 
D 0.043 0.059 0.034 0.117 
E 0.124 0.052 0.274 0.126 
Average Lower Sinus 
Velocity 
(m/s) 
A 0.032 0.027 0.089 0.067 
B 0.041 0.049 0.103 0.123 
C 0.039 0.017 0.129 0.066 
D 0.013 0.011 0.054 0.030 
E 0.021 0.013 0.164 0.043 
Table 5-6: Instantaneous data from PIV analysis for all configurations at all instants, 
with the exception of instant E for the fast flow width (as this was zero for all 
configurations), and only instant B is presented for the peak velocity and Reynolds 
shear stress. 
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Figure 5-7: PIV derived data. (a) Fast flow width at instants A-E of each configuration; 
Average velocity within the (b) whole- (c) upper- and (d) lower- sinus for each instant of 
each configuration 
  
Figure 5-8: Velocity profiles across sinotubular junction at each instant analysed for 
each configuration, with the 1/3 of peak velocity for each configuration indicated. (a) 
Configuration TA1; b) Configuration TA2; (c) Configuration TA3; (d) Configuration TA4 
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5.3.2.1 TA1, Aligned Valve within Native Leaflets 
The velocity fields of configuration TA1 are presented in Figure 5-9, whilst a 
contour map for the Reynolds shear stress (RSS) at peak flow (instant B) for 
each configuration is presented in Figure 5-10. Contour maps of the RSS, 
turbulence, and vorticity captured by the PIV analysis process for each instant 
of the physiological configuration are presented in Section 9.3, within the 
appendices. 
In early systole, the central fast flow expands after exiting the valve, extending 
to the root wall on the commissural side of the valve and occupying much of the 
STJ. The largest 𝑥0 is reached during peak flow (instant B), equal to 20.8 mm, 
with a 𝑣9 of 2.4 m/s across the STJ and an almost symmetrical distribution with 
flat central profile until late systole. Peak velocity across the entire cross-section 
was detected as 2.51 m/s ± 1.4 %, within the threshold for acceptable 
prosthesis performance260. The central jet is accompanied throughout systole 
by a small vortex at the exit of the native leaflets, on the sinus side of the valve 
at the level of the STJ, which appears to promote structured flow into the sinus. 
A vortex is apparent in the widest part of the sinus during mid-late systole. This 
sinus flow suggests washout of the chamber during the whole systolic cycle, 
with 𝑣= always between 0.025 and 0.072 m/s. Flow in the upper sinus is 
considerably higher than in the lower, with return flow at the end of systole 
raising 𝑣²= to a much greater extent than 𝑣5=. On the commissural side of the 
TAV, the flow extends to the root wall until late in systole, when another vortex 
is generated, again positioned at the exit of the native leaflets, but this structure 
does not appear to significantly affect the central jet flow at this time. 
Peak RSS occurs during peak flow, reaching a magnitude of 159 N/m2, 
concentrated downstream of the native leaflet on the sinus side of the TAV, 
which also coincides with the highest vorticity measured during the cycle (900 
/s). Turbulence is indicated to be highest during early systole, downstream, of 
the native leaflets on both sides of the TAV, with relatively little turbulence 
implied over the cross-section during late systole. 
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Figure 5-9: Velocity contour maps and streamlines for the aligned valve with native 
leaflets, configuration TA1. 
 
 
Figure 5-10: Reynolds shear stress contour maps for the various configurations at peak 
flow (instant B) 
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5.3.2.2 TA2, Non-aligned Valve within Native Leaflets 
The velocity maps obtained from the PIV data for configuration TA2 are 
presented in Figure 5-11. Non-alignment of the TAV, rotating it 60° out of phase 
compared to configuration TA1, resulted in little change to the global 
haemodynamic performance, as can be seen in the 𝛥𝑝 and 𝐸= line charts 
presented in Figure 5-4. The 𝑣9 for the cross-section throughout the cycle, 2.59 
± 1.8 %, and 𝑥0 throughout the cycle are both similar to the aligned 
configuration, although the fluid flow at the edge of the central flow is altered. A 
vortex is indicated above the cusp of the TAV leaflet, now on the commissural 
side of the root, as illustrated in Figure 5-11(a), with no equivalent vortex on the 
sinus side of the valve until late systole. The upper sinus flow is accordingly 
reduced during the cycle, as indicated in Figure 5-7(c), particularly during the 
high flow portion of the cycle, whilst lower sinus flow remains at similarly low 
levels to that observed for configuration TA1. The central jet flow no longer 
extends to the root wall on the commissural side of the valve – on the contrary, 
a region of unstructured slow flow, with oscillatory features evident from the 
downstream translation of vortices along the mock aortic tract and the changing 
location of where the central jet flow extends to the wall, is observed between 
the root wall and jet flow throughout systole. 
RSS of up to 120 N/m2 was measured on both sides of the valve in early 
systole, peaking during instant B, particularly concentrated on the commissural 
side. The relatively high magnitude regions of vorticity do not extend as far 
downstream as in TA1, but reach a similar intensity (up to 900 /s) near the valve 
outflow on the commissural side of the TAV, whilst remaining below 650 /s on 
the sinus side. Turbulence is indicated to affect similar areas as in the aligned 
configuration, but to a greater extent, especially on the commissural side of the 
valve. 
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Figure 5-11: Velocity contour maps and streamlines for the non-aligned valve with 
native leaflets, configuration TA2. 
 
 
Figure 5-12: Velocity contour maps and streamlines for the aligned valve in the 
absence of native leaflets, configuration TA3. 
 
5.3.2.3 TA3, Aligned Valve in the Absence of Native Leaflets 
The fluid velocities captured at the various instants throughout the cycle for 
configuration TA3 are illustrated in Figure 5-12. Absence of the native leaflets 
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from the experimental setup results in a reduced 𝛥𝑝 and 𝐸= for all stroke 
volumes, as presented in Figure 5-4, although a slightly increased 𝑉4, up to 25 
% greater, at higher stroke volumes. 
A 𝑣9 of 2.64 ± 1.4 %, similar to both previous setups, is measured, with the 
central jet establishing closer to the commissural wall. Although the maximum 𝑥0 is slightly reduced compared to the previous two cases, the central jet span 
is maintained longer into the systolic phase, justifying the larger 𝐸𝑂𝐴 measured 
via the Gorlin’s equation. On the sinus side of the root, a vortex generates early 
in systole, much larger than that observed for TA1, narrowing the jet flow of the 
central region. Consequently, flow in the sinus is much greater than for any 
other configuration, appearing to be well-defined and providing wash-out of the 
sinus, both upper and lower, throughout systole. There is no evidence of a 
commissural side vortex at any stage of systole for configuration TA3. 
A maximum RSS of 223 N/m2 was measured at peak flow (instant B), as 
presented in Figure 5-10, 40 % higher than for the equivalent configuration with 
native leaflets (TA1), and this relatively large region of elevated RSS persisted 
through early-mid systole, with RSS as high as 85 N/m2 observed at instant C 
on the sinus side of the root. This area was indicated to have with a persistent 
region of turbulence above the native leaflets on the SoV side, accompanied by 
relatively high vorticity (1300 /s) at peak flow. A smaller region of similarly 
intense vorticity was also observed on the commissural side of the TAV, which 
also displayed RSS acting in opposing directions during peak flow, as illustrated 
in Figure 5-10. 
5.3.2.4 TA4, Non-aligned Valve in the Absence of Native Leaflets 
Velocity fields for each analysed instant from the PIV analysis for configuration 
TA4 are shown in Figure 5-13. Removing the native leaflets from the 
experimental set up results in a bigger difference between the aligned and 
misaligned configurations than was observed in the cases that included the 
native leaflets. Global haemodynamic performance was similar to the two 
setups that included the native leaflets, with the exception of the 𝑉4, which was 
similar to that of configuration TA3. 
The same 𝑣9, 2.64 ± 1.5 %, was detected as in TA3, but there were differences 
in the fluid flow dynamics. Two comparably sized vortices were present on 
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either side of the valve through systole, narrowing 𝑥0. Sinus flow, though slower 
than in TA3, was considerably faster than for the native leaflet configurations, 
as shown in Figure 5-7(b-d), with well-defined streamlines detected throughout 
systole. A region of unstructured slow flow separates the central jet flow from 
the commissural side root wall throughout systole, including the transfer of 
vortices in a similar fashion to that observed in TA2. 
A large region of high RSS, reaching magnitudes of 190 N/m2, 58 % higher than 
the equivalent configuration with native leaflets, was present above the 
commissural side of the TAV frame until mid-systole (instant C), as well as 
smaller regions of similar magnitude on the sinus side. Turbulence was 
indicated to be less than in configuration TA3 and was predominantly on the 
commissural side of the root, where the flow also reached a vorticity of 1100 /s 
during peak flow (instant B). 
 
 
Figure 5-13: Velocity contour maps and streamlines for the non-aligned valve in the 
absence of native leaflets, configuration TA4 
5.4 Discussion 
The fluid flow of the post-TAV implantation aligned configuration has some 
differences to the flow observed in the healthy physiological setup of Chapter 4, 
which are primarily due to the continued presence of the native leaflets after 
valve replacement. In the healthy native aortic root, the modelling of which is 
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described in section 4.2.1 and the fluid dynamics summarised in section 4.4 the 
sinus side vortex that generates as the associated leaflet opens is confined 
within the chamber throughout systole, enabling the central jet flow to extend to 
the root wall and maximising its width, as illustrated in Figure 5-14 (a), 
minimising the peak velocity and shear stresses of the outflowing blood. The 
location of this vortex also contributes to the washout of the sinus, minimising 
stagnation and thrombogenic conditions. In contrast to this, the post-TAV 
central flow is separated from the sinus side root wall by a region of return flow, 
in a similar manner to the sub-annular SAV implantation or the undersized SAV 
as shown in Figure 5-14 (b-d). The RSS of the TAV within native leaflets flow 
reaches a peak of 159 N/m2, which is at the lower end of the 150-520 N/m2 
threshold indicated in the literature37,89,90, implying little or no haemolysis due to 
high shear at this resting heart rate. However, the thrombogenicity of the sinus 
could potentially increase, due to the diminished flow speeds measured in this 
region, and the lack of vortical dynamics providing washout of the chamber 
during systole. 
 
 
Figure 5-14: Alteration of fluid flow as a result of TAV: Fluid flow patterns for (a) healthy 
native valve, as described in section 4.4; (b) Post-TAV implantation, with TAV in 
correct alignment and slowed sinus flow indicated by red shading; (c) sub-annular 
implantation of a surgical bioprosthetic, previously characterised in section 4.4; (d) 
implantation of an undersized surgical bioprosthetic, as described in section 4.4 
The non-alignment of the implanted TAV within its host leaflet leaflets has little 
effect upon global haemodynamic performance indicators such as 𝐸𝑂𝐴 or ∆𝑃. 
The velocity fields show that the central jet flow properties of the aligned and 
misaligned configurations are also similar, following the trend of the global 
haemodynamics. However, the slower flow in the aortic root during systole is 
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modified as the rotation of the TAV in relation to the host root varies, resulting in 
reduced flow within the SoV, especially at the base of these chambers, and 
alterations to the flow in the vicinity of native commissures. The central jet flow 
of the TAV may be relatively unaffected by commissural alignment due to the 
presence of the native leaflets, extending beyond the downstream exit of the 
TAV in a pseudo-cylindrical shape. This relatively uniform geometry may mean 
the orientation of the TAV has little effect upon the central flow, with the cusp of 
this cylinder leading to vortex shedding all around the valve, as evidenced by 
the vortices present on both sides of the valve in late systole, as opposed to 
vortices primarily generating in the vicinity of the opening leaflets in the case of 
roots with surgical or native aortic valves. 
However, the dynamic leaflets of the TAV do have an effect upon the location of 
the circulations at the edge of this jet flow, with the strength of the resultant 
vortices affected by the orientation of the TAV with respect to the aortic root. 
Vortical dynamics in the sinus of the physiological root are connected to both 
the vortex shedding from the cusp of the moving leaflet102 and, as established in 
Chapter 4, the geometry of the root in relation to the valve. When the sinus 
bulge coincides with the centre of the moving leaflet, as in the aligned 
configurations, the resultant vortex on the SoV side of the root is stronger, as 
illustrated in Figure 5-15, resulting in increased flow back into the sinuses and 
improved washout of these chambers. On the other hand, non-alignment of the 
valve, common in TAV procedures259, may reduce this overlap of vortical 
factors, producing a weaker vortex in the vicinity of the largest part of each SoV 
and lessening the associated sinus washout. The jet flow no longer extends to 
the root wall, and the translation of vortices through the systolic cycle and 
related unstructured slow flow outside of the fast central flow is reminiscent of 
both the resultant root flow of a stenotic aortic valve100 and that of a dilated 
aortic root, previously characterised in section 4.4, as shown in Figure 5-16. 
Non-physiological vortices and blood recirculation of this type has been 
associated with intraluminal thrombosis, leaflet cusp deterioration or 
aneurysm129,261,262, whilst oscillatory low wall shear stress and flow separation 
have been linked to plaque formation and enhanced atherogenesis263. 
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Figure 5-15: Vortical behaviour changes. (a) due to presence/omission of native 
leaflets, where the native leaflets reduce the influence of the valve orientation and 
result in a significant region of stagnation in the native sinuses. (b) due to valve 
alignment. (i) commissure to commissure alignment results in centre of moving leaflet 
and maximum sinus bulge being aligned, resulting in a single, larger vortex next to the 
sinus; (ii) Non-alignment of the commissures means the factors are not aligned, 
resulting in 2 weaker vortices forming, one next to the bioprosthetic commissure and 
one next to the sinus. 
 
 
Figure 5-16: Similarities between the (a) dilated root and (b) non-aligned TAV PIV 
analyses – the central fast flow does not extend to the root wall in either case, and is 
surrounded by return flow and migrating vortices. 
Although the haemodynamic performance of the valve does not appear to be 
significantly affected, it is apparent that non-alignment of TAVs, which occurs in 
approximately 25 % of TAV procedures259, may result in some long-term 
consequences for the patient and a reduced functional life for the bioprosthesis, 
especially when considered in conjunction with the increased stresses 
experienced by non-aligned TAVs264. 
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Removing the mock native leaflets from the investigational setup resulted in a 
greater difference between the performance of an aligned and non-aligned 
configurations, as removal of the barrier between the TAV and the SoV enabled 
the 2 vortical generation factors described in Figure 5-15 to act in greater 
confluence, which may explain the higher levels of RSS observed at peak flow 
for both non-native leaflet configurations compared to their equivalents. The 
differences between the flow patterns and improved valve performance 
between the configurations with and without the mock native leaflets indicate 
that the inclusion of native leaflets during in vitro tests of TAVs is important for 
accurate results, and could be considered into the regulatory requirements. The 
presence of native leaflets has often been neglected in previous in vitro and in 
silico studies, possibly resulting in unrealistically optimistic flow patterns and 
valve performance indicators78,182,184,186. 
The presence of the native leaflets, necessary in most TAV implantations, 
appears to severely impair the washout of the sinuses, reducing the average 
sinus velocity to about 1/3 of that observed in equivalent configurations without 
native leaflets. Reduction and stagnation of blood flow is associated with an 
increase in thrombogenicity, providing a possible reason for the high incidence 
of subclinical leaflet thrombosis in TAVs265. Maximum misalignment of the 
bioprosthesis is indicated to further reduce this blood flow in the upper sinus 
during systole, particularly during early systole when the flow in the upper sinus 
is slowed to similar magnitudes as that in the lower sinus, already implicated as 
an area of thrombotic concern97,186. It can be extrapolated that the effect would 
be less severe for intermediate commissural misalignment. Although current 
imaging methods capable of identifying the rotational alignment of the TAV 
during the implantation procedure, such as real-time 3D Computed 
Tomography-fluoroscopy or 3D transoesophageal echocardiography-
fluoroscopy fusion imaging, are not commonly used257,258, a combination of 
multi-planar MRI and markers on the TAV could be used to reduce the 
incidence of misalignment. 
Recording the orientation of TAVs implanted into patients would be useful in 
providing some clinical support to the presented argument, and possible identify 
an association between the instances of subclinical leaflet thrombosis and 
misalignment of the TAV. 
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5.4.1 Limitations 
Some limitations were present in this study, and the interpretation of the results 
needs to take these into consideration. Firstly, the analysed cases are 
idealisations, where the model for the native leaflets was at the lower range of 
aortic leaflet thickness with a more uniformly cylindrical shape than calcified 
native leaflets would be expected to take266 with reduced potential for 
expansion away from the TAV during the cycle due to the adhesion to the TAV 
stent, and the deployment of the TAV was assumed to be circular, even though 
irregularities in the anatomical shape of the leaflets and calcification distribution 
can lead to asymmetrical expansions and altered fluid dynamics12,186. The 
consequence of a deployment that resulted in a TAV that was both non-aligned 
and asymmetrical could be an interesting future study. No coronary flow was 
modelled in the aortic root, which may result in a degree of asymmetry across 
the root, particularly in the sinuses. No aortic root compliance was modelled, but 
it should be considered that many TAV recipients are elderly patients189 with 
correspondingly lower compliance aortic roots267, making the findings of this 
investigation representative of a significant proportion of the patient population. 
The fluid used in this study was Newtonian, resulting in some departure from 
the flow behaviour of shear-thinning blood. All of these factors may affect the 
small difference observed in the wash-out flow associated with valve alignment. 
Finally, no out of plane motion or flow structures can be detected with the PIV 
setup used, although it is expected that the plane investigated in this study 
captures the most relevant flow structures of the aortic root. 
It must be noted that comparison of the flow dynamics acquired via PIV 
between the physiological, surgical, and percutaneous (TAV) models is limited 
by the flow rates imposed upon them, the forward flow rate of which was 4 lpm 
for the former two cases and 5 lpm for the latter setup. Whilst this makes 
quantitative comparison of data such as peak velocity and pressure drop 
inappropriate, it is expected that the qualitative comparisons of vortical 
generation and relative flow dynamics are still reasonable. 
5.5 Concluding Remarks 
The introduction of a TAV to the aortic root produces alterations to the flow 
dynamics of the region, displacing the central jet flow away from the sinus side 
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aortic wall and diminishing the sinus flow, increasing the thrombogenicity of the 
volume, especially at the end of the chamber closest to the aortic basal 
annulus. The presented study also indicates that the misalignment of a TAV 
within native leaflets has a negligible effect upon the quantified haemodynamic 
performance of the implanted valve, but does affect the flow patterns by the root 
wall, particularly in the vicinity of the native commissures, and within the 
sinuses, where the average flow velocity is particularly reduced in the volume of 
the chamber closest to the STJ. This suggest that correct alignment of TAVs 
may lead to some advantage in terms of sinus flow and reduction of non-
physiological vorticity in the neighbourhood above the native commissures. The 
design of novel devices improving the rotational control of TAVs, together with 
the use of advanced medical imaging, such as real-time 3D Computed 
Tomography-fluoroscopy or 3D transoesophageal echocardiography-
fluoroscopy fusion imaging257,258 could bear some benefit. 
In addition, this investigation indicates that simulations involving TAVs in 
unrealistic setups where the native leaflets are omitted may be characterised by 
substantially different flow features, with significant sensitivity to the prosthesis’ 
orientation. This implies that the presence of mock native leaflets is essential in 
determining veridical results, and reveals a need for the explicit requirement of 
this feature in the regulations for preclinical testing of these devices. 
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6 The Effect of Coronary Arteries upon Post-
TAVI Flow 
6.1 Introduction 
The coronary arteries (CAs) supply the muscle tissue of the heart itself with 
oxygenated blood40, and originate in two of the SoV of the aortic root, typically 
just upstream of the STJ, although this position varies from person to 
person42,70. The haemodynamics of the aortic root influence CA flow71,72, with 
increased turbulence in the SoV reported to reduce the flow though the CAs 
during diastole116. Reversing this consideration,has not yet reached consensus 
amongst previous reports, with few investigations into the effect of the coronary 
arteries upon the flow within the aortic root, especially within the sinuses of 
Valsalva, following TAV implantation, as stated in section 2.4.4. Some literature 
reports that the low velocity of blood flow through the coronaries during diastole 
has little effect upon the sinus that the relevant CA ostium is situated in102. On 
the other hand, other investigations report that, as the aortic valve leaflet 
associated with non-coronary artery (NCA) sinus has a greater tendency to 
calcify in comparison to the other two leaflets, the absence of diastolic CA flow 
results in lower shear stresses in the region72,120. The suctioning effect from the 
CAs results in an increased volume of the central root flow entering the 
associated sinus, reducing the stagnation at the base of these chambers, and 
flow towards the ostium, rather than the root axis and STJ, causes increased 
washout of the two coronary sinuses72.The enlarged regions of low shear 
observed in the NCA sinus substantially increase the residence time of the 
RBCs, increasing the thrombogenicity of the volume167. 
The post-TAV implantation effect upon coronary flow has been reported to 
depend upon the specific patient, with improved systolic CA flow in comparison 
the stenotic condition resulting from a reduced Venturi effect from the central 
flow and enhanced coronary bed pressure gradients71. However, patients with 
relatively low coronary ostia, situated closer to the basal annulus of the aortic 
root, have been reported to have up 20 % reduction in coronary flow in 
comparison to other recipients of TAV intervention95,96,208. Due to the improved 
efficiency of the left side of the heart after the prosthesis implantation, this 
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reduction may not be a critical issue on its own, but the severity for each patient 
depends upon long-term myocardial needs in combination with other cardiac 
deficiencies71. The volume of the sinus chambers is reduced by the displaced 
native leaflets, and systolic sinus flow is primarily in the region of each sinus 
closest to the STJ, in the vicinity of the cusps of the native leaflets201. The 
regions of permanently low level shear at the base of the SoV following TAV 
implantation may be exacerbated by the lack of coronary flow during diastole97, 
but as yet, there has not been any PIV investigation of the fluid dynamics within 
an aortic root, complete with CA, containing a TAV implanted into native 
leaflets. The modelling of CA has been included in previous PIV studies of SAV 
and TAV within an aortic root, but these studies did not model the presence of 
natives leaflets72,167. 
The aim of this chapter is to investigate the effect that coronary flow has upon 
the fluid flow of the aortic root, particularly within the sinuses, after TAV 
implantation, throughout a typical cardiac cycle, researching the third objective 
of this thesis, as stated in Section 2.4.5.3, ‘to determine whether the presence 
of the coronary arteries, and the flow into them during each cardiac cycle, has 
an effect upon the fluid dynamics of the aortic root, particularly within the sinus 
of Valsalva associated with each coronary artery, following TAV implantation’. 
This was achieved by developing a mock aortic root that included an outflow 
tube on each sinus, exiting the chamber in the equivalent position of a typical 
coronary ostium. Each tube could be individually narrowed or blocked off, 
enabling the setup to model the left, right, and non-coronary sinuses and 
associate artery outflow observed in the normal human anatomy, as well as the 
common in vitro configuration where coronary arteries are not represented at 
all. The mock root included silicone leaflets of a mock native aortic valve, into 
which a TAV device was placed. The entire assembly was then loaded into a 
pulse duplicator, obtaining global haemodynamic performance data from 
pressure and flow transducers, and PIV acquisitions were taken, elucidating 
local fluid fields for specific instants within the pulse duplicator imposed cardiac 
cycle. 
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6.2 Methods 
6.2.1 Setup of Coronary Arteries 
A 26 mm Edwards SAPIEN XT valve, as described in Section 0, was again 
used as the TAV, and was placed inside the 25C root, designed and 
manufactured as presented in Sections 3.5.1 and 3.5.2, which incorporated a 
silicone Thubrikar valve, detailed in Section 3.4.1.4, representing the calcified 
native valve hosting the bioprosthesis. The resultant mock coronary ostia were 
positioned 17.0 mm downstream of the same basal annulus, the average 
position in healthy adult humans as reported by Knight et al. 70 which located 
them just upstream of the STJ, with a diameter of 4 mm, and were attached, via 
a 4.0 mm diameter bore through the silicone root and tubing connectors with a 
3.0 mm internal diameter, to 0.5 m long silicone tubing with a 4.0 mm internal 
diameter, as illustrated in Figure 6-1(a). The route of the silicone bore had been 
designed with this PIV laser sheet in mind, leading away from the plane of the 
laser sheet as described in Section 3.5.2, so that the resultant PIV images had 
the minimum interference from the mock CAs. The outflow of the silicone tubing 
passed through the aortic compliance port of the pulse duplicator, and then 
poured into the open atrial chamber of the pulse duplicator during PIV data 
acquisition. Diverting the outflow of these silicone tubes to a chamber on top of 
a balance, attached to a computer, enabled coronary flow assessment by taking 
measurements from the balance at 5.35 Hz. The resulting measurements were 
then phase matched, so that each reading corresponded to a time through each 
cycle imposed by the pulse duplicator. To match up the coronary flow with the 
flow and pressure data acquisition from the pulse duplicator, a video was taken 
of the outlet of the coronary flow alongside the piston head of the pulse 
duplicator, enabling the peak CA outflow to be identified in relation to the 
position of the piston head imposing the simulated cardiac cycle. 
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Figure 6-1: Coronary Artery configurations for PIV analysis. (a) Height of mock ostia in 
relation to root annulus and TAV frame, with enlargement of tubing connection; (b) All 
mock CA are clamped off for the NoCA configuration; (b) The LCA (i), RCA (ii) and 
NCA (iii) configurations have the same combination of obstructed silicone tubing, but 
are rotated in relation to each other in order to analyse the LCA sinus, the RCA sinus, 
and NCA sinus respectively via PIV. 
6.2.2 Root Configurations 
In order to represent PIV investigations that do not model the coronary arteries, 
and to provide direct comparison of the setup to the aligned TAV within native 
leaflets configuration (TA1) from Chapter 6, the 3 silicone tubes connected to 
the mock coronary ostia were clamped shut, preventing any flow through them. 
The physiological condition was represented by clamping shut one of the tubes 
(modelling the NCA), reducing the internal diameter of another via the insertion 
of the RCA nozzle (to portray the lesser coronary flow of the Right Coronary 
Artery, RCA), and leaving the third tube fully open (to represent the higher 
coronary flow of the Left Coronary Artery, LCA). The larger LCA provides the 
majority of the blood flow for most people, although there is a lot of variation in 
the dominance of this artery, resulting in a flow rate of 156 ± 77 ml/min for the 
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LCA, 91 ± 70 ml/min for the RCA, and 270 ± 82 ml/min (or 80 ml/min/100 g of 
heart tissue) for the coronary flow as a whole108. The midpoint of the TAV was 
placed between 1 and 2 mm downstream of the basal annulus of the Thubrikar 
valve, as recommended for the clinical procedure214. 
The configurations studied in this investigation are illustrated in Figure 6-1(b 
and c), and were as follows: 
• NoCA – all mock CA silicone tubing clamped shut, 
representing common in vitro studies with no modelling of the 
CA flow, including configuration TA1 from Chapter 6; 
• LCA – the mock CA whose ostium is located within the sinus 
bisected by the laser sheet is left fully open. The mock CA 
situated clockwise of this (from a downstream transversal 
perspective) has the RCA nozzle inserted, and the last mock 
CA is clamped shut; 
• RCA – the mock CA associated with the sinus analysed by PIV 
has the RCA nozzle located at its outflow, the mock CA 
clockwise of this is clamped off, and the final length of silicone 
tubing is unobstructed; 
• NCA – the silicone tubing leading away from the analysed 
sinus is clamped off, the mock CA clockwise of this is 
unobstructed, and the final tubing has the RCA nozzle 
inserted. 
As the clamps and RCA nozzle were attached to the tubing outside of the pulse 
duplicator, it was possible to change between these configurations without 
taking the TAV or silicone root out of the pulse duplicator or altering the PIV 
data acquisition setup. 
As with the previous 2 PIV investigations presented in this thesis, the root was 
made of optically clear, solvent free, low viscosity silicone elastomer with 
refractive index n = 1.4, the thick walls of which resulted in negligible 
compliance, representative of older patients254. The solution described in 
Section 3.6.3, utilising KI, glycerol, and deionised and filtered water, was again 
used as the blood analogue, matching both the blood viscosity of 4.0 cP at 37 
°C, and the RI of the silicone material used in the mock aortic root. 
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6.2.3 Global Haemodynamics 
The hydro-mechanical pulse duplicator presented in Section 3.2 was again 
used to impose the equivalent of a physiological cardiac cycle upon the setup. 
All tests were performed at a heart rate of 70 beats per minute, with a mean 
aortic pressure of 100 mmHg, 35 % systole, and a stroke volume of 71.4 ml 
producing a cardiac output of 5 lpm. Pressure readings were obtained from 
transducers situated up- and down-stream of the TAV, whilst the 
electromagnetic flowmeter positioned just downstream of the valve provided 
flowrate data throughout each cycle. As detailed in Section 3.2.2 and as in the 
previous investigations, an average cycle of pressure and flowrate fluctuations 
was calculated from 20 cycles, taken from the first and last 10 cycles of PIV 
image acquisition for each configuration. This enabled calculation of: 
• The systolic transvalvular pressure drop (𝛥𝑝) across the valve, in mmHg 
• The Effective Orifice Area (𝐸𝑂𝐴) of the valve, in cm2 
• The closing regurgitant volume (𝑉4) of the valve, in ml 
• The energy losses during forward flow (𝐸0), valve closure (𝐸4), and valve 
leakage (𝐸5), the combination of these to give the total energy loss (𝐸?), 
in mJ. 
6.2.4 Local Fluid Flow 
Velocity fields of the central cross-section of the root, bisecting one of the 
sinuses, were obtained via 2D PIV, the process and theory of which is 
described in Section 3.3. 8 instants were identified within the cardiac cycle, to 
characterise the fluid flow dynamics of the full cardiac cycle. These instants 
corresponded to: 
A. Flow rate through the basal annulus of the root, as detected by the pulse 
duplicator flowmeter, increased to 1/3 of Peak flowrate 
B. Peak flowrate 
C. Flowrate decreased to 2/3 of peak flowrate 
D. Flowrate decreased to 1/3 of peak flowrate 
E. Flowrate decreased to zero 
F. Taken after 1/4 of the duration of diastole 
G. Taken after 2/4 of the duration of diastole 
H. Taken after 3/4 of the duration of diastole 
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I. Taken at the end of diastole, indicated by the first positive flow through 
the valve 
These instants were all the same for the LCA, RCA, and NCA configurations, as 
the valve-root-CA setup is the same but rotated for each, and the instants for 
the NoCA and the 3 CA setups are presented in Table 6-1, and illustrated for 
the CA configuration in Figure 6-2(a). 
 
Figure 6-2: PIV data properties: (a) Typical diagram of the flowrate vs the time through 
the heart cycle with the analysed instants shown; (b) Sinus area of cross-section for 
calculation of average sinus velocity from PIV data; (c) Calculation of Fast Flow Width 
(𝑥0) from velocities across the STJ profile.  
Setup 
Instant Time through Cycle (ms) 
A B  C D E F G H I 
NoCA 99 137 197 269 347 494 642 790 84 
CA 100 141 194 268 347 494 642 790 84 
Table 6-1: Time elapsed through cycle for each analysed instant for PIV data 
acquisition for each configuration 
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Phase resolved PIV processing was carried out on 100 image pairs acquired for 
each instant of each configuration, as described in Section 3.3.3.4. As in the 
previous PIV investigation in this thesis, the time interval of the image pairs (𝛥𝑡) 
for the systolic instants was calculated via equation (3-17), utilising the 
measured flowrate through the flowmeter, alongside a second set of image 
pairs taken with a 𝛥𝑡 of 250 𝜇s in order to capture the expected slower sinus 
flow. However, using the same methodology for the diastolic instants was not 
possible, as by definition there was very little, if any, flow through the flowmeter 
at these times. Therefore, it was decided to again acquire image pairs at 2 𝛥𝑡 
values, 100 at 250 𝜇s, the same as for the instant at the end of systole, and a 
further 100 image pairs at 1000 𝜇s, to maximise the accuracy of the PIV 
measurements during even very slow diastolic flow. The resultant image pair 
time intervals used to capture the fast flow dynamics during instants A-D for the 
various configurations is displayed in Table 6-2. 
Setup 
Time interval of image pair, Δt, at each Instant 
(𝜇s) 
A B  C D 
NoCA 243 81 122 243 
CA 244 81 122 244 
Table 6-2: Time interval for image pairs at instants A-D 
The maximum PIV velocity uncertainty for each instant and each setup was 
then calculated from these 𝛥𝑡 values and the magnification factor from the PIV 
setup, as presented in Table 6-3. As the camera was moved in between data 
acquisition for each configuration to get access to the pulse duplicator, the 
magnification factor had to be remeasured for each of the configurations, 
including the individual CA setups. 
Setup 
PIV Velocity Uncertainty for each Instant (m/s) 
A B  C D E - I 
NoCA 0.0090 0.0271 0.0181 0.0090 0.0088 
LCA 0.0090 0.0271 0.0181 0.0090 0.0088 
RCA 0.0091 0.0270 0.0180 0.0091 0.0088 
NCA 0.0090 0.0269 0.0179 0.0090 0.0088 
Table 6-3: Maximum PIV Velocity Uncertainty for each instant in each setup 
 187 
Velocity fields were derived from the image pairs via cross correlation, as 
described in Section 3.3.2, from which the RSS, vorticity, and standard 
deviation (as an indicator of turbulence) were calculated in accordance to the 
process defined in Section 3.3.3.1. Streamlines were also applied to the velocity 
images, as described in Section 3.3.3.2, enhancing the visualisation of the fluid 
flow for each instant. Extracting the peak velocity value, 𝑣9, across the cross-
section enabled quantitative comparison between the setups, and identification 
of the sinus region, illustrated in Figure 6-2(b), allowed the average sinus 
velocity, 𝑣=, to be determined. The investigation presented in Chapter 6, 
alongside previous reports from the literature97, indicated that flow at the base 
of the sinuses is particularly affected by TAV implantation inside the native 
leaflets, so this sinus data was further divided by the median y-value of the 
sinus co-ordinates into the upper (closer to the STJ) and lower (closer to the 
basal annulus) sinus, as illustrated in Figure 6-3, enabling the calculation of the 
average upper and lower sinus velocities, 𝑣²= and 𝑣5= respectively. The velocity 
values across the STJ were also extracted, enabling the quantification of the 
fast flow width (𝑥0), defined as the span of the stream where the downstream 
velocity, 𝑣ÊËÌ, is greater than 1/3 of the peak velocity, 𝑣9, detected across the 
entire cross-section, as indicated in Figure 6-2 (c). 
 
 
Figure 6-3: Illustration of upper- and lower-sinus regions. The upper sinus is shaded 
red, and the lower sinus is shaded orange, split around the centre line of the sinus, 
halfway between the basal annulus and the STJ. 
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6.3 Results 
6.3.1 Coronary Flow 
The outflow of the mock coronary arteries throughout a typical cardiac cycle 
during PIV acquisition is presented alongside measurements from previous in 
vitro and in vivo in the literature in Figure 6-4. Peak coronary flow was identified 
as occurring 350 ± 20 ms through the imposed cardiac cycle, which correlated 
with the end of systole and valve closure. 
 
Figure 6-4: Coronary Flow rates: (a) in vitro measurements reported by Moore et al.72; 
(b) in vivo measurements reported by Spiller et al.111; (c) Phase-averaged coronary 
flow measurements from the presented investigation, presented as (i) aortic and 
coronary flow vs time and (ii) coronary flow vs. cardiac phase. 
6.3.2 Global Data 
The hydrodynamic data for the 4 setups, in terms of the 𝐸𝑂𝐴, mean systolic 
transvalvular pressure drop (𝛥𝑝), closing regurgitant volume (𝑉4), and forward, 
closing, leakage, and total energy losses throughout the cycle (𝐸0, 𝐸4, 𝐸5 and 𝐸? 
respectively), alongside the peak velocity (𝑣9) and the maximum RSS for the 
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whole cross-section throughout the cycle, is presented in Table 6-4. The flow 
and pressure acquisitions throughout a typical cycle during PIV acquisition for 
each setup are illustrated in Figure 6-5. Errors in the haemodynamic data, 
resulting from the range of pressure readings acquired over the 20 cycles in 
combination with the resolution of the pressure and flow transducers, are 
indicated in the table above. The data for each parameter is compared to that of 
the mean of the 3 CA setups, and with the exception of leakage energy losses, 
all data acquired from the pressure and flow transducers of the pulse duplicator, 𝐸𝑂𝐴, 𝛥𝑝, 𝑉4, 𝐸0, and 𝐸4, were within 10 % of all the values from the other 
setups. 
Global Parameter NoCA LCA RCA NCA 
Effective Orifice Area 
(cm2) 
2.58 ± 0.02 
(101 %) 
2.56 ± 0.03 
Pressure Difference 
(mmHg) 
8.36 ± 0.13 
(99 %) 
8.44 ± 0.21 
Closing Volume 
(ml) 
1.29 ± 0.12 
(100 %) 
1.29 ± 0.23 
Forward Energy Loss 
(mJ) 
64.92 ± 1.01 
(96 %) 
67.87 ± 2.31 
Closing Energy Loss 
(mJ) 
4.85 ± 0.54 
(108 %) 
4.48 ± 0.87 
Leakage Energy Loss 
(mJ) 
14.99 ± 0.72 
(158 %) 
9.46 ± 0.93 
Total Energy Loss (mJ) 
84.76 ± 2.27 
(104 %) 
81.81 ± 4.11 
Peak Velocity 
(m/s) 
2.5 ± 0.027 
(89 %) 
2.8 ± 0.027 
2.5 ± 0.027 
(89 %) 
2.8 ± 0.027 
(100 %) 
Peak Reynolds shear 
stress (N/m2) 
127 ± 1.37 
(120 %) 
106 ± 1.14 
124 ± 1.33 
(120 %) 
95 ± 1.03 
(90 %) 
Table 6-4: Hydrodynamic global data for all configurations: mean value, ± standard 
deviation, and percentage value with respect to LCA configuration. 
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Figure 6-5: Pressure-time and flow-time charts for each configuration throughout a 
typical cardiac cycle during PIV acquisition: (a) NoCA; (b) mean results of the 3 CA 
setups. 
6.3.3 PIV Data 
PIV data for the fast flow width (𝑥0) and average velocity for the upper-, lower-, 
and full-sinus (𝑣²=, 𝑣5=, and 𝑣= respectively) as described in Figure 6-3, for each 
instant of each setup are presented in Table 6-5. Line charts in Figure 6-6 
provide visual comparison of the fast flow width and the average sinus velocity 
throughout the cycle of each configuration, and the velocity profiles at the STJ 
for instants A - E in each setup is displayed via line charts in Figure 6-7. 
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Parameter Instant NoCA LCA RCA NCA 
Fast Flow Width 
(mm) 
A 7.9 12.5 19.0 13.6 
B 13.8 16.4 14.0 14.3 
C 13.2 13.9 12.2 10.4 
Average Full Sinus 
Velocity 
(m/s) 
A 0.016 0.022 0.017 0.016 
B 0.044 0.075 0.034 0.057 
C 0.047 0.045 0.036 0.030 
D 0.015 0.027 0.022 0.016 
E 0.017 0.020 0.013 0.021 
F 0.020 0.028 0.018 0.015 
G 0.013 0.024 0.014 0.004 
H 0.011 0.021 0.021 0.008 
I 0.015 0.019 0.009 0.014 
Average Upper Sinus 
Velocity 
(m/s) 
A 0.025 0.039 0.031 0.020 
B 0.066 0.135 0.069 0.100 
C 0.066 0.072 0.072 0.041 
D 0.019 0.052 0.043 0.023 
E 0.016 0.040 0.029 0.035 
F 0.024 0.049 0.040 0.022 
G 0.016 0.049 0.031 0.006 
H 0.012 0.042 0.032 0.013 
I 0.020 0.036 0.022 0.025 
Average Lower Sinus 
Velocity 
(m/s) 
A 0.009 0.009 0.008 0.013 
B 0.024 0.033 0.016 0.027 
C 0.029 0.026 0.019 0.022 
D 0.012 0.010 0.011 0.012 
E 0.018 0.007 0.005 0.011 
F 0.017 0.012 0.007 0.011 
G 0.010 0.007 0.006 0.002 
H 0.009 0.006 0.016 0.004 
I 0.010 0.006 0.004 0.006 
Table 6-5: Instantaneous data from PIV analysis for all setups, presenting the fast flow 
width at instants A – C, and the average full-, upper-, and lower-sinus velocities at all 
instants. 
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Figure 6-6: PIV derived data. (a) Fast flow width for instants A-D of each setup; 
Average velocity within the (b) whole- (c) upper- and (d) lower- sinus for each instant of 
each setup 
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Figure 6-7: Velocity profiles across sinotubular junction at each instant analysed for 
each configuration, with the 1/3 of peak velocity for each configuration indicated. (a) 
NoCA b) LCA; (c) RCA; (d) NCA. 
6.3.3.1 NoCA 
The velocity fields of the NoCA setup are presented in Figure 6-8, with a 
contour map for the Reynolds shear stress (RSS) at peak flow (instant B) 
shown in Figure 6-9(a). Colour maps for the vorticity, standard deviation, and 
RSS during instants A-D are provided in the appendices. The fast flow is initially 
very centralised along the root axis with an arched velocity profile across the 
STJ, before gradually shifting towards the commissural side of the cross-section 
while the STJ velocity profile flattens out, with 𝑋0 reaching 13.8 mm at peak 
systole (instant B).  A vortex is generated at peak systole, downstream of the 
native leaflet cusp next to the sinus side root wall, which dissipates at the end of 
systole. Whilst the PIV images do not indicate a commissural side vortex, the 
velocity profile across the STJ does show some return flow on this side of the 
root cross-section during peak systole, and the fast flow never extends to the 
commissural root wall throughout the cycle. 𝑣9, acquired during peak systole, 
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was measured at 2.5 m/s, at which time the peak RSS and vorticity were also 
obtained, reaching 127 N/m2 and 850 /s respectively, primarily distributed 
downstream of the native leaflet cusp on the commissural side. Turbulence was 
indicated to be highest in the regions downstream of the native leaflet cusps 
during mid systole (instants B and C), in a roughly symmetrical distribution 
around the central flow, reaching a standard deviation across the acquired 
image pairs of each instant of 0.75 m/s. 
 
Figure 6-8: Velocity contour maps and streamlines for the NoCA setup. The full cross-
section velocity field is displayed for instants A – D, and enlarged sinus velocity fields, 
at a smaller velocity scale, are shown for all instants. 
Systolic flow does not establish a distinct pattern within the sinus, indicating 
alterations to the sinus flow from cycle to cycle, and peaks at 0.15 m/s within 
the sinus throughout the cardiac cycle. 𝑣²= is 0.045 m/s during systole (instants 
A – D), and 𝑣5= is equal to 0.020 m/s. Flow is reduced during early diastole in 
the upper sinus, lowering 𝑣²= to 0.0198 m/s over instants E and F, although 
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there is little reduction in flow in the lower sinus, which averages 𝑣5= at around 
0.019 m/s during these same instants. As diastole proceeds, 𝑣5= does decrease 
with time, approximately halving from that observed in the first half of diastole. 
Upper sinus flow, after the initially deceleration in early diastole, remains higher 
than the lower sinus, with a diastolic (instants G - I) 𝑣²= of 0.0165 m/s. 
 
 
Figure 6-9: Reynolds shear stress contour maps for the various setups at peak flow 
(instant B): (a) NoCA; (b) LCA; (c) RCA; (d) NCA 
6.3.3.2 LCA 
The velocity maps obtained from the PIV data for setup LCA are presented in 
Figure 6-10, and a colour field of RSS at peak flow (instant B) shown in Figure 
6-9(b). Colour maps for the vorticity, standard deviation, and RSS during 
instants A-D are provided in the appendices. The fast flow is initially skewed 
away from the sinus side of the root cross-section, with an arched velocity 
profile throughout systole, and 𝑋0 is always higher than at the equivalent instant 
for the NoCA setup, reaching 16.4 mm at peak systole (instant B), when 𝑣9 is 
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acquired, equal to 2.8 m/s. The peak RSS is also measured at this instant, 
equal to 106 N/m2, and 900 /s respectively. Turbulence distribution is indicated 
to be similar in both magnitude and distribution to that of the NoCA setup during 
mid systole (instants B and C), but in contrast to the previous configuration, 
there is also a large region of turbulence at the STJ level on the sinus side of 
the cross-section. A sinus side vortex is again present, although it only fully 
coalesces later in the cycle (instant C), with a less structured region of return 
flow indicated in the same area during peak flow (instant B). A commissural side 
vortex can be observed during late systole (instant D), forming adjacent to the 
native leaflet cusp on this side. 
 
 
Figure 6-10: Velocity contour maps and streamlines for the LCA setup. The full cross-
section velocity field is displayed for instants A – D, and enlarged sinus velocity fields, 
at a smaller velocity scale, are shown for all instants. 
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Systolic fluid flow in the LCA sinus is relatively structured and at a greater 
velocity compared to the NoCA setup, especially within the upper sinus, with a 
maximum velocity magnitude of 0.28 m/s measured and 𝑣²= averaging 0.0423 
m/s throughout the entire cycle. 𝑣²= is equal to 0.0745 m/s during systole in the 
upper sinus, with flow towards the mock CA from the upper sinus, and 𝑣5= is 
equal to 0.0195 m/s during this same period. Flow towards the CA continues 
during early diastole (instants E and F), although slowing to a 𝑣²= of 0.045 m/s, 
and flow at the base of the sinus has become very slow, 𝑣5= = 0.0095 m/s. The 
flow towards the CA becomes reduced during late diastole (instants G – I), 
although 𝑣²= remains fairly constant during this time, 𝑣²= remaining above 0.036 
m/s throughout. The sinus flow further away from the STJ and ostium also 
remains fairly constant, at the much slower rate of 𝑣5= = 0.0063 m/s during this 
period. 
6.3.3.3 RCA 
The PIV derived velocity fields for the various instants throughout the RCA 
setup cycle are illustrated in Figure 6-11, and a contour map of the RSS at peak 
flow (instant B) shown in Figure 6-9(c). Colour maps for the vorticity, standard 
deviation, and RSS during instants A-D are provided in the appendices. The 
fast flow is more centrally aligned with a flatter profile than for the LCA setup, 
with a region of high velocity flow apparent in the STJ profile on the sinus side 
of the cross-section during early systole (instant A), as can be observed in 
Figure 6-7(c), which contributes to the largest 𝑋0 (19.0 mm) observed across all 
configurations, and may contribute to a reduced 𝑣9 over the cross-section, 
equal to 2.5 m/s. For the remainder of systole (instants B – D), 𝑋0 is lower than 
that observed for the LCA, and a sinus side vortex forms downstream of the 
native leaflet cusp, whilst a commissural vortex is indicated by the PIV images 
throughout systole. The maximum RSS is again observed during peak systole 
(instant B), reaching 124 N/m2, slightly higher than that observed in setup LCA, 
but with a similar distribution, downstream of both sides of the native leaflet 
cusps in the cross-section. However, the highest vorticity for this configuration is 
observed during early systole (instant A), on both sides of the central flow, 
reaching magnitudes of 980 /s. The turbulence pattern during mid systole 
(instants B and C) is similar to that of both the NoCA and LCA setups, with large 
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distributions indicated downstream of the native leaflet cusps on both sides of 
the jet flow, whilst the turbulence during early systole (instant A) is more 
prevalent than in the NoCA setup, but not as extensive as that observed in the 
LCA sinus, again downstream of the native leaflet cusps on both sides of the 
cross-section.  
Similar to the LCA setup, there is structured flow in the upper sinus and towards 
the CA during systole, peaking at 0.27 m/s, with much slower flow in the lower 
sinus. However, this flow speed is on average only 71 % of the magnitude of 
that observed in the LCA, with a 𝑣²= = 0.058 m/s during diastole, with this value 
equal to 64 and 68 % of the average LCA flow across the sinus during early 
(instants E and F) and late (instants G – I) diastole respectively. Flow in the 
lower sinus is also diminished until late diastole in comparison to the LCA setup, 
with 𝑣5= = 0.016 m/s in systole and 𝑣5= = 0.0062 m/s in early diastole. In late 
diastole, this flow at the base of the sinus has an average magnitude greater 
than late of the LCA, but 𝑣5= remains below 0.016 m/s at all instants in this 
period, and averages 0.0084 m/s overall from instants G – I. A vortex is 
generated around the mid-point of the sinus in mid-diastole (instants F and G), 
although with very low vorticity, never rising above 10 /s. 
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Figure 6-11: Velocity contour maps and streamlines for the RCA setup. The full cross-
section velocity field is displayed for instants A – D, and enlarged sinus velocity fields, 
at a smaller velocity scale, are shown for all instants. 
6.3.3.4 NCA 
Velocity fields for each analysed instant from the PIV analysis for the NCA 
setup are shown in Figure 6-12, and a colour field of the RSS at peak flow 
(instant B) shown in Figure 6-9(d). Colour maps for the vorticity, standard 
deviation, and RSS during instants A-D are provided in the appendices. The 
central flow is again skewed towards the commissural side of the root, in 
similarity with the LCA cross-section, with an initially flat velocity profile across 
the STJ which becomes more arched as systole progresses, reflected by the 
NCA 𝑋0 being initially greater than the LCA equivalent before shrinking to a 
narrower central flow. 𝑣9 is equal to that of the LCA setup, 2.8 m/s during peak 
systole (instant B), and RSS reaches 95 N/m2 at this time, the lowest RSS 
across the configurations, concentrated more on the sinus side of the cross-
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section. The vorticity is also lower than the previous setups, peaking at 750 /s in 
the same region as the maximum RSS. The turbulence distribution is very 
similar to that observed in the LCA composition, reaching a maximum during 
mid systole (instants B and C) in the regions downstream of the native leaflet 
cusps with additional turbulence observed in early systole (instant A) on the 
sinus side of the cross-section. Return flow accompanied by a vortex 
downstream of the native leaflet cusp on the sinus side of the root is present 
throughout the mid-late systolic cycle (instants B – D), and a commissural side 
vortex is indicated in the relatively wide slow flow during late systole (instant D). 
Unlike the LCA and RCA sinuses, and in similarity to the NoCA setup, NCA 
sinus flow is initially unstructured, and very slow throughout systole, with 
velocities approximately 57 % of LCA, at similar magnitudes to that observed for 
the NoCA configuration. Flow remains very slow at the base of the sinus 
throughout the cycle, 𝑣5= < 0.027 m/s during systole and 𝑣5= < 0.011 m/s 
throughout diastole. For the upper half of the sinus, 𝑣²= averages 0.042 m/s in 
diastole, 57 % of the LCA and 78 % of the RCA equivalent velocity magnitudes, 
and a vortex present in the sinuses at the equivalent position of the CA in the 
LCA and RCA setups seems to direct returning flow away from the sinus. The 
average velocity of the upper sinus remains below both of the other two 
physiological setups in the remainder of the cycle, with 𝑣²= = 0.029 m/s during 
early diastole for the NCA sinus (66 % of the LCA 𝑣²= and 86 % of the RCA 𝑣²=), and diminishing further during late diastole, 𝑣²= = 0.0159 m/s (38 % of the 
LCA 𝑣²= and 57% of the RCA 𝑣²=), and comparable to the equivalent value of 
the NoCA setup. 
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Figure 6-12: Velocity contour maps and streamlines for the NCA setup. The full cross-
section velocity field is displayed for instants A – D, and enlarged sinus velocity fields, 
at a smaller velocity scale, are shown for all instants. 
6.4 Discussion 
For the first time, the flow within an aortic root containing native leaflets and an 
implanted TAV has been modelled and analysed via PIV, elucidating local fluid 
flow fields of instants throughout the systolic and diastolic cycles. The CA flow 
rates observed throughout the cycle were within the upper and lower extremes 
of the flows reported in the literature, with a similar flow pattern consisting of 
peak CA flow during very late systole and early diastole observed72,111. The 
average CA flowrates, 114.2 ml/min for the LCA and 52.1 ml/min for the RCA, 
were also within the in vivo ranges previously reported (79-233 ml/min for the 
LCA and 19-162 ml/min for the RCA, measured via angiography and 
intravascular ultrasound and the contrast transit time)108. This degree of 
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agreement with the data published in the literature is considered acceptable, 
especially when considering that the variability between patients results in a 
wide range of physiological coronary waveforms72. 
The global haemodynamic data acquired was very similar across the 4 setups, 
suggesting that the presence or otherwise of the CA has little effect upon the 
cycle to cycle performance of TAVs in terms of forward flow efficiency and valve 
function. The 𝐸𝑂𝐴, 𝛥𝑝, and 𝐸0 varied by less than 4 % across the setups, whilst 
the 𝑉4 and associated 𝐸4 were within 10 % for the configurations, equating to an 
additional 0.11 ml of regurgitation in the NCA setup in comparison to the LCA 
setup, marginally greater than the experimental error of ± 0.09 ml, but still well 
within the ISO requirements for a bioprosthetic implant268. This was expected 
for the 3 physiological setups (LCA, RCA, and NCA) as the only difference 
between these configurations was the location of the fully open, partially 
obstructed, and fully closed tubing in relation to the camera used for PIV image 
acquisition. The similarity of the global data of the NoCA setup to the 3 
physiological setups implies that in vitro testing where the primary/sole aim of 
the experiment is to obtain these performance indicators, the inclusion of CAs in 
the model is not necessary to achieve physiologically relevant findings. 
 
Figure 6-13: The velocity fields for instants A – D from configuration TA1 from Chapter 
6 
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The leakage during the diastolic part of the cycle was greater for the NoCA 
configuration than the other setups, although the measurement technique used 
did not enable differentiation between intra- and para-valvular leakage. 
However, it may be conjected that this additional leakage occurred as a result of 
the lack of CAs in the NoCA setup, which provide outflow for backflowing fluid 
and pressure during diastole in the 3 physiological setups. Instead, the lack of 
CA outlet for the flow during diastole results in additional leakage around and/or 
through the TAV. As the previous TAV experiments described and discussed in 
Chapter 5 were only concerned with the systolic portion of the cycle, direct 
comparison of the energy losses associated with the closed valve during 
diastole cannot be made, but the additional energy loss of 5.53 mJ in the NoCA 
setup is not thought to make a critical difference to the flow dynamics of the 
configuration, representing < 7 % of the total energy loss during the cycle. 
PIV analysis of the downstream flow from the TAV in the NoCA setup, as 
illustrated in Figure 6-8, shows similar flow patterns to those observed for the 
TA1 configuration from the previous investigation in Chapter 6, the aligned TAV 
within native leaflets, presented in Figure 6-13 for convenience. 
A summary of the fluid flow within the sinus for the different configurations is 
provided in Figure 6-14 . The forward flow extends to the commissural side wall 
during systole, with a small vortex sometimes observed above the native leaflet 
cusp here, whilst there is a larger and stronger vortex above the sinus side 
cusp, associated with a wider return flow next to the root wall that prevents the 
central jet from fully extending to the lumen. These flow patterns are also 
observed for the LCA, RCA, and NCA setups, although the sinus side vortex of 
the NCA flow is larger and further downstream than in the other physiological 
cross-sections. Systolic coronary flow may draw this vortex closer to the sinus, 
implied by closest position of this vortex to the sinus at mid systole in the LCA 
setup which has the highest CA flow, which then appears to increase flow into 
the sinus region as a whole. On the contrary, in the NCA setup, the backflow 
along the sinus side wall appears to be diverted away from the sinus and back 
along the cusp of the native and TAV leaflets by this vortex, reducing flow into 
the sinus. A small vortex, possibly generated by this return flow passing the 
relatively static flow of the sinus as theorised by Yap et al.102, is observed at the 
upper most point of the sinus from late systole until late diastole, providing 
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some washout of the upper sinus but not significantly influencing the flow of the 
lower sinus during this period, which remains below 0.012 m/s. The varying 
position of this sinus side vortex across the setups also explains the disparity 
between the STJ velocity profiles between X = +5.0 and +12.5 mm as shown in 
Figure 6-7, with the position of the vortex determining whether the flow across 
the STJ is primarily downstream or more lateral. 
  
Figure 6-14: Summary of sinus fluid flow for the (a) NoCA, (b) LCA, (c) RCA, and (d) 
NCA configurations in (i) systole and (ii) diastole. The systolic vortex at the STJ is 
drawn towards the sinus due to the CA flow in the LCA and RCA configurations, 
alongside increased flow into the sinus. Flow in the upper sinus of the LCA and, to a 
lesser extent, the RCA is directed towards the ostium, but it much slower and without a 
clear direction for the NoCA and NCA sinuses, with the exception of a small vortex 
close to the STJ in the upper NCA sinus. Flow at the base of the sinus is very slow 
without a clearly defined direction of flow for all configurations in both systole and 
diastole. 
Sinus flow is indicated to be much slower than that reported in previous in vitro 
investigations72 of the aortic root region following surgical implantation of an 
aortic valve prosthesis, as indicated in Figure 6-15, most likely due to the 
presence of the native leaflets around the TAV. This reduced sinus velocity is in 
agreement with previous investigations of the region that omitted the CAs but 
included the native leaflets in the model, which report that the flow speed of 
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blood within the native sinus (and towards the basal annulus of the root in 
relation to the permanently held open native leaflet cusps) remains below 0.1 
m/s throughout the entire cardiac cycle213. The LCA configuration results in flow 
in the upper sinus that remains above 0.05 m/s for the majority of each cycle, 
associated with a notable reduction in persistent stagnation, and accordingly a 
lower risk of thrombosis83,92. The RCA upper sinus flow is slower, and dips 
beneath this threshold during diastole, but the NoCA and NCA setups are much 
lower throughout diastole, never rising above 0.03 m/s, indicating a significantly 
elevated risk of thrombosis compared to the two coronary sinuses, especially 
the LCA, and measured at similar magnitudes to that measured for the lower 
sinus, already indicated by the literature to be of high thrombotic risk due to flow 
stagnation83,269.  
 
Figure 6-15: Comparison of lower sinus flow between (a) surgical aortic valve root72 
and (b) post-TAV implantation. The velocity data for (a) is taken from a single co-
ordinate from the cross-section, indicated by the red dot labelled ‘X’ in the figure, 
whereas the data for (b) is averaged over the full lower half of the visible sinus. 
The native leaflet, permanently displaced into an open configuration, fills much 
of the volume of the sinus, reducing the likelihood of vortical generation within 
the SoV. The extent of native leaflet presence is bound to be variable from 
patient to patient, as the extent and location of calcification across the leaflets is 
not uniform270, causing a multitude of native leaflet shapes around the 
implanted TAV. Accordingly, the modelling of the native leaflets with a simple 
vinyl wrap from the investigation in Chapter 5, resulting in a thin walled cylinder 
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surrounding the TAV, can be considered to be a relatively mild and/or uniform 
calcification of the native leaflets, whilst the thicker silicone leaflets of the model 
presented in this chapter represent a more severe calcification. As a result, 
more of the mock native leaflet occupies the thickest part of the sinus cross-
section, which is where a systolic vortex is present in the velocity fields acquired 
from configuration TA1 from Chapter 6, the equivalent setup of NoCA. A future 
study could involve varying the degree of sinus penetration by the native 
leaflets, possibly related to the thickness and/or calcification of the native 
leaflets, and establishing the relationship between this reduction of sinus 
volume and the sinus flow speed through the cardiac cycle, already indicated by 
this research to be substantially reduced from the physiological or post-surgical-
intervention environment20,72. 
Possibly as a result of this increased native leaflet intrusion into the native 
sinus, the flow at the base of the sinuses is not significantly affected by the 
presence or otherwise of CA flow. Fluid velocity remains very slow throughout 
the modelled cardiac cycle, with only a small increase during peak systole, yet 
still remaining below 0.04 m/s for all setups, indicating a very stagnant region of 
flow and, as blood flow speeds lower than 0.05 m/s are associated with a 
drastic increase in the likelihood of thrombosis, an elevated risk of blood 
clots83,92, which could cause local interference of leaflet function and/or 
downstream pathologies such as stroke. The minimal flow also indicates 
reduced wall shear stress along the lumen of the root in this region, reducing 
the alignment of endothelial cells and increasing the likelihood of 
inflammation83, which in turn raises the risk of the exposure of subendothelial 
tissue to the blood. Virchow’s triad of factors, made up of hypercoagulability, 
interruptions to the blood flow (such as blood flow stasis), and phenomena 
associated with the surfaces within and around the blood flow (such as 
exposure of the subendothelial layer of the lumen), indicate the main 
contributors to thrombosis83,269. The presence of two of these factors in the 
Valsalva sinuses post-TAV implantation, particularly towards the basal annulus 
region and especially in the non-coronary sinus, indicates an elevated potential 
for a highly thrombotic environment following non-surgical replacement of the 
aortic valve. These flow dynamics could therefore be strongly associated with 
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the reported raised incidence of sub-clinical leaflet thrombosis, stroke, and 
silent ischemic attacks following TAV implantation192,207. 
6.4.1 Limitations 
The interpretation of these results requires consideration of the limitations 
present in the setup of the investigation. The idealisation of the root and native 
aortic valve geometry for the silicone models is not reflective of all physiologies, 
with anatomical variability and irregular calcification distribution alongside the 
potential for asymmetrical and non-standard TAV deployments contributing to 
alterations to the fluid dynamics presented here12,186. In particular, modelling 
and analysing the variation of the CA position may reveal further information on 
the post-TAVI environment, e.g. a lower CA, with the ostium situated closer to 
the basal annulus, may experience a reduced CA flow but may also influence 
the flow at the base of the sinus more, resulting in less sinus flow stagnation. 
Rigid root walls were used, precluding the modelling of aortic compliance, 
however the extensive application of TAVs within the elderly community189, with 
lower compliance aortic roots267, makes the conclusions of this study 
representative of a major proportion of the patient population. Imposing different 
haemodynamic cycles, with variations to the CO and/or the mean aortic 
pressure could reveal alterations to the CA flow during the cardiac cycle, 
leading to variations in the influence of the flow to the CA upon the sinus flow. 
The Newtonian blood analogue used will result in altered fluid dynamics in 
comparison to the shear thinning properties of blood, particularly in the low 
shear regions within the native sinuses focused on in this report, where the 
raised viscosity of a non-Newtonian fluid in low shear would reduce the velocity 
of the fluid in comparison to the Newtonian fluid used in this investigation. 
Finally, the 2D PIV analysis technique used cannot measure any out-of-plane 
dynamics, although it is expected that the plane investigated contains the most 
relevant flow structures of the region. 
6.5 Concluding Remarks 
Mock coronary arteries were included in a model of the aortic root, and a 
commonly implanted TAV device was positioned within. The resultant flowrate 
through these coronary arteries was found to be within the net cycle flow and 
maximum flow speed of the coronary arteries compared to previous in vitro and 
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in vivo reports72,111.  The fluid dynamics within the upper sinus of an aortic root 
post-TAV implantation are affected by the presence of CA, with the mean 
velocity of the upper LCA sinus, 0.057 m/s, approximately twice that of the 
upper NCA or NoCA sinuses, 0.029 and 0.032 m/s respectively. Flow towards 
the LCA or RCA raises the flow speed in the associated chamber region closest 
to the STJ throughout the cardiac cycle, and non-modelling of these anatomical 
features during in vitro testing102,271 could lead to under estimation of the flow 
within the upper sinus for the LCA and RCA, halving the flow velocity. CA flow 
also appears to affect the position of the sinus side vortex during late systole, 
with the increased flow to the LCA drawing this vortex towards the sinus. This 
increased fluid velocity suggests increased washout of the coronary sinuses, 
which could help lower the risk of thrombosis and endothelium damage. 
Therefore it can be stated that flow into the coronary arteries has an effect upon 
the fluid dynamics of the aortic root after TAV implantation. 
Flow at the base of the sinus was relatively unaffected, remaining slow 
throughout the cycle and at elevated risk of thrombosis and endothelium 
damage, whilst global haemodynamic performance indicators were unaffected 
by the presence or otherwise of CAs. 
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7 Conclusions and Recommendations for 
Future Work 
7.1 The Present Contribution 
The major objective of this research was to establish the changes in the fluid 
dynamics of the aortic root due to the implantation of a TAV device. The 
increasing prevalence of treatment of aortic stenosis and other incurable aortic 
valve deficiencies with these novel prosthetics means a full understanding of 
the flow changes post-procedure is vital, especially when considered alongside 
the reported raised incidence of stroke and silent ischemic events after TAV 
implantation. These pathologies are strongly associated with (and often caused 
by) blood thrombosis, indicated by Virchow’s triad to be strongly influenced by 3 
broad categories of factors: interrupted blood flow (such as stagnation or 
turbulence), hypercoagulability (due to changes to the biological constitution of 
blood), and contact with non-standard surfaces (such as exposed sub-
endothelium or foreign materials)84. 
In order to characterise and evaluate the flow of the post-TAV implantation 
aortic root region, the local flow patterns within both healthy and surgically 
treated aortic roots were first determined, enabling the differences between TAV 
and its alternatives to be ascertained. 
The fluid flow patterns of the healthy native aortic valve and root were captured 
via in vitro analysis. Several configurations, representing the healthy condition 
as well as 5 distinct post-surgical treatment environments (an ‘ideal’ 
bioprosthetic sizing and positioning; the inclusion of a vascular graft that 
occludes the sinuses; a sub-annular implantation; an undersized bioprosthetic; 
a mechanical aortic valve implantation), were modelled and fixed inside a pulse 
duplicator, and physiological flow and pressure was imposed. Global 
haemodynamic performance parameters were calculated from pressure and 
flow transducers, enabling valve function to be compared across the 
configurations. Simultaneously, PIV images were acquired at several pre-
defined instants within the mock systolic flow, enabling velocity fields of a cross-
section of the aortic root to be generated, from which properties such as the 
RSS, vorticity, and turbulence could be quantified or elucidated. These local 
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fluid flow patterns could then be used to explain differences in the global 
haemodynamic performance data, as well as reveal characteristics of each 
configuration’s flow that would not be possible by pressure/flow analysis alone. 
The same pulse duplicator and PIV techniques were then employed to 
investigate the fluid flow of an aortic root after TAV implantation, enabling 
comparison of the contour maps to that of the healthy, native root, and 
characterisation of the resultant flow. As the native- and TAV-commissural 
alignment is essentially random following prosthesis implantation, the fluid 
dynamics of the TAV were captured at both perfect commissural alignment and 
maximum non-alignment, to establish whether valve performance or other more 
discrete flow properties were affected. As many previous in vitro studies have 
not modelled the native leaflets during their procedure, the effect of including 
and omitting these anatomical features was also represented. 
Finally, mock coronary arteries were designed and incorporated into the TAV 
analysis setup. The TAV was inserted into a mock aortic valve constructed from 
silicone, and the flowrate through the CAs was measured and compared to 
reported in vivo values. Each of the physiological sinuses, the LCA, the RCA, 
and the NCA sinus, was investigated using the pulse duplicator and PIV rig, in 
addition to a setup with all of these coronary arteries clamped off, representing 
both a configuration from the TAV alignment study and multiple reports from the 
literature, which have not included any representation of the CAs. 
7.2 Main Findings of the Investigation 
Investigation of the role of the valve-root system upon the functional mode and 
hydrodynamic performance of the left side of the heart revealed that significant 
alteration to the valve position or the geometric proportions of the aortic valve 
and/or root caused changes to the downstream fluid dynamics of the region. 
Common post-surgical environments resulted in a 32 – 42 % decrease in the 𝐸𝑂𝐴 and a 64 – 110 % increase in the systolic transvalvular pressure loss. 
These global haemodynamic performance indicators were accompanied by a 
10 – 40 % narrowing of the central jet flow and peak systole, increasing blood 
velocities as high as 3.0 m/s in contrast to the upper physiological limit of 1.7 
m/s55,98, and elevating the chance of RBC damage, a possible factor in the 
pathological incidence of calcification in bioprosthetics. These configurations 
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are also representative of common in vitro setups, providing reasoning for the 
non-consensus within the community in regard to the systolic fluid dynamics of 
the aortic region, as described in Section 2.1.3.2.1, in particular Figure 2-8, 
whereby some research claims the initial vortices persists within the SoV 
throughout systole and aid with valve closure18–21, whilst other work states that 
these first vortices migrate away and are replaced by a second set of vortices, 
often with the opposite rotation32–35. The position and containment of the initial 
vortices generated by the forward flow though the aortic valve, indicated to 
remain within the SoV throughout systole once generated in the healthy, native 
condition, varies across the different root-valve configurations of the experiment 
described in Chapter 4, leading to increased impingement of the central flow, 
generation of secondary counter-vortices, and alterations to the closing 
characteristics of the valve.  
Implantation of a TAV within the aortic district results in changes to the flow 
dynamics of the region in comparison to the healthy native environment. The 
central flow is narrowed and displaced away from the sinus side root wall, and 
the sinus flow is significantly diminished, especially at the base of the sinus, 
heightening the risk of thrombosis due to flow stagnation, and providing an 
explanation for the increased levels of sub-clinical thrombosis and thrombosis 
related pathologies, such as stroke and silent ischemic events, that have been 
reported following TAV procedures13–16. If the TAV is rotated from an ideal 
commissure-upon-commissure alignment, this sinus flow is further reduced, and 
flow patterns in the vicinity of the native commissures become altered from the 
flow patterns observed in the healthy, physiological condition modelled in 
Chapter 4, becoming more oscillatory, raising concerns of lumen pathologies. 
However, the haemodynamic performance indicators, such as 𝐸𝑂𝐴 and ∆𝑃, of 
the valve are unaffected, most likely due to the presence of the native leaflets, 
which form a pseudo-cylindrical structure extending around and beyond the 
outflow of the TAV. Omitting a model of these native leaflets from an in vitro 
investigation of TAVs may lead to substantially different flow features within the 
mock root, including significant, non-physiological sensitivity to the rotational 
alignment of the bioprosthesis, suggesting that representing the native valve is 
essential in producing accurate haemodynamics, and an explicit requirement for 
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their presence should be including in the regulations for preclinical testing of 
TAVs. 
Flow in the upper sinuses of the post-TAV implantation region is affected by the 
extent of flow to the CA, with diastolic flow in the upper NCA sinus (i.e. a sinus 
with no CA flow) 43 % lower than in the upper LCA sinus and 22 % lower than 
in the upper RCA sinus, indicating sinus flow could be under-estimated in 
studies omitting modelling of CA flow. The systolic vortical patterns observed in 
the central root are also affected by this coronary flow, which draws the 
associated vortex around the level of the STJ closer towards the chamber, 
possibly contributing to the increased washout of the CA sinuses. However, this 
coronary flow does not affect the flow in the lower sinuses, which remains 
extremely slow throughout the cycle in all 3 of the physiological sinuses, 
indicating risk of thrombosis and susceptibility of the endothelium to 
inflammation and damage, thus fulfilling two of the categories of Verchow’s 
triad84, and providing more explanation for the increased levels of thrombotic-
associated pathologies following TAV implantation13–16. 
7.3 Recommendations for Future Work 
The work presented in this thesis has provided information on the fluid 
dynamics of the aortic root, especially within the sinuses of Valsalva, before and 
after the implantation of a TAV bioprosthesis. Further work could build upon this 
work, whether by providing measurements that could not be taken using the in 
vitro methodologies employed here, or by further developing the bench top 
models.  
Numerical models have been used to simulate the aortic region in previous 
reports in the literature, and, once validated, can yield information about the 
dynamics of the volume that are difficult or impossible to derive from in vitro or 
in vivo studies of the equivalent anatomy. For example, wall shear stress is 
particularly difficult to estimate using PIV, as the cross-correlation method used 
to derive the velocity vectors over a given cross-section results in biasing 
estimation of these values near walls, due to high velocity gradients and lower 
concentration of particles272. Computational simulation would enable accurate 
calculation of the wall shear stress, providing information on low or highly 
oscillating regions of the aortic lumen, associated with early stage 
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atherogenesis and plaque localisation93,273. Numerical models could also enable 
3D analysis of the root, rather than being limited to the pseudo-2D laser sheet 
of the presented PIV technique, and alterations to the fluid and root properties, 
such as modelling the non-Newtonian response of blood to shear and the 
inclusion of various levels of compliance in the root wall, could be more easily 
incorporated into the simulation. Work towards this goal has been undertaken 
via the validation of a fluid-structure interaction model with the experimental 
data of the physiological configuration from Chapter 4 of this thesis, wherein a 
numerical model was designed to simulate as closely as possible the 
configuration from the PIV study, and velocity maps of the equivalent cross-
section of the two investigations were compared250. Once validated, this 
computational construct was modified, introducing wall compliance, matching 
the viscosity of the blood at high shear, and removing the prosthesis frame from 
the simulation, and rerun. The removal of the prosthetic frame appeared to 
cause substantially altered systolic positioning of the active leaflets, as they 
moved further into the sinus chamber without the polymer scaffold inhibiting 
them. 
Continuing with the idea of removing the presence of a non-physiological frame 
from a model of the physiological environment, the combined silicone root and 
valve, used in Chapter 6 to represent the native root and valve and described in 
Sections 3.4.1.4 and 3.5.2, is currently being developed to more closely 
represent the healthy native anatomy, and reproduce the associated 
haemodynamics. In TRIZ parlance, the unresolved contradiction of silicone 
leaflets that are too thick and/or stiff to reproduce the dynamics of the healthy 
aortic leaflets, as indicated by the PIV results presented in Figure 7-1, but 
simultaneously not durable enough to withstand the rigours of testing at 
physiological pressure and flow within the pulse duplicator requires an inventive 
solution. Novel blood analogue solutions, incorporating polyacrylamide, xanthan 
gum, dimethylsulfoxide, hyaluronic acid, and/or sucrose, have been indicated to 
more closely match the shear thinning properties of blood, as well as matching 
the RI (± 0.03) of the silicone used to model the aortic root274. If these chemicals 
cause no significant change to the mechanical characteristics of the active 
leaflets and are suitable for PIV analysis, use of one or more these solutions 
could provide more accurate fluid dynamic responses for data acquisition. 
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Figure 7-1: Cross-sectional images of native aortic district (a) PIV derived velocity field 
of a cross-section of the root at peak systole at an imposed cardiac output of 5 lpm at 
100 mmHg mean aortic pressure. In comparison with (b) the computational cross-
section250, and (c) 4D-flow MRI in vivo image, the in vitro leaflet does not extend as far 
into the sinus, is positioned too low, and does not reproduce the same vortical patterns. 
Study of the degree of sinus penetration into the sinus chambers by the native 
leaflets following TAV implantation, which may vary due to the degree of non-
uniform leaflet calcification270, could elucidate the extent of the effect this has 
upon the sinus flow speeds. A threshold of sinus penetration could then 
potentially be associated with increased flow stagnation and subsequent 
elevated risk of thrombosis, leading to improved therapeutic advice concerning 
anti-coagulation medication. Reversing this information pathway, the recording 
of TAV rotational alignment with their host native commissures in correlation 
with the cause of death of the patient could lend weight to the suggestion of 
increased thrombosis resulting from misalignment, or reveal other associated 
pathologies, which could then be specifically investigated within an in vitro 
experiment. 
 
Figure 7-2: PIV velocity field of a CoreValve TAV device. Considerable artefacts 
resulting from the nitinol wire frame downstream of the valve are evident in the central 
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jet flow, and reflection from these metallic struts also reduces the quality of the data 
acquisition from the sinus region 
As the TAV device investigated in this thesis was the Edwards SAPIEN XT 
prosthesis, it would be beneficial to also study a device representative of the 
other major TAV type used, the Medtronic CoreValve, previously described in 
Section 2.3.3.1.2. Preliminary PIV analysis of this technology has been 
hindered by the increased amount of metal struts and pericardial tissue 
incorporated into the design, which have caused increased out of plane 
reflection of the laser sheet, leading to central jet flow artefacts and reducing 
the quality of the data for the sinus region, as indicated in Figure 7-2, despite 
efforts such as dyeing the leaflet tissue black and coating the frame with a matt 
finish. Once these issues are resolved, comparison of the CoreValve data with 
the Edwards SAPIEN XT data presented in this thesis could provide improved 
therapeutic advice based on the prosthesis chosen for each patient, and inform 
future device design. Alternative methods of PIV analysis, such as time-
resolved streak vectors or dye injection72,243,275, could further elucidate the flow 
dynamics of the region, especially the paths and residence time of RBCs. 
Finally, the duration of the study of the effects of the chemicals investigated in 
the appendices could be extended, providing information on the storage or 
longer-term testing (i.e. more than 24-hours) of devices partially or fully made 
up of GA-fixed pericardium tissue, particularly glycerol, which, as discussed in 
Section 9.1.4, was indicated to affect the low stretch modulus of the pericardial 
tissue, albeit to an acceptable degree for the scope of these experiments. 
Exposure for extended periods of time (e.g. 6 months) to these testing fluids 
may eventually cause significant stiffening or loosening of the tissue, leading to 
substantially altered hydrodynamic responses. Additionally, the increased 
translucency observed after storage in 100 % glycerol may have beneficial 
uses, as long as the mechanical characteristics of the tissue are not significantly 
altered. The ability to see through the valve tissue during operation in the pulse 
duplicator could lead to PIV elucidation of the fluid velocity at the very centre of 
the valve during peak flow. 
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9 Appendices 
9.1 Assessment of the Potential Influence 
of Testing Solution upon the 
Mechanical Properties of GA Fixed 
Tissue 
9.1.1 Introduction 
As of 2015, all FDA-approved TAVs were produced with either GA fixed bovine 
(such as the Edwards SAPIEN valves detailed in Section 0) or porcine 
pericardium, and the bioprosthetic surgical valves planned to be used during 
these investigations are constructed using GA-fixed porcine aortic valve leaflets, 
as outlined in Section 3.4.1.1. However, some research has indicated that 
glycerol, used to raise the viscosity level of the blood analogue used to a more 
physiological level during in vitro testing21,102,239, may alter the mechanical 
properties of the leaflet tissue of bioprosthetic valves240,241. Wright suggested 
that a water-glycerol solution may cause stiffening of the tissue241, whilst Parker 
et al. reported that soft tissue samples stored in glycerol “developed a patchy 
distribution of the collagen, which had a loose, disorganised arrangement when 
compared with the fresh control tissue”, with a corresponding fall of up to 30 % 
in elastic properties240. Other reports refute these claims however, stating that 
hydrodynamic testing in glycerine based fluids for up to 80 days caused no 
trend of change in the valvular performance caused by absorption of the 
glycerine, although these reports were based on qualitative comparison of valve 
performance rather than mechanical characterisation of the tissue276,277. 
As the planned tests for this thesis involved exposing the GA fixed pericardium 
to different fluids made up of some combination of glycerol, saline, deionised 
water, and potassium iodide (KI) for periods of hours, it was decided to avoid 
using glycerol until it could be established that it did not significantly affect the 
mechanical properties of the tissue leaflets used. Although there have been no 
reports of potassium iodide or buffered phosphate saline mechanically affecting 
the tissue, it was also decided to investigate the effect of the fluids that 
contained no glycerol but were intended for use in these investigations.  
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GA fixation of soft tissue causes modifications, dependent upon the 
concentration of and exposure to the GA and the temperature during the 
fixation, but allows stabilisation of the tissue and reduces antigenicity, reducing 
rejection by the immune system of the patient278, but also triggers structural 
damage to the extra cellular matrix and increases the risk of tissue 
calcification279,280, reducing the performance of the valve if the pericardium 
based on that tissue. Mechanical characterisation of pericardial tissue does not 
yet currently have a univocal process, making inter-experimental comparison 
problematic218. Even with these restrictions in mind, native and GA fixed 
pericardial tissue shows qualitatively similar stress-strain responses218. 
The mechanical properties of heart valve tissue are most commonly ascertained 
using uniaxial testing125, and the J-curve is a commonly used description of the 
stress-strain relationship of pericardium124,218,281, presented in Figure 9-1(a), 
where the various parts of the curve may be split into regions where specific 
physiological functions dictate the characteristics of the mechanical 
response125. The tissue has a relatively large region characterised by a large 
strain response to low stresses, corresponding to the crimped collagen fibres 
straightening and the elastin fibres elongating, in an approximately linear 
fashion, defined by a low stretch modulus (𝐸6)125,281. Once the collagen fibres 
start to become uncrimped, any further extension of the tissue requires the 
stretching of these collagen fibres, which are much stiffer than the elastin fibres, 
and so the strain response to stress decreases, and enters a non-linear 
transition phase as the collagen fibres transition from straightening to stretching, 
marked on Figure 9-1(a) by 𝜀6. With continued extension of the tissue, the 
stress-strain relationship enters a third phase at a strain of 𝜀7. Like the first 
phase, this region is again approximately linear, but with a much-reduced strain 
response to additional stress, defined by a high stretch modulus (𝐸7), as now all 
the collagen fibres are fully straightened and aligned. Further stretching of the 
sample results in the tissue entering the rupture phase, a second non-linear 
phase as shown in Figure 9-1(a), as the elastin and collagen fibres break. 
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Figure 9-1: Mechanical Characteristics of Bovine and Porcine Pericardial Tissue: (a) J-
curve stress-strain relationship of pericardial tissue, adapted from Hasan et al. 2014125; 
(b) Range of stress-strain moduli reported in the literature, adapted from Aguiari et al 
2016218 
Previous uniaxial tests in the literature report a wide range of high stretch 
moduli for the GA fixed pericardial tissue, with bovine 𝐸7 in the range of 15 to 
150 MPa (and outlying values of up to 250 MPa reported) and porcine 𝐸7 
varying from 60 to 130 MPa (with outlying values as low as 47 MPa and as high 
as 150 MPa)218, with these ranges illustrated in Figure 9-1 for clarity. This is due 
to inconsistencies in the test methods and large variabilities in the material 
properties, related to the phenotype, age, and sex of the animal, as well as the 
location, fibre orientation, and testing temperature of the sample. 
Uniaxial testing of GA fixed bovine and porcine pericardial tissue was 
undertaken, with the force-displacement readings recorded during each cycle, 
which were then converted into stress and strain values. These measurements 
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were then repeated after the tissue was exposed for 24 hours, representing the 
maximum duration of a PIV testing setup and hence the maximum exposure of 
tissue to a particular testing fluid, to one of the various fluids being investigated, 
and then the investigation was repeated for the same tissue sample for the 
remaining solutions. Concurrently, samples taken from the same original sheet 
of GA fixed pericardium as the sample being uniaxially tested were periodically 
examined for shrinkage or expansion over a 150-hour time span. 
9.1.2 Methods 
9.1.2.1 Tissue 
In order to investigate whether the stiffness of the bioprosthetic tissue of the 
valves would be altered by exposure to the working fluids described in Section 
3.6, samples of equivalent bovine and porcine tissue were required. 
For the bovine tissue282, heart lung blocks were collected, and chilled on ice 
prior to pericardium removal. The pericardial sacs were dissected from the 
heart, cleaned of excess fat and parietal pericardium, thoroughly rinsed in 
sterile saline (20 mM HEPES-Saline (pH 7.4) containing 13 mM MgCl2-H2O), 
and fixed in a 0.5% solution of GA for 48 hours. They were then removed from 
the 0.5% GA solution, and stored at 4 °C in a 0.2% GA solution, ready for 
thickness mapping and uniaxial tensile testing. 
The porcine tissue procedure283 was the same as for the bovine pericardium, 
except the fixation solution was 0.6% GA, matching the fixation of the Labcor 
TLPB valves230, and the fixation period was 24 hours . 
9.1.2.2 Fluids 
9.1.2.2.1 Phosphate Buffered Saline 
The saline used in the investigations was Phosphate Buffered Saline (PBS, 
Fisher Bioreagents BP2438-20), containing 0.137M NaCl, 0.0027M KCl, and 
0.0119M phosphates. PBS is a Newtonian fluid, used both to store bioprosthetic 
heart valves213 and as a medium to contain biological soft tissue during uniaxial 
testing284, and adheres to the ISO 5840-2:2015 requirements for the testing 
fluid of cardiac valve prostheses268. At a temperature of 25 °C, the PBS has a 
dynamic viscosity, 𝜂=, of 0.001 Pa.s, as measured by a viscometer (Viscolite 
700, Hydramotion, UK), and a density, 𝜌Ê, of 1.01 g/cm3.  
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9.1.2.2.2 Viscosity Matched Testing Fluid 
A solution of 40 % glycerol and 60 % saline (by weight), used during pulse 
duplicator testing in order to match the viscosity of blood at high shear97,104,220, 
labelled as the 𝜂 solution. Although is a Newtonian fluid, in contrast to the non-
Newtonian nature of blood, the shear-thinning effects are less pronounced in 
the relatively large diameter vessels of the aortic root 237, and so many tests use 
a fluid reproducing the viscosity of blood for a given shear97,104,220. As blood at 
37 °C exits the aortic valve, it reaches shears of > 100 s-1, tending towards a 
dynamic viscosity of 0.0035 – 0.004 Pa.s81. The 𝜂 solution used in this 
investigation has a dynamic viscosity, 𝜂Ï, of 0.004 Pa.s, and a density, 𝜌Ï, of 
1.11 g/cm3. 
9.1.2.2.3 Refractive Index and Viscosity Matched Testing Fluid 
A solution of 15.2 % KI, 36.2 % glycerol, and 48.5 % deionised and filtered 
water, used during PIV investigations to both raise the RI and match the 
viscosity to that of blood at high shear (𝜂-RI solution)97. As the RIs of glycerol 
and PBS are 1.47 and 1.33 respectively, a mixture of 50% glycerol and 50 % 
saline242 would be required to match the RI of the resultant fluid to that of Med-
6015, a typical silicone used in PIV studies107,250 with a RI of 1.40, and thus 
avoid image distortion due to RI mismatch. This would result in a dynamic 
viscosity of 0.007 Pa.s, indicating a much more viscous fluid than that observed 
in large blood vessels at high shear81. The high RI of 1.67 for KI in its crystalline 
form, alongside its high solubility in water at 25 °C, minimal risk for human 
health, and affordability, makes it an ideal chemical to be used alongside to 
raise the RI of the analogue fluid whilst keeping the dynamic viscosity similar to 
that of blood at high shear242. The presence of ions in the resultant solution, due 
to the inclusion of KI, removes the requirement of using PBS to provide ions to 
be detected and measured by the electro-magnetic flowmeter of the pulse 
duplicators commonly used in heart valve assessment97,104,220, and so it was 
preferred to use deionised and filtered water instead of PBS. The 𝜂-RI solution 
used in this investigation has a dynamic viscosity, 𝜂ÏÆ, of 0.004 Pa.s, and a 
density, 𝜌ÏÆ, of 1.29 g/cm3. 
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9.1.2.3 Shrinkage and Expansion of Tissue 
An alteration to the mechanical characteristics of the tissue could be caused by 
an increase or decrease in the stiffness of the tissue, but it could also be 
caused by shrinkage or expansion of the tissue. In order to establish whether 
the various fluids the GA fixed pericardial tissue was being tested in caused the 
samples to shrink or expand, image analysis of a sample before and after 
exposure to the fluid was taken out. 
A sample of bovine or porcine pericardial tissue was taken from the each sheet 
of GA fixed tissue as used in the uniaxial testing described in Section 9.1.2.4, 
with each shrinkage/expansion sample consisting of one of the end Sections of 
a type 4 test sample as recommended by ISO 37-2011285, illustrated in Figure 
9-2(a). Each tissue sample had the thickness at its centre measured and was 
then placed between two glass slides, with sufficient corresponding testing fluid 
to completely surround the sample within the slides, and photographed 
alongside a reference distance of 10 mm from a height of 200 mm above the 
top surface of the slides, as described in Figure 9-2(b). This enabled calculation 
of the sample width, 𝐿= (m), via acquisition of the pixel length of the sample 
width using image analysis software (ImageJ, National Institutes of Health, 
Maryland, USA), as illustrated in Figure 9-2(c), and conversion into length in 
metres by inputting into: 
 𝐿= = Á𝐿=9 ∗ 0.01	𝑚𝐿³9 Â 
(9-1) 
where 𝐿=9 is the sample width in pixels, 𝐿³9 is the image length of the reference 
distance in pixels, and 0.01 m is the chosen reference distance.  
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Figure 9-2: Shrinkage/Expansion test: (a) shape of tissue sample, taken from the head 
of the dumbbell cut-outs from the uniaxial testing; (b) a tissue sample held between two 
slides alongside reference measurements for image acquisition and analysis; (c) 
schematic of photo acquisition setup. 
After this, each sample was immersed in 300 ml of the corresponding testing 
fluid contained within a plastic box, and kept at a room temperature of 25 °C. 
Further photos were taken after 25, 50 and 150 hours. These photos were then 
analysed using the same method as described above, to ascertain the width of 
each sample at each time point, to see whether any shrinkage or expansion of 
the GA fixed pericardium had occurred. The change in width of each sample, ∆𝐿 
(%), was defined as: 
 ∆𝐿 = 𝐿? − 𝐿?𝐿?  ∗ 100 
(9-2) 
 250 
where 𝐿? was the sample width after immersion in a fluid after 𝑡 hours (m) and 𝐿? was the initial sample width before immersion (m). After the final immersion 
period, the thickness of tissue was again taken from the centre of each sample. 
The following 5 fluids were investigated: 
• PBS, described in Section 9.1.2.2.1, and used as a control in this 
investigation 
• The 𝜂 solution described in Section 9.1.2.2.2 
• A solution of 43.5 % KI and 56.5 % deionised and filtered water (by 
weight), used during PIV investigations in order to raise the RI of the fluid 
to reduce optical distortion of the acquired image pairs for cross 
correlation107,250 (RI solution)  
• The	𝜂-RI solution described in Section 9.1.2.2.3 
• Pure glycerol, to further investigate the effects of glycerol in the absence 
of water, due to previous reports of glycerol potentially affecting the 
properties of pericardial tissue240,241. 
9.1.2.4 Uniaxial Testing 
9.1.2.4.1 Uniaxial Testing Rig 
The uniaxial testing rig (BT1-FR5.0TN, Zwick Roell Group, Ulm, Germany) 
consisted of two grips, with coapting face surfaces of 30 x 45 mm, arranged 
vertically, holding either end of a tissue sample being tested, as shown in 
Figure 9-3(a). The upper grip was servo controlled and attached to a 0.5 kN 
loading cell (KAP-TC, Zwick Roell Group, Ulm, Germany), measuring the force 
applied to the tissue through the grip. An open liquid container was positioned 
around the sample and grips, submersing the sample in a user chosen solution 
throughout the testing procedure. The temperature of this solution was 
monitored and controlled by a low temperature thermostat (E300 Ecoline, 
Lauda Brinkmann, New Jersey, USA), with resolution 0.05 °C. This fluid could 
be drained and refilled with the sample still loaded between the grips, enabling 
testing of multiple fluids without altering the sample’s fixation. Upon starting the 
test, the upper grip moved away from the lower grip at a rate defined from the 
attached software (TestXpert II, Zwick Roell Group, Ulm, Germany), and the 
force exerted on and the displacement of the upper grip were recorded at  
sampling rate of 10 Hz. 
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Figure 9-3: Tensile testing of tissue: (a) Uniaxial testing rig: 
1 – Upper clamp; 2 – Lower clamp; 3 – Acetate loader (highlighted in white, snipped 
along dashed lines); 4 – Tissue sample; 5 – Thermostat; 6 – Fluid reservoir; (b) critical 
dimensions and fibre alignment of dumbbell shape tissue samples. Thickness 
measurements are taken at each location marked by •; (c) acetate sample loader – the 
central double dashed line is cut before the sample is placed on top of the acetate, 
whilst the single dashed outside lines are cut once both uniaxial rig clamps have been 
tightened onto the ends of the sample. 
 
9.1.2.4.2 Tissue Samples 
The pericardial tissue being investigated was cut by a punch into a dumbbell-
shape with a central section of 12 mm length and 2 mm width, in accordance 
with type 4 test sample dimensions as recommended by ISO 37-2011285, 
illustrated in Figure 9-3(b). Samples were cut so that the extracellular matrix 
fibres were running close to a 45 ° angle across the tissue for each sample, in 
order to represent both parallel and perpendicular fibre alignments. Samples 
were chosen with fibre distribution and orientation as uniform as possible, in 
order to obtain more uniform stress and strain distributions217,286. The thickness 
of each sample was measured at three locations, as indicated in Figure 9-3(b), 
with a thickness gauge (Mitutuyo 543-402BS, Sakado, Japan) with resolution 
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0.01 mm, and then averaged to produce an average cross-sectional area for 
each sample. 
9.1.2.4.3 Uniaxial Testing Procedure 
In order to overcome the limitations associated with the large variabilities of 
tissue properties, 7 samples of GA-foxed bovine tissue and 7 samples of GA-
fixed porcine tissue were tested before and after 24 hours of immersion in one 
of the test fluids, to assess variations to the mechanical properties, and this was 
repeated for each of the test fluids. The fluid reservoir of the uniaxial rig was 
filled with the first of the fluids under investigation, which were tested in the 
following order: 
1. PBS 
2. 𝜂 solution 
3. 𝜂-RI solution 
The tissue samples were tested individually and loaded onto the uniaxial tensile 
rig via the use of an acetate loading template, displayed in Figure 9-3(c). The 
central sprue of the template was cut in half before the wet tissue sample was 
placed on top of the template, positioned so that the central portion of the 
dumbbell aligned with the central portion of the template. With the wet tissue 
adhered to the acetate and the uniaxial grips set 12.0 mm apart, the assembly 
was clamped into the rig, so that the central portion of the dumbbell was 
between the two grips. The fluid container was filled so that it covered the tissue 
sample, releasing the tissue from the acetate and, as the density of the fluid is 
close to that of the tissue, reducing the pre-stressing of the samples by gravity. 
The outside sprues of the acetate template were then cut, resulting in the 
configuration shown in Figure 9-3(a) where only the tissue sample is connected 
between the two grips. Once the temperature of the fluid bath had stabilised at 
the designated level, the force sensors were zeroed. A pre-load, 𝐹9 (N), was 
applied, mitigating any differences caused by slight variations in the loading 
procedure286, applying a stress of 50 kPa across the tissue. 𝐹9 was determined 
by applying the equation: 
 𝐹9 = 50,000	𝑃𝑎 ∗ 𝐴4= 
(9-3) 
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where 𝐴4= is the cross-sectional area (m2) of the central portion of the unloaded 
dumbbell for each tissue sample. With the pre-load applied to the tissue, the 
force sensors were zeroed again, and the displacement was set as zero. The 
uniaxial testing schedule is illustrated in Figure 9-4. 
 
Figure 9-4: Strain magnitude and timing of uniaxial tests. After filling the fluid reservoir 
with PBS and loading the tissue, each sample was gradually brought to testing strain 
(A), and then cycled at testing strain until the stress at testing strain was constant (B) 
and 10 cycles of stress-strain data were acquired (C). The sample was then left 
submerged in PBS for 24 hours (i), after which the sample was conditioned with 10 
cycles at testing strain, and then had 10 cycles of stress-stain data acquired (D). The 
reservoir was then drained of PBS and refilled with the 𝜂 solution (40 % glycerol and 60 
% PBS) (ii), the sample was conditioned, and another 10 cycles of stress-strain data 
were acquired (E). The sample was left in the 𝜂 solution for 24 hours (iii), followed by 
sample conditioning and data acquisition (F). The reservoir was drained of the 𝜂 
solution and refilled with the 𝜂-RI solution (glycerol, KI, and deionised water) (iv), 
followed by tissue conditioning and data acquisition (G). The sample was left 
submerged in the 𝜂-RI solution for 24 hours (v), after which the tissue was again 
conditioned followed by 10 cycles of stress-strain data acquisition (H). 
Testing strain was determined as 0.25, equivalent to a 3 mm extension of the 
12 mm length of the tissue dumbbell within the two grips, chosen because the 
maximum physiological strain of leaflet tissue is reported as 0.25287, and this 
level of strain is sufficient to assess both the low stretch modulus (𝐸6) and high 
stretch modulus (𝐸7) of the tissue288, at a strain rate of 0.008 /s288. Each sample 
was gradually brought to this testing strain of 0.25 over 4 x 10 cycles, with each 
block of 10 cycles peaking at a maximum strain of 0.18, 0.21, 0.23 and 0.25 
respectively. In order to ensure uniformity of the tissue’s strain response to the 
applied force, the tissue was repeatedly cycled up to the testing strain of 0.25, 
until the force necessary to produce this maximum strain was constant (± 0.5%) 
for 10 cycles. Ten cycles up to this strain were run, and the force and 
displacement throughout each cycle was acquired and recorded. The sample 
was then left in the clamps submersed in PBS for a 24-hour period. The force 
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sensors were not zeroed at this point, in order to indicate whether a shrinkage 
or expansion of the tissue had taken place during the 24-hour time span, 
indicated by a positive or negative force respectively at a strain of zero. The 
tissue samples were pre-conditioned for 10 cycles at testing strain before data 
acquisition of 10 cycles. The reservoir was then drained of saline and refilled 
with the next fluid, the 𝜂 solution of 40 % glycerol and 60 % saline, with the 
sample still in place between the grips throughout the fluid change. This was 
followed by a re-zeroing of the force sensors, necessary due to the change in 
fluid density altering the buoyant forces acting upon the top grip. Another 10 
cycles of pre-conditioning at testing strain were carried out, followed by the 10 
cycles of data acquisition, followed by a 24-hour period of tissue exposure, then 
data acquisition as for the saline. This process was then repeated one last time 
for the 𝜂-RI solution of KI, glycerol, and deionised water. 
9.1.2.4.4 Identification of Elastin and Collagen Regions 
Due to the viscoelastic properties of pericardium, resulting in hysteresis and 
significant relaxation during strain cycles218, the tissue has a different force-
displacement response during loading than unloading. To maintain uniformity 
and enable comparison between data sets, only the loading cycles of the tissue 
were analysed. The sampling of the data acquisition led to measurements being 
recorded at slightly different displacements from cycle to cycle, so it was 
decided to take one sample cycle (the tenth in each block of cycles) rather than 
an average of the 10 cycles. 
The stress acting upon the sample can be calculated from the force 
measurements in several different ways. The nominal stress can be determined 
by basing the calculation upon the original cross-sectional area of the sample, 
whilst the true stress is calculated from the cross-sectional area of the sample 
at the moment of analysis, so that as the sample becomes elongated, the cross-
sectional area will decrease. Cauchy stress, a common form of true stress, is a 
symmetric tensor defined by the forces acting on an element of infinitesimal 
area in the deformed body, with the force components and the normal to the 
area having fixed directions in space. Fixing these directions to be defined 
along the material’s direction throughout the deformation, e.g. due twisting or 
bending of the sample, results in Second Piola-Kirchhoff stress. However, use 
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of the current tissue cross-sectional area required estimation of the Poisson 
ratio and lateral contraction of the samples during testing, so removing these 
factors from the calculation of the relative stress of each measurement would 
increase the precision of the result54. Although Engineering Stress may 
underestimate the true stress content of the sample, it is an appropriate quantity 
for comparing tissue properties within a test group54, and has been used for 
many previous soft tissue uniaxial tests278,284,289,290. Accordingly, the force 
applied to the sample, 𝐹? (N), was used to calculate the nominal tensile 
engineering stress, 𝜎? (MPa) across the centre of the sample as follows: 
 𝜎? = 𝐹?𝐴4= ∗ 10Ó 
(9-4) 
Several different types of strain can be measured from the testing. Similarly to 
the stress definitions, the Engineering (or Nominal) Strain is based upon the 
original length of the sample at the start of testing, the True Strain is based 
upon the current length of the sample undergoing a given stress defined 
according to fixed directions in space, and the Lagrange-Green strain, useful for 
geometrically non-linear cases, contains derivatives of the sample 
displacements with respect to the original configuration. In line with the 
selection of Engineering Stress in this investigation, Engineering Strain, 𝜀, was 
used, defined as the ratio between the elongated length, 𝐿 (m), and the original 
length, 𝐿 (m), and calculated by: 
 𝜀 = 𝐿 − 𝐿𝐿  
(9-5) 
In order to relate these results to the J-curve description identified in numerous 
investigations as reported by Aguiari et al218, identification of the elastin phase 
(with a corresponding low stress-strain modulus, 𝐸6), the non-linear transition 
phase (starting at a lower strain of 𝜀6 and ending at a higher strain of 𝜀7), and 
the collagen phase (with high stress-strain modulus, 𝐸7), as shown in Figure 
9-1(a), was necessary. The crossover point of the elastin phase to the transition 
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phase was identified as when the change in the modulus, 𝑇Ô, increases to 0.02, 
as shown in Figure 9-5, with 𝑇Ô calculated according to 
 𝑇Ô = 𝜎Å − 𝜎Å»f𝜎Å  
(9-6) 
where 𝜎Å is the stress (MPa) at the 𝑛th sample of the cycle and 𝜎Å»f is the 
stress (MPa) of the sample before. A linear line of best fit was applied to the 
stress-strain results before this sample, and the gradient of this line was equal 
to the 𝐸6 (in MPa). The strain at this lower transition point was recorded as the 
‘elastin transition strain’, 𝜀6. The collagen region was identified in a similar 
manner to the elastin region, with the region defined when 𝑇Ô decreases to 0.02 
after the transition region, illustrated in Figure 9-5. Once again, a linear line of 
best fit was applied to the stress-strain results within this region, and the 
gradient of this line was equal to the 𝐸7 (in MPa). The strain at this upper 
transition point was recorded as the collagen transition strain, 𝜀7. 
 
Figure 9-5: Identification of Low and High Stretch Regions of soft tissue stress-strain 
response. 
 257 
9.1.3 Results 
9.1.3.1 Shrink/Expansion results 
The average change in width of the tissue samples for each fluid type after 25, 
50 and 150 hours is presented in Table 9-1, with the distribution for each fluid 
after 150 hours shown in box and whisker charts for both bovine and porcine 
pericardium in Figure 9-10. The thickness of the bovine pericardium across all 
samples was measured as 0.31 ± 0.13 mm, whilst the porcine pericardium was 
measured as 0.11 ± 0.06 mm. No change in thickness after immersion 
exceeded ± 0.02 mm, with no observable trend of increase or decrease in 
thickness. No change in width exceeded 1 % for any of the fluids or tissue 
types, but the 100 % glycerol resulted in an expansion between 0.28 and 0.63 
% for both GA fixed bovine and porcine pericardium.  
Fluid 
Time in solution 
(hours) 
Mean change in width (%) 
Porcine Bovine 
Buffered 
Saline 
25 -0.12 +0.07 
50 -0.22 -0.33 
150 +0.13 +0.11 
40 % Glycerol 
25 -0.14 -0.07 
50 -0.09 -0.06 
150 -0.90 -0.01 
RI Solution 
25 -0.44 -0.02 
50 -0.16 -0.07 
150 -0.09 -0.12 
RI and 𝜂 
Solution 
25 -0.26 -0.04 
50 -0.38 -0.09 
150 -0.12 -0.07 
100 % 
Glycerol 
25 +0.28 +0.63 
50 +0.32 +0.57 
150 +0.42 +0.43 
Table 9-1: Change in size of tissue samples after exposure to different testing fluids 
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Observationally, it was noticed that the 100 % glycerol solution also resulted in 
the pericardial tissue becoming more translucent than before the fluid exposure, 
as presented in Figure 9-6. 
 
Figure 9-6: Pre- (a) and Post- (b) 150-hour exposure of GA fixed porcine pericardium 
to pure glycerol. 
9.1.3.2 Uniaxial Results 
The average thickness of the uniaxial GA fixed bovine samples was 0.29 ± 0.07 
mm, with an initial - i.e. after pre-conditioning but at the start of exposure to the 
buffered saline - 𝐸6 of 1.93 ± 5.69 MPa with an average R2 value of 0.941 ± 
0.057 for the line of best fit, and an initial 𝐸7 of 76.40 ± 28.67 MPa (R2 value of 
0.993 ± 0.008). The average transition phase between the LSM and HSM for 
the bovine tissue samples occupied a strain period of 0.0717 ± 0.0337. A plot of 
the stress-strain during a typical loading cycle of a tissue sample is presented in 
Figure 9-7. 
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Figure 9-7: Stress-strain data from uniaxial test. Data taken from loading cycle of GA 
Fixed Bovine Pericardium submersed in buffered saline for 0 hours. The transition 
points from linear elastin to transition and from transition to linear collagen are derived 
in terms of strain from data analysis as detailed in Section 9.1.2.4.4, and then a line of 
best fit is applied to each set of data within the two linear region, the gradient of which 
is equal to the modulus of the tissue in that region 
The GA fixed porcine samples were thinner, with an average thickness of 0.12 ± 
0.02 mm. 𝐸6 after initial precondition was 2.24 ± 0.76 MPa (R2 value of 0.940 ± 
0.076) whilst 𝐸7 was 81.37 ± 19.46 MPa (R2 value of 0.996 ± 0.036). The 
average transition phase between the LSM and HSM occupied a strain range of 
0.0876 ± 0.0374. 
The mean values and changes to 𝐸6, 𝐸7, 𝜀6 and 𝜀7 after the samples were 
submerged in the three solutions are presented in Table 9-2, and box and 
whisker plots of these changes, showing the statistical variation across the 7 
samples tested for each tissue type, is illustrated in Figure 9-8 and Figure 9-9 
for the bovine and procine results respectively.  
The 𝐸6 of the tissue samples had the greatest relative variation of the 4 
measured parameters after exposure to the fluids, decreasing by up to 0.293 
MPa (12.89 %) after 24 hours exposure to the glycerol, KI, and water solution, 
and by up to 0.105 MPa (9.19 %) in the buffered saline, showing a trend of 
decreasing 𝐸6 for both bovine and porcine GA fixed pericardium. However, both 
tissue types appeared to stiffen after exposure to the 40 % Glycerol solution, 
especially the porcine pericardium, which displayed an average change in 
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modulus of 0.145 MPa, a 6.52 % increase. None of the average transition 
strains between the linear elastin region and the transition phase changed by 
more than 3.9 % after solution exposure. For the collagen region, no 𝐸7 
changed by more than 1.337 MPa (1.56 %) across all the tests, and the 𝜀7 
remained within a strain of 0.0011 (a change of 0.93 %). 
 
Figure 9-8: Changes in stiffness of GA Fixed Bovine Pericardium. Box and whisker 
charts for the change in size of tissue samples after 24 hours exposure in the various 
testing fluids. For each fluid, the mean value is represented by an ‘X’, the median value 
by the central line, the box plot is bounded by the upper and lower quartiles, and the 
extremes of the whiskers are bound by the inter-quartile range from the median value. 
 
Figure 9-9: Changes in stiffness of GA Fixed Porcine Pericardium. Box and whisker 
charts for the change in size of tissue samples after 24 hours exposure in the various 
testing fluids. For each fluid, the mean value is represented by an ‘X’, the median value 
by the central line, the box plot is bounded by the upper and lower quartiles, and the 
extremes of the whiskers are bound by the inter-quartile range from the median value. 
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Table 9-2: Uniaxial testing results. Results for GA fixed bovine and porcine pericardium 
after 24 hours exposure to each of 3 solutions – buffered saline, 40 % glycerol (𝜂), and 
glycerol/KI/deionised water (RI and 𝜂) - given as the absolute value before and after 24 
hours’ immersion in each fluid, the absolute value change (with standard deviation 
across all sample results), and the relative value change, expressed as a percentage. 
9.1.4 Discussion 
As no shrink/expansion test resulted in an average change of more than 0.9 % 
(and no individual sample had a change above 1.6 % for any time period) after 
150 hours of submersion in the various solutions, as presented in Figure 9-10, it 
can be reasonably expected that any changes to the size of the tissue in the 
valve due to exposure to these solutions would not be large enough to cause 
significant changes to the functioning of the valves, such as a reduction in 
leaflet coaptation or increased stress on the stent attached to the leaflets. 
Property Buffered Saline 𝜂 RI and 𝜂 
Bovine Porcine Bovine	 Porcine	 Bovine Porcine 
EÖ 
(MPa) 
0 hr 
24 hr ∆EÖ 
% change 
1.931 2.243 1.691 2.170 1.739 2.523 
1.825 2.054 1.694 2.315 1.162 2.230 
-0.105 
(0.088) 
-0.189 
(0.115) 
+0.004 
(0.112) 
+0.145 
(0.299) 
-0.126 
(0.104) 
-0.293 
(0.221) 
-9.19 % -8.33 % +1.64 % +6.52 % -8.60 % -12.89 % 
εÖ 
0 hr 
24 hr ∆εÖ 
% change 
0.1247 0.1300 0.1248 0.1279 0.1237 0.1321 
0.1209 0.1285 0.1259 0.1300 0.1224 0.1298 
-0.0038 
(0.0045) 
-0.0015 
(0.0040) 
+0.0011 
(0.0060) 
+0.0021 
(0.0052) 
-0.0013 
(0.0022) 
-0.0023 
(0.0025) 
-3.88 % -0.95 % +2.63 % +1.72 % -1.86 % -1.90 % 
εØ 
0 hr 
24 hr ∆εØ 
% change 
0.1964 0.2176 0.1983 0.2174 0.1987 0.2159 
0.1975 0.2182 0.1988 0.2169 0.1994 0.2161 
+0.0011 
(0.0023) 
+0.0006 
(0.0020) 
+0.0005 
(0.0009) 
-0.0005 
(0.0025) 
+0.0007 
(0.0012) 
+0.0001 
(0.0006) 
+0.93 % +0.28 % +0.49 % -0.21 % +0.33 % +0.06 % 
EØ 
(MPa) 
0 hr 
24 hr ∆EØ 
% change 
76.40 81.37 76.77 80.45 77.10 79.30 
77.06 81.28 78.11 80.68 77.66 80.37 
+0.65 
(1.934) 
-0.087 
(0.901) 
+1.34 
(2.167) 
+0.234 
(0.106) 
+0.557 
(2.134) 
+1.06 
(1.112) 
+0.89 % -0.05 % +1.56 % +0.31 % +0.85 % +1.28 % 
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However, it is interesting to note that the 100 % glycerol appeared to cause a 
slight swelling of the tissue in almost all cases, as well as causing the tissue to 
lose its opacity, as shown in Figure 9-6. 
 
Figure 9-10: Box and whisker charts for the change in size of tissue samples after 150 
hours exposure in the various testing fluids. For each fluid, the mean value is 
represented by an ‘X’, the median value by the central line, the box plot is bounded by 
the upper and lower quartiles, and the extremes of the whiskers are bound by the inter-
quartile range from the median value. 
The indications of the uniaxial experiments are that the effect of the fluids used 
during in vitro testing of bioprosthetic valves upon the stiffness of GA fixed 
porcine and bovine pericardial tissue is mainly confined to the elastin phase of 
deformation. Solutions of buffered phosphate saline, commonly used in the 
storage and testing of these devices, and a solution comprising glycerol, KI, and 
water, used to match the viscosity of the blood analogue used in testing to that 
of blood at high shear whilst also reducing PIV image artefacts via RI matching 
of the testing chamber and the fluid, both reduced the stiffness of the tissue by 
8 – 13 % over a 24-hour period, a decrease in the modulus of the tissue of 0.1 – 
0.3 MPa. This was observed for almost all of the samples to some degree as 
shown by the diagrams for 𝐸6 in Figure 9-8 and Figure 9-9, with just one of the 
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bovine samples showing an increase in stiffness of any magnitude. This 
reduction in stiffness could also be due to viscoelastic effects and 
microstructural reorganisation of collagen fibres away from the direction of the 
load291. 
Conversely, exposure of the tissues to a solution of 40% glycerol and 60 % 
buffered phosphate saline (by weight) indicated a stiffening of the samples on 
average, by 1.64 % (0.0035 MPa) for the bovine tissue and 6.52 % (0.145 MPa) 
for the porcine tissue. However, unlike the loosening effect observed for the 
other two solutions, consideration of the results for individual samples reveals 
that while most samples were stiffened after the exposure, others were 
loosened by up to 10.7 % for the bovine tissue and 15.0 % for the porcine 
tissue, making the overall average values obtained less compelling. 
The maximum average change of high stress tissue stiffness, described by 𝐸7, 
of 1.56 % across the different fluids is not sufficient to cause any major 
deviations in the response of the tissue to the flows during the in vitro 
experiments undertaken during the research for this thesis. Similarly, the 
change to the beginning or end to strain range of the transition phase (𝜀6 and 𝜀7 
respectively) of the tissue after 24-hour exposure to the various fluids did not 
exceed 3.9 %. In addition, these three parameters delivered both positive and 
negative changes to the recorded values at the start of testing for both tissue 
types and all fluids, suggesting that any effect caused by the solutions was 
within experimental variability, making conclusive statements about mechanical 
characteristic alteration unwise. Instead, it can be said that any changes to the 
3 parameters discussed here,	𝐸6, 𝜀6 and 𝜀7, as a result of up to 24-hours 
exposure to the testing fluids to be used in the ensuing experiments would not 
result in functional differences to the response of the pericardial tissue between 
the start and end of testing. 
Although these findings indicate that the mechanical characteristics of the GA 
fixed pericardial tissue is altered within low stress environments after exposure 
to the common testing fluids presented, the changes within the expected 
lifetime of the tests planned for this thesis keep the 𝐸6 well within the expected 
range encountered both during this test and in the literature218. Due to the 
variability of the mechanical properties of both GA fixed- and native- pericardial 
tissue, a change of 0.3 MPa within a range of 1.93 ± 5.96 MPa or 2.24 ± 0.76 
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MPa (the measured range of 𝐸6 for bovine and porcine GA fixed pericardium in 
this experiment) will not significantly alter the mechanical response of the tissue 
in comparison to another piece of tissue. In other words, the tissue will still 
respond to low stresses after 24-hours submersed in one of the testing fluids in 
a similar way to another piece of tissue that has not been exposed. 
However, the consistent stiffening of the porcine and bovine GA fixed 
pericardium after exposure to glycerol, alongside the slight expansion and 
translucent effect caused by the 100 % glycerol solution in the shrink/expansion 
test, indicates that glycerol does alter the mechanical characteristics of GA fixed 
bovine and porcine pericardial tissue over time, as previously indicated in the 
literature240,241, even if it does not do so to a valve-function altering extent 
during the lifetime of these experiments. Further investigation of the long-term 
effect of glycerol upon GA fixed pericardial tissue could elucidate further detail 
on the alterations, and storage of bioprosthetic valves with GA fixed pericardial 
leaflets in glycerol is to be avoided until the effects of the chemical can be 
clarified. 
9.1.4.1 Limitations 
The results presented in this chapter are based on some assumptions and 
limitations that need to be addressed in order to ensure that the conclusions 
above are taken in the correct context. Firstly, in order to simplify the analysis, 
the cross-sections of the tissue samples were assumed to be a uniform 
rectangular shape, with 2 sides equal to the average thickness of each sample 
and 2 sides equal to 2.0 mm, the intended width of the central strip of the 
dumbbell. However, these values may not be uniform along the strip of tissue, 
and furthermore this cross-section will be altered in accordance to Poisson’s 
ratio as the sample is extended and unloaded. Stress concentrations at the grip 
edges will have been reduced by use of a dumbbell shaped tissue sample290, 
but it is not expected that their effect was completely eliminated from the 
experiment. In addition, although the tissue samples were cut with an attempt to 
broadly keep the fibre alignment at 45 ° through the sample, this was not 
completely achievable due to the variation of fibre alignment in every sheet of 
GA fixed pericardial tissue. 
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However, as the intent of this experiment was to observe relative mechanical 
differences to the tissue samples before and after exposure to the various 
testing fluids investigated, these limitations do not fundamentally affect the 
findings. 
9.1.5 Concluding Remarks 
In this chapter, GA fixed bovine and porcine pericardial tissue, used in both 
surgical and transcatheter bioprosthetic heart valves, was uniaxially tested 
before and after 24-hour exposure to 3 solutions used during in vitro testing, in 
order to determine whether these fluids would affect the mechanical 
characteristics of the tissue leaflets during the testing procedure, making 
comparison between a setup used at the start of testing and a setup used at the 
end of testing problematic. It was concluded that the high stretch modulus and 
transition phase of both tissues are negligibly affected by all of the fluids during 
a testing time period, and that the low stretch modulus may be altered, but, if 
so, the mechanical properties of the tissue at low stress remain representative 
of the tissue type, and should not functionally change the fluid dynamics 
resulting from the bioprosthetic valve. It was also concluded that the tissue 
would not undergo significant shrinkage or expansion during the benchtop 
studies of the valves. 
Accordingly, it was decided that these three solutions, buffered phosphate 
saline, 40 % glycerol/ 60 % buffered saline, and a combination of KI, glycerol, 
and deionised and filtered water, could be used during in vitro experiments 
where the required testing procedure did not require the valves to be 
submersed in the testing fluid for a period of more than 24 hours. As none of 
the subsequent investigations are expected to require the bioprosthetic valves 
to be in the pulse duplicator for more than 24 hours in total, it can be confirmed 
that Glycerol and Potassium Iodide, chemicals used to alter the properties of 
fluids used during in vitro tests upon heart valves, do not significantly alter the 
stiffness of the porcine or bovine pericardial tissue of the valves during the 
lifetime of the test.  
As the experiments for Chapter 4, Physiological Vortices in the Sinuses of 
Valsalva, had already necessarily commenced before the investigation 
described in this chapter could be concluded, due to the time constraints of the 
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PhD programme, the use of glycerol, previously indicated by the literature to 
have an effect upon the GA fixed pericardial tissue, was omitted, meaning the 
blood analogue did not have a dynamics viscosity similar to that of blood at high 
shear. Accordingly, the blood analogue used consisted of deionised water and 
KI in a 100:77 ratio by weight, in order to raise the RI of the fluid to reduce 
image distortions due to the non-orthogonal interface of silicone mock aortic 
root and blood analogue. However, the benchtop experiments of Chapters 5 
and 6 did incorporate the findings of this chapter, and the fluid used in these 
experiments could match both the RI of the silicone mock aortic root and the 
viscosity of blood at high shear. 
 
9.2 Additional PIV images from 
Physiological Vortices in the Sinuses of 
Valsalva 
 
Figure 9-11: RSS contour maps for the physiological root configuration. 
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Figure 9-12: Vorticity contour maps for the physiological root configuration. 
 
Figure 9-13: Standard Deviation contour maps for the physiological root configuration. 
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Figure 9-14: RSS contour maps for the optimal surgical root configuration. 
 
Figure 9-15: Vorticity contour maps for the optimal surgical root configuration. 
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Figure 9-16: Standard Deviation contour maps for the optimal surgical root 
configuration. 
 
Figure 9-17: RSS contour maps for the sinusless root configuration. 
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Figure 9-18: Vorticity contour maps for the sinusless root configuration. 
 
Figure 9-19: Standard Deviation contour maps for the sinusless root configuration. 
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Figure 9-20: RSS contour maps for the oversized/dilated root configuration. 
 
Figure 9-21: Vorticity contour maps for the oversized/dilated root configuration. 
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Figure 9-22: Standard Deviation contour maps for the oversized/dilated root 
configuration. 
 
Figure 9-23: RSS contour maps for the sub-annular root configuration. 
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Figure 9-24: Vorticity contour maps for the sub-annular root configuration. 
 
Figure 9-25: Standard Deviation contour maps for the sub-annular root configuration. 
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Figure 9-26: RSS contour maps for the mechanical root configuration. 
 
Figure 9-27: Vorticity contour maps for the mechanical root configuration. 
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Figure 9-28: Standard Deviation contour maps for the mechanical root configuration. 
 
Figure 9-29: Velocity contour maps for the mechanical valve configuration, with the PIV 
laser sheet over the cross-section of the root and valve where the valve is at 90 ° 
rotation to that of the orientation shown in Figure 4-16. 
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Figure 9-30: RSS contour maps for the mechanical valve configuration, with the PIV 
laser sheet over the cross-section of the root and valve where the valve is at 90 ° 
rotation to that of the orientation shown in Figure 4-16. 
 
Figure 9-31: Vorticity contour maps for the mechanical valve configuration, with the PIV 
laser sheet over the cross-section of the root and valve where the valve is at 90 ° 
rotation to that of the orientation shown in Figure 4-16. 
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Figure 9-32: Standard Deviation contour maps for the mechanical valve configuration, 
with the PIV laser sheet over the cross-section of the root and valve where the valve is 
at 90 ° rotation to that of the orientation shown in Figure 4-16. 
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9.3 Additional PIV images from Does 
Transcatheter Aortic Valve Alignment 
Matter? 
 
Figure 9-33: RSS contour maps for the TA1 configuration. 
 
Figure 9-34: Vorticity contour maps for the TA1 configuration. 
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Figure 9-35: Standard Deviation contour maps for the TA1 configuration. 
 
Figure 9-36: RSS contour maps for the TA2 configuration. 
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Figure 9-37: Vorticity contour maps for the TA2 configuration. 
 
Figure 9-38: Standard Deviation contour maps for the TA2 configuration. 
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Figure 9-39: RSS contour maps for the TA3 configuration. 
 
Figure 9-40: Vorticity contour maps for the TA3 configuration. 
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Figure 9-41: Standard Deviation contour maps for the TA3 configuration. 
 
Figure 9-42: RSS contour maps for the TA4 configuration. 
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Figure 9-43: Vorticity contour maps for the TA4 configuration. 
 
Figure 9-44: Standard Deviation contour maps for the TA4 configuration. 
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9.4 Additional PIV images from The Effect 
of Coronary Arteries upon Post-TAVI 
Flow 
 
Figure 9-45: RSS contour maps for the NoCA configuration. 
 
Figure 9-46: Vorticity contour maps for the NoCA configuration. 
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Figure 9-47: Standard Deviation contour maps for the NoCA configuration. 
 
Figure 9-48: RSS contour maps for the LCA configuration. 
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Figure 9-49: Vorticity contour maps for the LCA configuration. 
 
Figure 9-50: Standard Deviation contour maps for the LCA configuration. 
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Figure 9-51: RSS contour maps for the RCA configuration. 
 
Figure 9-52: Vorticity contour maps for the RCA configuration. 
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Figure 9-53: Standard Deviation contour maps for the RCA configuration. 
 
Figure 9-54: RSS contour maps for the NCA configuration. 
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Figure 9-55: Vorticity contour maps for the NCA configuration. 
 
Figure 9-56: Standard Deviation contour maps for the NCA configuration. 
